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A B S T R A C T
Background
Given the significant impact epilepsy may have on the health-related quality of life (HRQOL) of individuals with epilepsy and their families,
there is increasing clinical interest in evidence-based psychological treatments, aimed at enhancing psychological and seizure-related
outcomes for this group.
This is an updated version of the original Cochrane Review published in Issue 10, 2017.
Objectives
To assess the impact of psychological treatments for people with epilepsy on HRQOL outcomes.
Search methods
For this update, we searched the following databases on 12 August 2019, without language restrictions: Cochrane Register of Studies
(CRS Web), which includes randomized or quasi-randomized controlled trials from the Specialized Registers of Cochrane Review Groups
including Epilepsy, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid, 1946 to 09 August 2019), and PsycINFO
(EBSCOhost, 1887 onwards), and from PubMed, Embase, ClinicalTrials.gov, and the World Health Organization International Clinical Trials
Registry Platform (ICTRP). We screened the references from included studies and relevant reviews, and contacted researchers in the field
for unpublished studies.
Selection criteria
We considered randomized controlled trials (RCTs) and quasi-RCTs for this review. HRQOL was the main outcome. For the operational
definition of 'psychological treatments', we included a broad range of skills-based psychological treatments and education-only
interventions designed to improve HRQOL, seizure frequency and severity, as well as psychiatric and behavioral health comorbidities for
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adults and children with epilepsy. These psychological treatments were compared to treatment as usual (TAU), an active control group
(such as social support group), or antidepressant pharmacotherapy.
Data collection and analysis
We used standard methodological procedures expected by Cochrane.
Main results
We included 36 completed RCTs, with a total of 3526 participants. Of these studies, 27 investigated skills-based psychological interventions.
The remaining nine studies were education-only interventions. Six studies investigated interventions for children and adolescents, three
studies investigated interventions for adolescents and adults, and the remaining studies investigated interventions for adults. Based on
satisfactory clinical and methodological homogeneity, we pooled data from 11 studies (643 participants) that used the Quality of Life in
Epilepsy-31 (QOLIE-31) or other QOLIE inventories (such as QOLIE-89 or QOLIE-31-P) convertible to QOLIE-31. We found significant mean
changes for the QOLIE-31 total score and six subscales (emotional well-being, energy and fatigue, overall QoL, seizure worry, medication
eBects, and cognitive functioning). The mean changes in the QOLIE-31 total score (mean improvement of 5.23 points, 95% CI 3.02 to 7.44; P
< 0.001), and the overall QoL score (mean improvement of 5.95 points, 95% CI 3.05 to 8.85; P < 0.001) exceeded the threshold of minimally
important change (MIC: total score: 4.73 points; QoL score: 5.22 points), indicating a clinically meaningful postintervention improvement
in HRQOL. We downgraded the certainty of the evidence provided by the meta-analysis due to serious risks of bias in some of the included
studies. Consequently, these results provided moderate-certainty evidence that psychological treatments for adults with epilepsy may
enhance overall HRQOL.
Authors' conclusions
Implications for practice: Skills-based psychological interventions improve HRQOL in adults and adolescents with epilepsy. Adjunctive use
of skills-based psychological treatments for adults and adolescents with epilepsy may provide additional benefits in HRQOL when these
are incorporated into patient-centered management. We judge the evidence to be of moderate certainty.
Implications for research: Investigators should strictly adhere to the CONSORT guidelines to improve the quality of reporting on their
interventions. A thorough description of intervention protocols is necessary to ensure reproducibility.
When examining the eBectiveness of psychological treatments for people with epilepsy, the use of standardized HRQOL inventories, such
as the Quality of Life in Epilepsy Inventories (QOLIE-31, QOLIE-31-P, and QOLIE-89) would increase comparability. Unfortunately, there is
a critical gap in pediatric RCTs and RCTs including people with epilepsy and intellectual disabilities.
Finally, in order to increase the overall quality of RCT study designs, adequate randomization with allocation concealment and blinded
outcome assessment should be pursued. As attrition is oFen high in research that requires active participation, an intention-to-treat
analysis should be carried out. Treatment fidelity and treatment competence should also be assessed. These important dimensions, which
are related to 'Risk of bias' assessment, should always be reported.
P L A I N   L A N G U A G E   S U M M A R Y
Psychological treatments for people with epilepsy
Review question
In this Cochrane Review, we wanted to find out if the well-being (quality of life) of people with epilepsy could be improved by participation
in educational or skills-based psychological therapies.
Why is this important?
Epilepsy is a brain-condition in which sudden bursts of intense electrical activity happen in the brain and cause the brain's messages to
get mixed up, resulting in a seizure. Seizures aBect people in diBerent ways: they may cause unusual sensations, movements or feelings,
loss of awareness, falls, stiBness or jerking. Epileptic seizures can occur repeatedly and without any triggers. Seizures can happen anytime
and anywhere; they can come on suddenly and can happen oFen.
Epilepsy can significantly impact a person’s wellbeing and quality of life. For instance, many people with epilepsy experience depression
and anxiety, memory problems, unemployment and discrimination, adverse side eBects from medications, challenges to independence
and worries about seizures and their consequences.
Treatments for epilepsy typically focus on stopping or reducing the number of seizures a person has with as little side eBects as possible.
However, psychological therapies, usually delivered by psychologists, psychiatrists or other healthcare professionals could improve well-
being in people with epilepsy.
What did we do?
Psychological treatments for people with epilepsy (Review)
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On 12 August 2019, we searched research databases for studies that measured the eBects of psychological therapy oBered to people with
epilepsy on their quality of life. We found 36 studies, which involved 3,526 people with epilepsy. Participants of most studies were adults
(27 studies); only three studies included adolescents and adults, and six involved children and adolescents.
Most studies (27) measured the eBects of “skills-based” psychological therapies. These treatments teach people skills they can use in their
daily lives. The treatment approaches of skills-based therapies included: cognitive behavioral therapy (CBT) including CBT techniques such
as breathing, reasoning or visualizing; counseling; and exercises in mindfulness. The other nine studies measured educational therapies.
These treatments aimed to increase people’s knowledge of epilepsy and related conditions, treatments for epilepsy, or about how the
brain works. The studies compared the eBects of the psychological therapies with a person's usual care, antidepressant medicines or social
support.
The 36 studies had diBerent designs and assessed people's quality of life using diBerent scales, so we couldn't compare them all. However,
we were able to compare the results of 11 studies of skills-based therapies because they used the same scale to assess quality of life.
What did we find?
The 11 studies (involving 643 adults and adolescents) were conducted in Europe (3 studies), the USA (4), Hong Kong (2), Mexico (1) and
Australia (1). People in the studies were followed and assessed from 12 weeks to 2 years.
The 11 studies measured diBerent aspects of quality of life. People received skills-based psychological therapies reported better quality of
life overall than those who received usual care (8 studies), social support (2) or antidepressant medicines (1).
Ten of these 11 studies also looked at subscales of the quality of life questionnaires to assess specific aspects of quality of life. People in
these studies reported better results on the six subscales, - emotional well-being, energy and fatigue, overall well-being, seizure worries,
medication eBects, and social function, which are combined to calculated overall quality of life.
Key messages
We concluded that skills-based psychological therapies may improve well-being (quality of life) in adults and adolescents with epilepsy.
We are moderately confident in our result from these 11 studies of psychological therapies in people with epilepsy. We believe that more
studies on this specific outcome of quality of life would be unlikely to change our findings.
This review is current up to 12 August 2019.
Psychological treatments for people with epilepsy (Review)








































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Psychological treatments compared with usual or supportive care
Psychological treatments compared with usual or supportive care
Patient or population: adolescents and adults with epilepsy
Setting: outpatient clinic or outpatient clinic and by phone or in-home sessions and by phone
Intervention: skills-based psychological interventions
Comparison: wait-list control (WLC), usual care (UC) or supportive care (SC) or antidepressant drug treatment
Comparative effect sizes* (95% CI)Outcomes
Wait-list control, usual














The range of mean change
in the control groups was
−1.9 to 15.96 points.
The range of mean change in the intervention groups was 3.27 to 17.2 points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 5.23 higher (95% CI 3.02 to 7.44 higher)







































































































































































The range of mean change
in the control groups was
−6.23 to 24.95 points.
The range of mean change in the intervention groups was 0.91 to 20.57
points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 4.96 higher (95% CI 0.70 to 9.21 higher)










The range of mean change
in the control groups was
−5.3 to 17.69 points.
The range of mean change in the intervention groups was 0.44 to 18.75
points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 5.25 higher (95% CI 1.56 to 8.93 higher)









The range of mean change
in the control groups was
−2.63 to 15 points.
The range of mean change in the intervention groups was 0.13 to 19.64
points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 5.95 higher (95% CI 3.05 to 8.85 higher)









The range of mean change
in the control groups was
−5.18 to 17.26
points.
The range of mean change in the intervention groups was 2.74 to 28.56
points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 4.35 higher (95% CI 1.35 to 7.35 higher)










The range of mean change
in the control groups was
−2.71 to 13.17 points.
The range of mean change in the intervention groups was 2.28 to 16.16
points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 4.18 higher (95% CI 1.82 to 6.54 higher)










The range of mean change
in the control groups was
−8.11 to 12.04 points.
The range of mean change in the intervention groups was 0.93 to 6.64 points.
The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 3.16 higher (95% CI 0.01 to 6.32 higher)








The range of mean change
in the control groups was
−4.28 to 13.98 points.








































































































































The pooled mean change from baseline in the intervention groups measured
at postinterventionb was on average 3.09 higher (95% CI -0.17 lower to 6.35
higher) than the control groups
* Comparative effect sizes were calculated from the mean changes between baseline and post-intervention in the intervention and control groups.
CI: Confidence interval; QOLIE: Quality of life in epilepsy; RCT: randomized controlled trial
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.
aRange 0 - 100 points, higher score means higher quality of life.
bThe median postintervention measurement point was 3 months (8 weeks to 2 years).
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B A C K G R O U N D
This review is an update of a review previously published in the
Cochrane Database of Systematic Reviews (2017, Issue 10; Michaelis
2017).
Description of the condition
Epilepsy is defined as the chronic predisposition of the brain
to have recurrent unprovoked seizures. According to the most
recent update of the clinically-oriented definition of epilepsy, the
diagnosis can be made aFer an individual suBers only one reflex
or unprovoked seizure, if further diagnostic test results indicate the
likelihood of a predisposition to recurring seizures (Fisher 2014).
Recent epilepsy definitions also emphasize that epilepsy should
not be conceptualized solely in terms of seizures, as many people
with epilepsy experience associated behavioral, psychological, and
social consequences that form part of their condition (Fisher 2005).
It is estimated that between 0.6% (pediatric) to 1% (adult) of
the world's population have epilepsy, making it one of the most
common neurological conditions (CDC 2012; Russ 2012; WHO 2017).
Aproximately a third to a half of individuals with epilepsy have
drug-resistant seizures (Kwan 2000); even the latest generation
of antiseizure medicines (ASMs) have  failed to increase the
proportion of people with epilepsy who become seizure-free
with drug treatment. Some individuals with drug-resistant
seizures may be eligible for epilepsy surgery (Téllez-Zenteno
2005). However, in cases where surgical treatment options
have been recommended, potential complications of permanent,
significant neurological injury and seizure recurrence need to
be taken into account (Tanriverdi 2009; Téllez-Zenteno 2010;
Wellmer 2012). Furthermore, the other main epilepsy treatments,
surgical resection, neuromodulation (e.g. vagus nerve stimulation,
responsive neurostimulation, and deep brain stimulation) and diet,
fail to control epileptic seizures fully in 10% to 40% of patients (Jehi
2014).
Individuals with epilepsy oFen have lower health-related quality of
life (HRQOL) compared to those with other chronic diseases (Wang
2012). Even a single seizure may be associated with reduced HRQOL
(Modi 2011). This impact is not surprising, given the potential extent
of medical, social, and emotional ramifications of epilepsy. As a
result, it is recommended that the comprehensive management
of epilepsy should go beyond merely managing seizures, and
additionally aim to improve the HRQOL of people with epilepsy
(Jacoby 2008).
Factors contributing to poor HRQOL include medical aspects, such
as seizure frequency and severity (Camfield 2001; Cramer 1999;
Devinsky 1999; Williams 2003), ASM side eBects (Benavente-Aguilar
2004; Gilliam 2004; Loiselle 2016), medication adherence (Wu 2014),
as well as socioeconomic status (Loiselle 2016) and psychological
comorbidities (Loiselle 2016; Ramsey 2016). Notably, psychological
factors, such as distress and loneliness, show robust correlations
with HRQOL, while seizure-related factors appear to be less closely
related (Suurmeijer 2001; Baca 2011). When investigating the
association between medical parameters and HRQOL, ASM side
eBects (Loiselle 2016; Modi 2011; Ramsey 2016; Wu 2014), and the
number of prescribed ASMs have emerged as stronger predictors of
HRQOL than seizure control (Ferro 2013; Ramsey 2016). Individuals
with epilepsy are also at increased risk of psychiatric comorbidities
or psychological diBiculties, which may significantly impact HRQOL
(Selassie 2014; Wagner 2015; Scott 2017). For example, children
and adolescents with epilepsy are at a three- to six-fold increased
risk (21% to 60%) of psychological comorbidities (e.g. attention
deficit hyperactivity disorder [ADHD] and depression [Ott 2001; Ott
2003]), compared to the general population and youth with non-
neurological (Davies 2003; Ekinci 2009; Rutter 1970) or neurological
medical conditions (Wagner 2015).
Epilepsy and psychiatric disorders share a bi-directional
relationship, which has been supported by both population-based
and experimental studies in human and animal models (Chang
2011; HesdorBer 2006; Jones 2013; Kanner 2006; Kanner 2009).
Individuals with a previous history of psychiatric disorders are
four to seven times more likely to develop an unprovoked seizure
or chronic epilepsy, compared to individuals without this history
(HesdorBer 2000; HesdorBer 2006). In a review of seizure incidence
in psychopharmacological clinical trials (N = 75,873), the incidence
of seizures was significantly lower amongst participants who
received antidepressants compared to those receiving placebo
(standardized incidence ratio = 0.48; 95% CI 0.36 to 0.61). The study
concluded that second-generation antidepressants, other than
bupropion, could potentially have apparent anticonvulsant eBects.
In addition, the diagnoses of depression, psychotic disorders,
and obsessive compulsive disorder were associated with reduced
seizure thresholds (Alper 2007). These findings prompted further
research into the role of psychological states in the development
and manifestation of seizures, as well as the potential eBects of
psychological therapy on individuals with epilepsy (Kanner 2006;
Tang 2014).
Psychiatric comorbidity in epilepsy appears to be strongly
associated with psychosocial factors (Gandy 2012). For instance,
the increase in depression and anxiety one year aFer diagnosis of
epilepsy is correlated with the degree to which an individual senses
loss of self-control, rather than the actual number of seizures
(Velissaris 2012). Moreover, HRQOL is correlated with depression
symptoms in epilepsy (Gilliam 2002). Concerns over recurring
seizures may diminish HRQOL, even in individuals with well-
controlled epilepsy (Snyder 1990). These concerns may hamper
psychosocial functioning and the achievement or maintenance
of higher education and employment, despite seizure freedom
(Gilbert 2012). By permeating the individual's sense of self-eBicacy
and consequently decreasing self-confidence, concerns about
seizure recurrence that stem from the perceived unpredictability of
the course of epilepsy can be far more disabling than the seizures
themselves (Stevanovic 2007). Reported depressive symptoms
were also associated with negative coping, suggesting that
interventions targeting negative coping may improve depressive
symptoms in youth with epilepsy (Wagner 2010). Daily routines
and activities of daily living are oFen aBected, including sleep,
work productivity, school, and recreational and sports activities.
This impact on work productivity may incur significant indirect
costs for the wider economy (Larson 2012; Painter 2014). Notably,
the healthcare costs for children with epilepsy in the first year
of diagnosis are approximately USD 20,000 per patient. Seizure
control, side eBects, and HRQOL are strong drivers of healthcare
charges (Ryan 2015; Ryan 2016).
Self- or family-management has been identified as a key
health variable and is broadly defined as encompassing the
personal resources needed to manage a chronic condition in
the context of everyday life. Self-management of adult epilepsy
Psychological treatments for people with epilepsy (Review)









Cochrane Database of Systematic Reviews
has been defined as “activities that an individual can perform
alone that are known to either control frequency of seizures
or promote well-being of the person with seizures” (Dilorio
1992). In pediatric chronic illness, self-management behaviors are
modifiable behaviors linked to influences (e.g. coping responses)
through processes (e.g. allocation of treatment responsibility).
These self-management behaviors and processes operate within
individual, family, community, and healthcare system domains
(Dilorio 1992; Modi 2012; Schilling 2002). Comprehensive evidence
in the Institute of Medicine's Report on Epilepsy supports the
relevance of self-management domains in epilepsy, regardless of
the age at onset, or of the epilepsy type (Institute of Medicine 2012).
An adult self-management instrument has been developed and
published to measure behaviors with psychometrics showing high
internal consistency factor reliability (EscoBery 2015a; EscoBery
2015b). Pediatric self-management instruments are also available,
but have tended to focus on specific aspects of self-management
(Smith 2018).
Description of the intervention
In the treatment of epilepsy, physicians aim to reduce seizures
using ASMs, surgical interventions (including neuromodulation),
or diet treatment. Adjunctive psychological interventions
for individuals with epilepsy provided by a range of
diBerent professionals (including psychologists, psychiatrists,
psychotherapists, nurses and social workers) aim to optimize
HRQOL, and to improve mental health and seizure control.
Given the high prevalence of mental health disorders in the
epilepsy population, and the significant influence epilepsy and
its treatments can have on the HRQOL of individuals with
epilepsy and their families, psychological interventions are
commonly used as an important adjunctive treatment. In addition,
psychological treatments may assist with self-management and
adherence to epilepsy management, which is pivotal to improving
and maintaining health outcomes for people with epilepsy. To
operationalize the definition of 'psychological therapy', studies
reviewed included a broad range of interventions that used
psychological techniques for children and adults with epilepsy.
These interventions can be grouped into two main categories,
according to the opinion of the Psychology Task Force of the
International League Against Epilepsy (ILAE) and based on general
psychotherapy research:
Education-only interventions provide de-individualized facts and
knowledge to the observational learner, while skills-based
psychological interventions (which may involve educational
elements) require an engaged learner who contributes to a
personalized curriculum by applying knowledge for behavioral
change.
1. Skills-based psychological interventions
Skills-based psychological interventions aim to improve HRQOL
by improving the person's use of adaptive coping skills.
These interventions are usually based on at least one theory
of psychotherapy. The specific skills taught can encompass
a broad range of treatment methods and treatment goals.
Even though diBerent psychotherapy theories use diBerent
terminology, therapeutic principles common to many emphasize
the development of a person’s awareness of current feelings
and repeated patterns of behavior followed by the translation of
their enhanced understanding of behavioral patterns into more
eBective functioning (including interpersonal relationships and
processing of emotions) to promote mental health and adjustment
to chronic illness. These interventions are designed to increase
learning, practice, and generalization of adaptive psychological
skills through a variety of psychotherapeutic strategies. However,
at the core of skills-based psychological interventions is the
intention to enhance the practice and adoption of adaptive
psychological skills in the person's everyday life outside of
the intervention session. Skills-based psychological interventions
usually begin with psycho-educational components to justify the
teaching of specific psychological skills. Examples include cognitive
behavioral or behaviorally-based interventions, mindfulness-
based interventions, and other psychotherapeutic methods. The
delivery of skills-based psychological interventions encourages an
empathic and supportive approach from the therapist, inviting
collaboration with the person. Depending on the treatment
goal, certain skills-based psychological interventions can be
focused on self- or family-management interventions or adherence
interventions. Self- or family-management interventions typically
focus on enhancing skills to improve medication-taking, managing
seizure triggers, avoiding certain foods while on the ketogenic diet,
and managing comorbidities associated with epilepsy.
2. Education-only interventions
Educational interventions (including psychoeducation) are defined
as interventions that aim to increase knowledge about epilepsy,
its comorbidities, and its treatments, or the working of the brain.
They may accommodate the opportunity for participants to learn
about certain skills (such as coping skills) but they do not guide
participants through their practice, and do not place emphasis on
incorporating these skills into their daily living.
How the intervention might work
The high level of psychiatric comorbidities in people with
epilepsy has yielded intervention eBorts for both children
and adults. Several studies, with varying approaches,  have
been conducted with the objective of improving mental health
and HRQOL in adults with epilepsy (e.g. Project UPLIFT,
PEARLS [Ciechanowski 2010; Thompson 2010]). For instance,
one approach compared a community-integrated home-based
program (PEARLS) for managing depression in adults with epilepsy
with a usual-care control group. This study found that, over
12 months, the proportion of participants with suicidal ideation
diBered significantly between groups, increasing by 12% in the
control group and decreasing by 24% in the PEARLS group
(Ciechanowski 2010). Compared with participants in the control
group, participants assigned to the intervention group also had less
severe depression.
Another approach is described by Martinović 2006, who delivered
an intervention based on cognitive behavioral therapy (CBT)
to prevent depressive symptoms in youths with epilepsy who
were at risk of depression. Further approaches have attempted
to improve well-being in individuals with epilepsy by using
general stress reduction or tolerance techniques, which aim to
be eBective by reducing psychological stress and its physiological
correlates (Novakova 2013). For example, Tang 2015 developed
a mindfulness-based therapy for participants with drug-resistant
epilepsy. Significantly more participants in the mindfulness-based
therapy group had a clinically important improvement in the
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Quality of Life in Epilepsy Inventory (QOLIE-31) compared to those
in the attention-placebo intervention control group.
Reiter 2009 developed a multi-modal therapy for people with
epilepsy that included biofeedback, relaxation, aura identification,
and behavioral modification. Aura interruption techniques may
also be part of psychological therapy, and allow individuals to learn
new sets of reactions to pre-ictal and early ictal phenomena, which
may decrease fear of recurring seizures and provide a subjective
sense of control (Elsas 2011; Fried 1990; Michaelis 2012). Based
on the bi-directional model of epilepsy and psychological states,
psychological therapy for people with epilepsy can also emphasize
the individuals’ role and participation in the management of
their own condition. Thus, there have also been several programs
aimed at improving coping and self-management of epilepsy
in both youths (Wagner 2010) and adults (DiIorio 2011; Gandy
2016). Adherence-promotion interventions that used intention as
a strategy (Brown 2009), or family-based problem-solving about
adherence barriers (Modi 2013; Modi 2016a), may merit further
investigation..
Why it is important to do this review
Psychological treatments have been developed that aim to
enhance psychological well-being and seizure control, and reduce
psychiatric comorbidities in people with epilepsy. Establishing
evidence of the eBects of such interventions is methodologically
challenging. A review of the current evidence is needed to help
inform future therapeutic recommendations and research designs.
O B J E C T I V E S
To assess the impact of psychological treatments for people with
epilepsy on HRQOL outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs), or quasi-RCTs (e.g. studies in
which the randomization is according to the day of the week or date
of birth).
Types of participants
Men, women and children of any age with any type of epilepsy,
drug-responsive or drug-resistant, with or without intellectual
disabilities, whether or not they were taking antiseizure medication
(ASM).
Types of interventions
For the operational definition of 'psychological treatments',
we included a broad range of treatments that were designed
to improve health-related quality of life (HRQOL), seizure
frequency and severity, and reduce psychological and psychiatric
comorbidities. We explain these diBerent broad types of
psychological treatments in detail in the Description of the
intervention:
1. Skills-based psychological interventions (including educational
elements);
2. Education-only interventions.
We included studies of comparisons of two or more of the above
treatments, and comparisons to 'wait-list control', 'treatment as
usual', and antidepressant pharmacotherapy.
Types of outcome measures
Main outcome measures
We included all studies that reported changes from baseline
in validated HRQOL measures. If those studies also reported
other quality-of-life-related parameters, symptoms of psychiatric
comorbidities or seizure-related outcome measures we also
extracted data from those parameters. We excluded studies without
a HRQOL measure.
Primary outcomes
1. Mean of change from baseline, or comparisons of
postintervention scores from validated HRQOL measures
Secondary outcomes
1. Comparisons of postintervention scores on validated measures
of psychiatric comorbidities, such as depressive and anxiety
symptoms
2. Comparisons of postintervention data from validated seizure-
related outcome measures
Search methods for identification of studies
Electronic searches
We ran searches for the original review in March 2016, and
subsequent searches in September 2016, February 2019, and
August 2019. For the latest update, we searched the following
databases on 12 August 2019. There were no language restrictions.
1. Cochrane Register of Studies (CRS Web); search strategy shown
in Appendix 1.
2. MEDLINE Ovid (1946 to 09 August 2019); search strategy shown
in Appendix 2.
3. PsycINFO EBSCO host (1887 onwards); search strategy shown in
Appendix 3.
CRS Web includes randomized or quasi-randomized controlled
trials from the Specialized Registers of Cochrane Review Groups
including Epilepsy, the Cochrane Central Register of Controlled
Trials (CENTRAL), PubMed, Embase, ClinicalTrials.gov, and the
World Health Organization International Clinical Trials Registry
Platform (ICTRP).
Searching other resources
References from published studies and relevant systematic
reviews
We reviewed the reference lists of retrieved studies and reviews to
search for additional reports of relevant studies.
Other sources
We contacted colleagues to ask if they were aware of any studies or
unpublished data that we had missed.
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Data collection and analysis
Selection of studies
Two review authors (RM and VT) independently assessed
trial abstracts for inclusion, resolving disagreements through
discussion.
Data extraction and management
The same two review authors independently extracted the
following data, using an electronic Cochrane data collection form
that we had adapted to fit the scope of this review:
Study methods
1. Type of intervention used
2. Design
3. Dates the study was conducted
4. Duration of study
5. Timepoints for outcome assessment
6. Sequence generation and allocation concealment
7. Blinding method
8. Controlled confounding variables
9. Other 'Risk of bias' concerns
10.Sources of study funding and potential conflicts of interest
Participants
1. Total sample size and total number of participants allocated to
each group
2. Age, sex, and gender distribution
3. Seizure type and epilepsy syndrome
4. Duration of epilepsy
5. Etiology of epilepsy
6. Seizure frequency and severity
7. Presence or absence of learning disability or intellectual
disability (ID)
8. Presence or absence of psychiatric comorbidity or other medical
diagnoses
9. Antiseizure medication and co-medication
10.Setting of the study
11.Inclusion and exclusion criteria
12.Country of study
Outcome data
1. Name and definition of outcome
2. Units of measurement
Results
1. Study attrition
2. Sample size for each outcome
3. Missing data
4. Summary data for intervention and control groups (for example,
means and standard deviations for all outcomes)
The authors tested the applicability of the data collection form by
piloting the form. Again, we resolved any diBerences of opinion
through discussion.
Assessment of risk of bias in included studies
The same two review authors independently assessed risks of
bias for each randomized trial using Cochrane's recommended
domain-based evaluation tool for randomized trials, in which
we made critical assessments separately for diBerent domains,
including selection bias (random sequence generation, allocation
concealment), performance bias (blinding of personnel), detection
bias (blinding of outcome assessment), attrition bias (incomplete
outcome data), reporting bias (selective reporting), and other
potential sources of bias, including treatment infidelity, treatment
competence (in terms of the training background of the
professionals who delivered the treatment, and the quality of
treatment delivery), and selective recruitment (Higgins 2017).
We examined all outcomes reported in papers for selective
outcome reporting. We resolved any diBerences of opinion by
discussion.
Measures of treatment e;ect
We expressed the treatment eBect for each continuous outcome
measuring HRQOL as a mean diBerence (MD) with a 95%
confidence interval (CI). For studies that did not provide mean
and standard deviation (SD) values for changes from baseline,
we used correlation values, baseline values and postintervention
values from other studies of comparable intervention method,
treatment setting (group versus individual), and total treatment
time to estimate change from baseline values.
We performed meta-analyses only for HRQOL data. Since HRQOL
constituted the main outcome measure for this review, and we
only included studies that investigated HRQOL, we excluded some
studies that covered other outcome measures, e.g. psychiatric
symptoms. From this perspective, a meta-analysis of any outcome
other than HRQOL would imply a serious selection bias.
Unit of analysis issues
When assessing randomized trials, we took the level at which
randomization occurred into account.
In trials with cluster-randomization, we considered the biases
particular to a cluster-randomized trial, such as recruitment
bias, baseline imbalance, loss of clusters, incorrect analysis, and
comparability with individually-randomized trials, and chose the
appropriate measure of analysis (e.g. adjusting results from cluster-
randomized trials with intracluster correlation coeBicients to
combine with individually-randomized trials in meta-analysis if
appropriate).
Considering the lasting nature of the intervention in question, a
cross-over trial design would not have been appropriate, because
of the likelihood of serious carry-over. Hence, we would only have
included data from the first period.
When assessing multi-intervention studies, we listed all
intervention groups in the Characteristics of included studies
tables. We only used the intervention groups relevant to the review
in analyses. We would have included studies that included three
or more of the interventions listed in Types of interventions as
separate comparisons in the analysis.
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Dealing with missing data
Whenever possible, we contacted the original investigators to
request missing data and clarification of methodology. If we
assumed that the data were missing for reasons unrelated to
the intervention, we said the data were ‘missing at random’ and
we based the analyses on the available data. We discussed the
potential reasons for the missing data and addressed the potential
impact of missing data on the findings in the Discussion section of
the review.
Assessment of heterogeneity
We assessed clinical heterogeneity by examining the distribution
of important prognostic variables between studies. To assess the
statistical heterogeneity of observed diBerences of study results,
we used the Chi2 test, forest plots, and the I2 statistic. We judged
that an I2 greater than 70% and a Chi2 result of P < 0.01 to indicate
statistical heterogeneity of concern.
Assessment of reporting biases
We compared the reported outcomes with the outcome measures
and points of measurements stated in the study methods to
assess reporting bias within the publication. We assessed reporting
biases by comparing the reported outcomes with the original
study protocol. To assess reporting biases and to collect missing
information if needed, we contacted all study investigators for their
original protocols or comparable documents.
Where we could include 10 or more studies within a meta-analysis,
we visually inspected funnel plots and considered whether any
observed asymmetry may be due to publication bias. We produced
funnel plots only for total HRQOL scores and not for subscales.
As subscales contribute to the total score and publication bias is
determined at study level, we determined that if publication bias
appeared to be present within analysis of the total scores, it would
also be present within the analyses of the subscales.
Data synthesis
To assess whether meta-analysis was appropriate, we compared
the types of interventions and types of outcome measures or
scales used in the studies, by tabulating the study characteristics.
AFer we completed this, a group of studies appeared to be
suBiciently homogeneous for meta-analysis (see criteria outlined
in Assessment of heterogeneity). We meta-analyzed the results
of clinically and statistically homogeneous studies using Review
Manager 5 soFware (RevMan 2014). We used the inverse variance
method for continuous outcomes with a random-eBects model. We
conducted a narrative synthesis for any outcomes for which the
included studies were not suBiciently homogeneous, or for which
we had insuBicient data for meta-analysis.
Subgroup analysis and investigation of heterogeneity
Due to the scope of this review, there were several diBerent
interventions of interest, and the included studies were diverse. We
identified the following subgroups. However, since they were either
comparatively small or the information was unavailable, we did not
undertake any subgroup analysis:
1. Children versus adults
2. Individuals with drug-resistant epilepsy versus individuals with
drug-responsive epilepsy
3. Individuals with primary generalized epilepsy versus individuals
with focal epilepsy versus unclassified epilepsy syndromes
4. Individuals with nocturnal seizures versus individuals with
diurnal seizures (seizure-related outcomes only)
5. Individuals with seizure warning (aura) versus individuals
without seizure warning (seizure-related outcomes only)
6. StaB-based versus non-staB-based treatments (i.e. web-based
interventions)
7. Participants with intellectual disabilities (IQ below 70) would
have been separately analyzed
We assessed methodological heterogeneity by examining the study
design.
Sensitivity analysis
If reasonable, we would have conducted a sensitivity analysis by
comparing the results of a second meta-analysis, including only
studies at low risk of bias, to those in the overall meta-analysis.
Summary of findings and assessment of the certainty of the
evidence
We used the GRADE approach to interpret findings (Schünemann
2017), and GRADEpro GDT soFware (which imports data from
Review Manager 5 soFware [GRADEPro 2015]), to create a
'Summary of findings' table for the primary outcome of HRQOL.
R E S U L T S
Description of studies
We searched for RCTs and quasi-RCTs that investigated
psychological treatments for individuals with epilepsy and used
validated HRQOL outcome parameters.
Results of the search
The electronic search yielded 2165 titles from the databases
outlined, and we found four titles through handsearching.
Following the removal of duplicates, 1675 titles remained. We
ruled out 1237 titles as irrelevant (i.e. these titles clearly indicated
that the studies were neither RCTs nor quasi-RCTs related to
the investigation of psychological interventions for people with
epilepsy). We screened the abstracts of the remaining 438 titles
for eligibility, and obtained the full texts of 85 reports to assess
for eligibility. We excluded 26 full text reports (24 studies, see
Figure 1 and Characteristics of excluded studies) because they did
not examine HRQOL outcomes. Two studies were ongoing (see
Characteristics of ongoing studies).
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Figure 1.   Study flow diagram.
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Included studies
We included 36 completed RCTs (3526 participants) in 57
publications in this review. Table 1 and the Characteristics of
included studies tables outline the details of the studies and the
components of the interventions. Nine studies were conducted
in the USA (Caller 2016; Ciechanowski 2010; DiIorio 2011; Fraser
2015; Gilliam 2019; Pramuka 2007; Sajatovic 2016; Sajatovic 2018;
Thompson 2010), six in Germany (Jantzen 2009; May 2002; Meyer
2019; PfäBlin 2016; Rau 2006; Schröder 2014), three in Iran (Hosseini
2016; Pakpour 2015; Yadegary 2015) and the UK (Dorris 2017;
Ridsdale 2018; Ring 2018), two in Australia (Edward 2019; Gandy
2014), Canada (Brown 2019; Hum 2019), Hong Kong (Au 2003;
Tang 2015), and Sweden (Lundgren 2006; Lundgren 2008). The
remaining studies were conducted in Italy (Beretta 2014), Malaysia
(Lua 2013), Mexico (Orjuela-Rojas 2015), Norway (Helde 2005),
Netherlands (Leenen 2018), Serbia (Martinović 2006) and Turkey
(Turan Gurhopur 2018).
Interventions
The authors grouped the investigated psychological treatments
according to the above-mentioned operational definition of
'psychological treatments' for adults and children with epilepsy
(see also Table 1).
1. Skills-based psychological interventions (27 studies, 2240
participants)
Nine skills-based psychological interventions were cognitive or
behavior-based interventions, or both, with the primary goal
of treating depressive symptoms in adolescents or adults or
both, with epilepsy and varying levels of depression severity
(Ciechanowski 2010; Gandy 2014; Gilliam 2019; Hum 2019;
Martinović 2006; Meyer 2019; Orjuela-Rojas 2015; Schröder 2014;
Thompson 2010). The most common treatment strategies were
cognitive restructuring to address depressive thoughts, and
behavioral and social activation (see Characteristics of included
studies for additional strategies in each study). Five of the studies
delivered the intervention on an individual basis (Ciechanowski
2010; Gandy 2014; Gilliam 2019; Meyer 2019; Schröder 2014), while
the other four used a group format (Hum 2019; Martinović 2006;
Orjuela-Rojas 2015; Thompson 2010). Four of the interventions
were conducted in a clinical setting (Gandy 2014; Gilliam 2019;
Martinović 2006; Orjuela-Rojas 2015), two interventions were
Internet-based (Meyer 2019; Schröder 2014), one intervention
was phone-based (Hum 2019), one was Internet-based with
complementing telephone calls (Thompson 2010), and one was
home-based (Ciechanowski 2010). Three of these interventions
included mindfulness techniques (Hum 2019; Schröder 2014;
Thompson 2010).
Four studies focused on the primary treatment goal of
improving HRQOL. Three of them used mindfulness techniques in
combination with seizure management techniques, by introducing
acceptance and coping related to seizure disturbances (Lundgren
2006; Lundgren 2008; Tang 2015). Lundgren 2006 and Lundgren
2008 included management of seizure triggers and development
of aura interruption techniques. Hosseini 2016 investigated
motivational interviewing, which focused on enhancement of
internal motivation for coping with epilepsy. One intervention
combined a single epilepsy education group session, covering
epilepsy knowledge (including the topic of drug adherence) and
nurse-led personalized counseling, with the primary treatment
goal of enhancing quality of life (Helde 2005).
Four skills-based psychological interventions (labeled consumer-
driven psychoeducation by the authors) focused on epilepsy-
specific self-management behaviors as primary (Fraser 2015;
Leenen 2018; Pramuka 2007) or secondary treatment goals (Dorris
2017; primary treatment goal: HRQOL), by discussing medical and
psychosocial aspects of epilepsy self-management in a face-to-
face group setting with children and adolescents (Dorris 2017)
or adults (Fraser 2015; Leenen 2018; Pramuka 2007). Another
self-management intervention applied a similar approach, but
evaluated the impact of the intervention on HRQOL outcomes
(Yadegary 2015). One Internet-based self-management program
(WebEase) focused on the primary treatment goals of improving
adherence and perceived stress levels, by targeting medication
adherence, stress and sleep management (DiIorio 2011). Two
consumer-driven self-management programs targeted special
subgroups: one program was designed for people with comorbid
mental illness focused on empowerment and support to increase
coping with mental illness and epilepsy (Sajatovic 2016), and one
program was designed for people who had recently experienced
epilepsy-related complications and aimed at reduction of such
negative health events (Sajatovic 2018). One home- and telephone-
based intervention combined self-management and cognitive
training (Home-Based Self-management and Cognitive Training
Changes lives (HOBSCOTCH) in order to increase quality of life,
mood, and objective and subjective neurocognitive functions
(Caller 2016).
Two skills-based psychological interventions focused on seizure
control and HRQOL. Au 2003 used CBT-based components (e.g.
cognitive restructuring) with seizure management techniques (e.g.
identifying and addressing seizure-provoking situations) on adults
with epilepsy and subjective psychological distress. Ring 2018
investigated a nurse-led competency framework with the particular
focus on supporting adults with epilepsy and intellectual disability
with the primary treatment goal of improving seizure frequency
and HRQOL
Two studies used motivational interviewing as their primary
intervention strategy (Hosseini 2016; Pakpour 2015). Hosseini 2016
applied motivational interviewing with adults with epilepsy in a
group format aiming to improve HRQOL; the intervention was
designed to enhance internal motivation for changing through
exploration, identification, and overcoming doubts and dualism.
Pakpour 2015 investigated an adherence intervention using
motivational interviewing in an individual setting. In this study, a
program was designed to enhance medication adherence behavior
and clinical outcomes in people with epilepsy, as measured
by drug adherence, drug-taking behaviors, seizure severity, and
HRQOL. An additional study (Brown 2019) used behavioral methods
(e.g. performance feedback) to target physical activity in children
with epilepsy and positively influence depressive symptoms and
HRQOL.
2. Education-only interventions (9 studies, 1286 participants)
Education-only interventions focused on epilepsy knowledge,
advocacy topics, daily self-management behaviors, and
psychosocial aspects in order to enhance quality of life (six
trials: Jantzen 2009; Lua 2013; May 2002; Ridsdale 2018, Turan
Gurhopur 2018, Edward 2019), increase knowledge and coping
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(Rau 2006), or satisfaction of participants with information and
support (PfäBlin 2016), or reduce drug-related problems (Beretta
2014). Four intervention programs were designed to be delivered
in a group setting during a two-day weekend course (Flip&Flap
(Jantzen 2009); FAMOSES (Rau 2006); MOSES (May 2002); SMILE
(UK) (Ridsdale 2018). Three of these interventions were geared
towards the education of children, adolescents, and their parents
(Jantzen 2009, Rau 2006, Turan Gurhopur 2018). One intervention
investigated the MOSES material using a short message service
(SMS)-based system to deliver the general content of the
educational intervention, complemented by information tailored
to the individual (Lua 2013). One intervention provided participant-
tailored medication education in individual sessions in order to
reduce drug-related problems (Beretta 2014). Another provided a
brief education intervention on lifestyle self-management in the
control of seizures that was developed based on self-determination
theory in order to improve HRQOL, satisfaction with life and
resilience (Edward 2019).
Intervention delivery
A specialized team, usually consisting of medical (doctors,
nurses) or mental health specialists (e.g. psychologist, psychiatric
nurses, social workers) or both delivered most of the
education interventions, except for one educational intervention
that was delivered by an epilepsy nurse specialist and
an electroencephalography (EEG) technician (Ridsdale 2018).
Psychologists with diBerent levels of clinical experience and
training delivered most of the skills-based interventions. Five
interventions included a peer coach with epilepsy (Fraser 2015;
Hum 2019; Sajatovic 2016; Sajatovic 2018; Thompson 2010). One
pragmatic design leF the delivery of the educational intervention
to the treating physician (Beretta 2014). Skills-based psychological
interventions had a median duration of eight weeks (range 3 weeks
to 2 years). Education-only group interventions (Jantzen 2009; May
2002; Ridsdale 2018; Turan Gurhopur 2018) took two to three days;
education-only interventions with individual sessions comprised
one (Edward 2019; PfäBlin 2016), two (Beretta 2014) or 12 (Lua
2013) sessions. For more detailed information about the duration of
each intervention please refer to Characteristics of included studies
tables.
Control groups
FiFeen trials included a wait-list control (WLC) group (Au 2003;
DiIorio 2011; Dorris 2017; Fraser 2015; Gandy 2014; Hosseini
2016; Hum 2019; Jantzen 2009; May 2002; PfäBlin 2016; Rau
2006; Sajatovic 2018; Schröder 2014; Thompson 2010; Turan
Gurhopur 2018). Eight studies included an immediate active
control group: EpINFO program with education intervention,
coping strategies and skill-building activities (Hum 2019); paper-
based education intervention (Lua 2013); supportive therapy
(Lundgren 2006); yoga (Lundgren 2008); counseling as usual
(Martinović 2006); pharmacotherapy with a selective serotonin
reuptake inhibitor (Gilliam 2019; Orjuela-Rojas 2015); attention-
placebo social support (Tang 2015). The remaining 13 studies used
usual care or treatment as usual as the control group (Beretta 2014;
Brown 2019; Caller 2016; Ciechanowski 2010; Helde 2005; Leenen
2018; Meyer 2019; Pakpour 2015; Pramuka 2007; Ridsdale 2018;
Ring 2018; Sajatovic 2016; Yadegary 2015). Hum 2019 used both an
active control group (epilepsy information and self-management)
and a wait-list control group. The use of a usual-care or treatment-
as-usual design instead of a wait-list control group was especially
comprehensible in long-term interventions (six months or longer
[Ciechanowski 2010; Helde 2005]). One study did not describe in
detail the format of the control group used (Edward 2019).
Outcome measures
We organized the outcome measures according to the types of
outcome defined in the protocol (Types of outcome measures).
The Characteristics of included studies tables outline the outcome
measures and measurement points in each study. Altogether,
the included studies used more than 50 diBerent outcome
measures. Skills-based psychological interventions carried out
a median postintervention follow-up of six months (range 0 to
18 months). Education-only interventions carried out a median
postintervention follow-up of six months (range 0 to 12 months).
Health-related quality of life
'Quality of Life in Epilepsy' inventories (QOLIE)
Twenty-five studies used the most commonly-used epilepsy-
specific HRQOL questionnaires to measure outcomes (Quality
of Life in Epilepsy-10/-31/-31P/-48/-89). Eleven studies used the
QOLIE-31 (Au 2003; Beretta 2014; Caller 2016; Ciechanowski 2010;
Fraser 2015; Gandy 2014; Lua 2013; Martinović 2006; Orjuela-
Rojas 2015; Pakpour 2015; Schröder 2014), four studies used the
patient-weighted QOLIE-P (Leenen 2018; Ridsdale 2018; Tang 2015;
Yadegary 2015), four studies used the QOLIE-89 (Gilliam 2019;
Helde 2005; Hosseini 2016; Pramuka 2007), four studies used the
QOLIE-10 (DiIorio 2011; Meyer 2019; Sajatovic 2016; Sajatovic 2018),
and single studies used the QOLIE-48 (Turan Gurhopur 2018) and
a subscale item of the QOLIE-31 to inquire about overall QoL
(PfäBlin 2016). The QOLIE-31-P is a modification of the QOLIE-31,
with an additional question about the individual's subjective
level of distress in each of the six subscales, which allows for
an individually-weighted calculation of scores for the individual's
subjective evaluation (Cramer 2003). All studies using QOLIE-10,
QOLIE-31, QOLIE-31-P, QOLIE-48 and QOLIE-89 questionnaires
reported pre- and postintervention mean scores (± standard
deviation [SD]). Three studies included the mean diBerence
between pre- and postintervention scores (± SD; [Fraser 2015; Helde
2005; Tang 2015]). Only Tang 2015 reported the percentage of
participants achieving a minimum clinically important change.
Of the 25 studies that used the QOLIE measures, we considered
14 skills-based psychological intervention studies to be suBiciently
clinically and methodologically homogeneous for meta-analysis
(Au 2003; Caller 2016; Ciechanowski 2010; Fraser 2015; Gandy 2014;
Gilliam 2019; Helde 2005; Hosseini 2016; Leenen 2018; Martinović
2006; Orjuela-Rojas 2015; Pramuka 2007; Tang 2015; Yadegary
2015). We did not include education-only interventions in the
meta-analysis. Due to substantial baseline diBerences between
intervention and control groups, we used the mean change from
baseline (± SD) for the meta-analysis, rather than postintervention
scores (± SD). We sought required data from all authors. Seven
study authors provided unpublished data we could include in the
meta-analysis: Caller 2016 provided the unadjusted mean change
from baseline (± SD); Fraser 2015 provided the mean change from
baseline (± SD) for the control group; Gilliam 2019 and Helde
2005 provided raw data so we could convert the results from
QOLIE-89 to QOLIE-31; Orjuela-Rojas 2015 provided raw data to
calculate the mean change from baseline (± SD); Tang 2015 and
Leenen 2018 provided raw data so we could convert the results
from QOLIE-31-P to QOLIE-31. Three studies did not provide the
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mean change from baseline [± SD; (Au 2003; Ciechanowski 2010;
Martinović 2006]). We calculated the mean change from baseline
as a diBerence between pre- and postintervention means. In order
to calculate an adjusted SD, we grouped these three studies
with studies investigating interventions that were comparable in
intervention method, treatment setting (group versus individual),
and total treatment time: Au 2003 with Tang 2015; Ciechanowski
2010 with Gandy 2014; and Martinović 2006 with Orjuela-Rojas
2015. This allowed us to calculate the adjusted SD of the mean
change from baseline, based on the correlation between pre- and
postintervention means (± SD) of the studies with which they
were grouped. Unfortunately, Martinović 2006 could not provide
QOLIE-31 subscale outcomes, so we only included the total score
from his study. We present in narrative form the results of the
studies that did not provide the raw QOLIE-89 data (Hosseini 2016;
Pramuka 2007), or raw QOLIE-31-P data (Yadegary 2015) that would
allow us to convert the results into QOLIE-31 scores. As a result,
the meta-analysis finally comprised data from 11 studies (Au 2003;
Caller 2016; Ciechanowski 2010; Fraser 2015; Gandy 2014; Gilliam
2019; Helde 2005; Leenen 2018; Martinović 2006; Orjuela-Rojas
2015; Tang 2015).
We did not include six studies using QOLIE-31 outcome measures
in the meta-analysis because of meaningful clinical heterogeneity.
In two skills-based psychological interventions, the intervention
delivery was not face-to-face; it was either web-based (Schröder
2014), or SMS-based (Lua 2013). In one skills-based psychological
intervention, the intervention goal was very narrowly defined:
Pakpour 2015: increasing drug-adherence. Three interventions
were 'education only' (Beretta 2014; PfäBlin 2016; Ridsdale 2018).
We present their results in narrative form. Two authors provided
raw data that allowed us to calculate and present unpublished
QOLIE-31 scores (Beretta 2014; Schröder 2014).
Other HRQOL outcome measures
Four studies used the World Health Organization Quality of Life
instrument, short version (WHOQOL-BREF); (Hum 2019; Lundgren
2006; Lundgren 2008; Schröder 2014). Four studies used the
Satisfaction with Life Scale (SWLS); (Edward 2019; Lundgren 2006;
Lundgren 2008; Thompson 2010). Edward 2019 used the Short Form
12 (SF12).
Pediatric studies in particular used heterogeneous HRQOL
measures: Brown 2019 used the Childhood Epilepsy Quality of Life
scale (CHEQOL) and KIDSCREEN-27; Dorris 2017 used the Paediatric
Quality of Life Inventory PedsQL™ version 4.0 and the Glasgow
Epilepsy Outcome Scale for Young Persons (GEOS-YP); and Rau
2006 used the German questionnaire KINDL.
One study that only included participants with intellectual
disability used the Epilepsy and Learning Disabilities Quality of Life
(ELDQoL) (Ring 2018).
We present all of these other HRQOL outcomes in narrative form.
Psychiatric comorbidities: depression and anxiety
Several included studies also assessed psychiatric comorbidities.
Even though some of them used the same outcome measure, we
grouped individual results by outcome measures in narrative form
rather than a meta-analysis. Since HRQOL constituted the main
outcome measure of this review, we only included studies that
investigated HRQOL, which led to the exclusion of some studies
that included psychiatric symptoms as an outcome measure, but
not HRQOL. From this perspective, a meta-analysis of any outcome
other than HRQOL would imply a serious selection bias.
Depression
Seventeen studies examined changes in the level of symptoms of
depression (Brown 2019; Caller 2016; Ciechanowski 2010; Dorris
2017; Fraser 2015; Gandy 2014; Gilliam 2019; Hum 2019; Leenen
2018; Martinović 2006; May 2002; Orjuela-Rojas 2015; Ridsdale
2018; Schröder 2014; Sajatovic 2016; Tang 2015; Thompson
2010). Six studies used the Beck Depression Inventory or Beck
Depression Inventory-II (Gilliam 2019; Martinović 2006; Orjuela-
Rojas 2015; Schröder 2014; Tang 2015; Thompson 2010); four
studies used the Patient Health Questionnaire (Caller 2016; Fraser
2015; Sajatovic 2016; Thompson 2010). Four studies used the
Hospital Anxiety and Depression Scale (Gandy 2014; Leenen 2018;
Orjuela-Rojas 2015; Ridsdale 2018), three other studies used the
Neurological Disorders Depression Inventory-Epilepsy Scale (Caller
2016; Gandy 2014; Hum 2019), Sajatovic 2016 used the Montgomery
Asberg Depression Rating Scale as an additional measurement
of depression symptom severity, Dorris 2017 used the Paediatric
Index of Emotional Distress (PI-ED), Brown 2019 used the Children's
Depression Inventory — Short (CDI-S), Gilliam 2019 also used
the Center for Epidemiologic Studies Depression Scale (CES-D)
and the Mini-International Neuropsychiatric Interview to assess
depression. Two studies assessed suicidal ideation (Ciechanowski
2010; Orjuela-Rojas 2015). The studies used nine diBerent outcome
measures for depression.
Anxiety
Six studies examined changes in the level of anxiety symptoms.
Four studies used the Hospital Anxiety and Depression Scale for
assessing anxiety (Gandy 2014; Leenen 2018; Orjuela-Rojas 2015;
Ridsdale 2018). One study used the Generalized Anxiety Disorder-7
(Fraser 2015), and one study used the Beck Anxiety Inventory (Tang
2015).
Seizure-related outcomes
Thirteen studies measured seizure frequency (Au 2003;
Ciechanowski 2010; Gilliam 2019; Jantzen 2009; Leenen 2018;
Lundgren 2006; Lundgren 2008; May 2002; Rau 2006; Ridsdale
2018; Ring 2018; Sajatovic 2016; Tang 2015). Four studies used
seizure severity measures: the National Hospital Seizure Severity
Scale (NHS3) (Leenen 2018), the Liverpool Seizure Severity Scale
(Pakpour 2015), the Epilepsy and Learning Disabilities Quality of
Life Seizure Severity Scale (ELDQoL-SSS) (Ring 2018), and the
Seizure Severity Index (Tang 2015).
Participants
Most studies evaluated the benefit of interventions for adults with
epilepsy. One study investigated CBT for adolescents and young
adults with epilepsy (Martinović 2006), Dorris 2017 investigated
a consumer-driven self-management intervention for children
and adolescents, Jantzen 2009, Rau 2006 and Turan Gurhopur
2018 investigated educational interventions for children and
adolescents with epilepsy, and Brown 2019 investigated a behavior-
change counseling intervention aimed at increasing physical
activity in children with epilepsy. Two studies investigated skills-
based interventions for adolescents and adults (Caller 2016; Helde
2005), and three studies investigated educational interventions for
adolescents and adults (May 2002; PfäBlin 2016; Ridsdale 2018).
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Several studies used participants' psychological functioning (e.g.
depressive symptoms) as one of the inclusion criteria. Seven
studies included only adults with epilepsy and depressive
symptoms (Ciechanowski 2010: PHQ-9 score ≥ 10; Gilliam 2019:
CES-D score > 14; Hum 2019: a minimum score of 12 on the
Center for Epidemiologic Studies Depression Scale Revised (CESD-
R); Meyer 2019: at least moderate depression (PHQ > 9); Orjuela-
Rojas 2015: major depression according to the diagnostic criteria
of the Diagnostic and Statistical Manual of Mental Disorders-
IV [DSM IV]; Schröder 2014: self-reported depressive symptoms;
Thompson 2010: score of < 38 on the CESD-R). One study included
adults with epilepsy and a DSM IV diagnosis of schizophrenia,
schizoaBective disorder, bipolar disorder, or chronic/recurrent
major depressive disorder (Sajatovic 2016). Most studies did
not specifically recruit participants with comorbid psychiatric
diagnoses. Two studies recruited participants who experience
elevated levels of psychological diBiculties without reaching
diagnostic criteria: one study included adolescents and young
adults with epilepsy and subthreshold depressive symptoms
(Martinović 2006), and one study included adults with epilepsy
and self-reported psychological distress (Au 2003). One study only
included adults with epilepsy and other chronic comorbidities,
because the intervention targeted adverse eBects stemming
from drug interactions (Beretta 2014). Another study included
adolescents and adults with subjective memory complaints, since
the intervention included special cognitive and memory training
(Caller 2016).
Ten studies used inclusion criteria related to seizure frequency,
epilepsy type, or drug-responsiveness: Au 2003 only included
participants with at least two seizures per month; Brown 2019
and Gilliam 2019 only included participants with at least one
seizure in the previous 12 months, Hosseini 2016 only included
participants with primary generalized tonic-clonic epilepsy and
uncontrolled seizures; Meyer 2019 only included participants with
"active epilepsy" (i.e. having taken ASDs within the past five
years or a seizure within the past 10 years), Lundgren 2006 and
Lundgren 2008 only included participants with at least four seizures
over three months; Ridsdale 2018 only included participants
reporting at least two seizures in the previous year; Sajatovic
2018 included participants with at least one negative epilepsy-
related health event within the past year; Tang 2015 only included
participants with drug-resistant epilepsy; and Yadegary 2015 only
included participants with at least one seizure during the past
year. Altogether, the number of individuals with drug-responsive
epilepsy and primary generalized epilepsy was comparably small in
the study populations of all included studies. None of the studies
reported whether individuals experienced nocturnal or diurnal
seizures, or if individuals experienced focal unaware seizures or
prodromal seizure warnings.
Most studies excluded individuals with intellectual disability
(ID). Four studies did not explicitly mention ID as an exclusion
criterion but intellectual functioning was also not included in the
demographic characterization of the patient population (DiIorio
2011; Edward 2019; Hosseini 2016; Yadegary 2015). Only one
study investigated a nurse-led intervention and included only
participants with epilepsy and ID (Ring 2018).
We include more details on study participants in Table 1 and the
Characteristics of included studies tables. Since the subgroups
outlined in the review protocol were either comparatively small
or the information was unavailable, we did not undertake any
subgroup analysis.
We found two studies that were still ongoing. See Characteristics of
ongoing studies for details.
Excluded studies
We excluded 26 RCTs because they did not examine HRQOL
outcomes.
Risk of bias in included studies
We include details of our judgments and the rationale in the
Characteristics of included studies tables, and display summaries
in Figure 2 and Figure 3. We shared the details of our judgments with
all study authors prior to the publication of this review, for further
clarification.
 
Figure 2.   'Risk of bias' graph: review authors' judgements about each 'risk of bias' domain presented as
percentages across all included studies
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment (detection bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
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Low risk of bias Unclear risk of bias High risk of bias
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Au 2003 - - - + + + -
Beretta 2014 + + - + + + +
Brown 2019 + + - + + + ?
Caller 2016 + - - + - + ?
Ciechanowski 2010 + + - + + - ?
DiIorio 2011 - + - - - + -
Dorris 2017 + - - + - + +
Edward 2019 - ? - ? - + ?
Fraser 2015 + + - + - + -
Gandy 2014 + + - - - + -
Gilliam 2019 + + - - - + +
Helde 2005 + + - + + + +
Hosseini 2016 ? ? - + - + -
Hum 2019 + ? ? ? - + ?
Jantzen 2009 - - - + + + ?
Leenen 2018 + + - + + + -
Lua 2013 + ? ? ? + + ?
Lundgren 2006 + + - - + + -
Lundgren 2008 + + - - + + -
Martinovi# 2006 + + + + + - ?
May 2002 + - - + - + -
Meyer 2019 + + - + - + -
Orjuela-Rojas 2015 - - - + - + ?
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Figure 3.   (Continued)
Meyer 2019 + + - + - + -
Orjuela-Rojas 2015 - - - + - + ?
Pakpour 2015 + ? - ? + + +
Pfäfflin 2016 + + - + - + +
Pramuka 2007 + ? - - - - ?
Rau 2006 - - - + - + -
Ridsdale 2018 + + - + - + +
Ring 2018 + + + + + + +
Sajatovic 2016 + + - - - + +
Sajatovic 2018 + - - - + + +
Schröder 2014 + + - + - + -
Tang 2015 + + - + + + +
Thompson 2010 ? - - ? - - +
Turan Gurhopur 2018 + + - ? + + ?
Yadegary 2015 + ? - ? ? + ?
 
Allocation
Most studies (N = 28) reported an adequate method of random
sequence generation (Beretta 2014; Brown 2019; Caller 2016;
Ciechanowski 2010; Dorris 2017; Fraser 2015; Gandy 2014; Gilliam
2019; Helde 2005; Hum 2019; Leenen 2018; Lua 2013; Lundgren
2006; Lundgren 2008; Martinović 2006; May 2002; Meyer 2019;
Pakpour 2015; PfäBlin 2016; Pramuka 2007; Ridsdale 2018; Ring
2018; Sajatovic 2016; Sajatovic 2018; Schröder 2014; Tang 2015;
Turan Gurhopur 2018; Yadegary 2015). Two studies did not provide
a suBicient description of the randomization process, hence were
classified as unclear (Hosseini 2016; Thompson 2010). Reasons for
a high risk of bias rating included quasi-randomized trial designs,
such as a matched design (Au 2003), alternating assignment
(DiIorio 2011), the placement of participants in the control group if
they were unable to attend the intervention face-to-face sessions
(Edward 2019), and allocation based on participants' application to
one of two available courses in a wait-list control design (Jantzen
2009; Rau 2006). We rated one study at very serious risk of bias,
since the allocation depended on the participants' ability to attend
the meetings (Orjuela-Rojas 2015). One author provided further
information to clarify the randomization procedure that had not
been suBiciently described in the publication (Rau 2006).
Most of the studies (N = 20) reported proper procedures for
allocation concealment (Beretta 2014; Ciechanowski 2010; DiIorio
2011; Fraser 2015; Gandy 2014; Gilliam 2019; Helde 2005; Hosseini
2016; Lundgren 2006; Lundgren 2008; Leenen 2018; Martinović
2006; Meyer 2019; PfäBlin 2016; Ridsdale 2018; Ring 2018;
Sajatovic 2016; Schröder 2014; Tang 2015; Turan Gurhopur 2018).
Allocation concealment can be considered inherent in study
designs investigating a web-based intervention with a web-
based registration and allocation procedure, hence a study with
a low-quality randomization procedure could indeed feature a
high-quality allocation concealment (DiIorio 2011). Nine studies
reported an unconcealed allocation procedure (Au 2003; Caller
2016; Dorris 2017; Jantzen 2009; May 2002; Rau 2006; Sajatovic
2018; Thompson 2010; Orjuela-Rojas 2015), and seven studies
provided insuBicient descriptions (Brown 2019; Edward 2019; Hum
2019; Lua 2013; Pakpour 2015; Pramuka 2007; Yadegary 2015).
Ten authors provided further information to clarify the allocation
concealment procedure that had not been suBiciently described in
the publication (Au 2003; Beretta 2014; Dorris 2017; Fraser 2015;
Lundgren 2006; Lundgren 2008; May 2002; Ring 2018; Sajatovic
2018; Tang 2015).
Blinding
Blinding of participants and personnel is almost impossible to
achieve when studying psychological treatments, so most studies
had a high risk of bias (N = 30: Au 2003; Brown 2019; Beretta 2014;
Caller 2016; Ciechanowski 2010; DiIorio 2011; Dorris 2017; Fraser
2015; Gandy 2014; Helde 2005; Hosseini 2016; Jantzen 2009; Leenen
2018; Lundgren 2006; Lundgren 2008; May 2002; Meyer 2019;
Orjuela-Rojas 2015; Pakpour 2015; PfäBlin 2016; Pramuka 2007;
Rau 2006; Ridsdale 2018; Sajatovic 2016; Sajatovic 2018; Schröder
2014; Tang 2015; Thompson 2010; Turan Gurhopur 2018; Yadegary
2015). Four studies blinded the participants in both the treatment
and the active control group, by telling them that they would
participate in an intervention to improve coping with epilepsy (Lua
2013; Lundgren 2006; Lundgren 2008; Tang 2015). This was possible
only if the study designs used an immediate and active control arm
(social support group in two trials, Lundgren 2006; Tang 2015; yoga
in one trial, Lundgren 2008; and paper-based education material
in one trial, Lua 2013). There were no randomized personnel in
three studies investigating a web-based intervention (DiIorio 2011;
Meyer 2019; Schröder 2014). Two studies were classified as overall
low risk, as the therapists who delivered the treatment (CBT and
counseling as usual) were blinded to the participants' group status:
the researchers only told the therapists that they would deliver
psychological means to improve coping with epilepsy (Martinović
2006). Ring 2018 facilitated blinding of personnel and participants
through cluster-randomization of intervention sites. In one study,
the blinding status of the personnel delivering an SMS-based
intervention remained unclear (Lua 2013) and in another study with
an active control group and a WLC, the blinding status of personnel
and participants remained unclear (Hum 2019).
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We considered the risk of non-blinding of any type of control
group that did not receive an immediate control intervention
to be especially problematic, since it might lead to baseline
imbalances of participant-reported outcome parameters, due
to disappointment, i.e. the impression of having been denied
an opportunity. Thus, we rated the risk lower in studies that
obtained baseline measures prior to randomization. Thirteen
studies reported this procedure (Brown 2019; DiIorio 2011; Fraser
2015; Gandy 2014; Gilliam 2019; Helde 2005; Hosseini 2016; Lua
2013; Meyer 2019; PfäBlin 2016; Ridsdale 2018; Sajatovic 2016;
Sajatovic 2018).
Blinding of the assessment of participant-reported outcome data
was adequate in most studies (N = 21: Au 2003; Brown 2019; Beretta
2014; Caller 2016; Ciechanowski 2010; Dorris 2017; Fraser 2015;
Helde 2005; Hosseini 2016; Jantzen 2009; Leenen 2018; Martinović
2006; May 2002; Meyer 2019; Orjuela-Rojas 2015; PfäBlin 2016; Rau
2006; Ridsdale 2018; Ring 2018; Schröder 2014; Tang 2015). Eight
studies provided insuBicient information (Brown 2019; Edward
2019; Hum 2019; Lua 2013; Pakpour 2015; Thompson 2010; Turan
Gurhopur 2018; Yadegary 2015). Eight studies had a high detection
bias, because personnel conducting the outcome assessment
were aware of the treatment status (DiIorio 2011; Gandy 2014;
Gilliam 2019; Lundgren 2006; Lundgren 2008; Pramuka 2007;
Sajatovic 2016; Sajatovic 2018), although additional information
was provided by Lundgren 2006 and Lundgren 2008 that outcome
assessment was blinded only on seizure-related data. Thirteen
authors provided further information on 16 studies to clarify
the blinding of outcome assessment that had been insuBiciently
described in the publication (Au 2003; Brown 2019; Beretta 2014;
DiIorio 2011; Fraser 2015; Gandy 2014; Jantzen 2009; Leenen 2018;
Lundgren 2006; Lundgren 2008; Martinović 2006; May 2002; Orjuela-
Rojas 2015; Ring 2018; Sajatovic 2016; Sajatovic 2018).
Incomplete outcome data
We rated three studies at low risk of attrition bias because all
randomized participants completed the study (Au 2003; Lundgren
2006; Lundgren 2008). We rated 13 studies at low risk, as there
were only a small amount of missing data, which were balanced
across the groups, with justifiable reasons (Beretta 2014; Brown
2019; Ciechanowski 2010; Helde 2005; Jantzen 2009; Leenen 2018;
Lua 2013; Martinović 2006; Pakpour 2015; Ring 2018; Sajatovic 2018;
Tang 2015; Turan Gurhopur 2018). We rated 17 studies at high risk of
bias, because of larger amounts of missing data (we applied a cut-
oB of 15% for short-term interventions [less than six months], and
20% for long-term interventions [at least six months]). Losses were
balanced in three studies (Fraser 2015; Gilliam 2019; Ridsdale 2018),
and unbalanced in 12 studies (Caller 2016; DiIorio 2011; Dorris
2017; Edward 2019; Gandy 2014; Hosseini 2016; Hum 2019; Meyer
2019; Orjuela-Rojas 2015; PfäBlin 2016; Pramuka 2007; Sajatovic
2016). One study excluded participants who had missed more than
one intervention session, which indicated that no intention-to-
treat (ITT) analysis had been undertaken (Hosseini 2016). Three
studies with overall high attrition only provided the total number
of participants lost to follow-up, without reporting whether they
belonged to the intervention or the control group (May 2002; Rau
2006; Thompson 2010). We assigned an unclear risk to one study
that did not provide data on their attrition rate (Yadegary 2015).
The risk of attrition is usually quite high in experimental
studies that require regular, active, and personal involvement of
study participants, as is the case with psychological treatments.
There were two studies that reimbursed their participants for
participation in the study, but nonetheless had a high attrition rate
(DiIorio 2011; Pramuka 2007).
Selective reporting
We rated 30 studies at low risk of bias as there was no evidence
of selective outcome reporting within the publications, when
examining all outcomes reported in the papers (Au 2003; Beretta
2014; Brown 2019; Caller 2016; Dorris 2017; Edward 2019; Fraser
2015; Gandy 2014; Gilliam 2019; Helde 2005; Hosseini 2016; Hum
2019; Jantzen 2009; Leenen 2018; Lua 2013; Lundgren 2006;
Lundgren 2008; May 2002; Meyer 2019; Orjuela-Rojas 2015; Pakpour
2015; PfäBlin 2016; Rau 2006; Ridsdale 2018; Ring 2018; Sajatovic
2016; Sajatovic 2018; Tang 2015; Turan Gurhopur 2018; Yadegary
2015). We had initially rated six studies at a high risk of bias,
as there was evidence of selective outcome reporting within
the publications (Ciechanowski 2010; DiIorio 2011; Martinović
2006; Pramuka 2007; Schröder 2014; Thompson 2010). Two
authors provided additional data (DiIorio 2011; Schröder 2014). We
therefore ended up assessing four studies at high risk of bias due
to evidence of selective outcome reporting within the publications
(Ciechanowski 2010; Martinović 2006; Pramuka 2007; Thompson
2010).
Four research groups had previously published their study protocol
as a separate publication (Leenen 2018; Meyer 2019; Ridsdale
2018; Sajatovic 2016). We requested study protocols from all
other authors. We received 10 responses with complete registered
protocols or documentation of the included outcome measures,
and assessed the risk against these documents (Beretta 2014; Caller
2016; DiIorio 2011; Fraser 2015; Helde 2005; May 2002; Rau 2006,
Sajatovic 2018; Schröder 2014; Tang 2015). We confirmed a rating
of low risk of bias in 10 of the studies for which study protocols
were available, as there was no evidence of selective outcome
reporting following review of the documents (Beretta 2014; Caller
2016; Fraser 2015; Leenen 2018; Meyer 2019; Rau 2006; Ridsdale
2018; Sajatovic 2016; Sajatovic 2018; Tang 2015). For one study,
additional outcome measures that would have been part of the
scope of this review had originally been planned but then not
obtained, due to a change of protocol (Schröder 2014). For three
studies, it appeared that additional outcome measures had been
obtained during the course of the study, but were not mentioned in
the final publication (DiIorio 2011, Helde 2005; May 2002). However,
these data were not part of the scope of this review. Nonetheless,
we sought and obtained these data in two cases (DiIorio 2011; May
2002). In one case, the omitted outcome data that had aimed at
capturing the development of the health economic variables (such
as frequency of hospital admissions, missed school or work days,
etc.) had been collected, but had never been analyzed (Helde 2005).
Other potential sources of bias
We considered other potential sources of bias, such as language
bias, fidelity to the intervention protocol, competence in treatment
delivery, and selective recruitment.
Our search yielded only one non-English publication, which was
published in German (Rau 2006). However, we did not search non-
English databases, so language bias remained unclear.
In general, we had little information to judge risks of bias in
fidelity to the intervention protocol. Six studies reported the
use of measures to assess adherence (Gandy 2014: regular
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supervision with adherence checklist; Orjuela-Rojas 2015: regular
monitoring with adherence checklist; Ridsdale 2018: all courses
were audio-recorded and, of those, approximately 25% were
chosen for the fidelity evaluation; Sajatovic 2016, Sajatovic
2018: sessions were audio-recorded and non-interventionist study
staB evaluated fidelity; and Gilliam 2019: weekly supervision,
monitoring and feedback by lead/senior psychologist with CBT
adherence checklist). The results of their analysis were reported in
two recent studies (Ridsdale 2018; Sajatovic 2018). Risk of infidelity
to treatment protocol was rated low in these latter sudies. As
a result, we sought clarification from all authors who had not
reported the use of measures to assess fidelity to intervention
protocol or the results thereof. Sajatovic 2016 replied that they
had a high degree of fidelty and was therefore rated as low risk
of bias. Eight studies provided additional details on their attempts
to assess fidelity to the intervention protocol, with results (Beretta
2014: monitoring was carried out with regular on-site monitoring
visits and verification of protocol adherence; Dorris 2017: audio
recordings of each session were checked for fidelity ratings and
regular supervision; Leenen 2018: forms were used to record if all
sessions adhered to the intervention and session flip charts were
reviewed aFer sessions) or without results; (Ciechanowski 2010:
standard training protocols and supervision; Lundgren 2006 and
Lundgren 2008: regular supervision; May 2002: regular supervision
and video-taping of some sessions; Thompson 2010: adherence
checklists). Beretta 2014 and Dorris 2017 were therefore rated
as low risk of bias. We considered the risk of infidelity to the
intervention protocol as low in three studies in which the delivery
of the intervention was Internet-based (DiIorio 2011; Meyer 2019;
Schröder 2014). In all other studies risk of infidelity to the
intervention protocol was rated unclear (Au 2003; Brown 2019;
Caller 2016; Edward 2019; Fraser 2015; Helde 2005; Hosseini 2016;
Hum 2019; Jantzen 2009; Martinović 2006; Pakpour 2015; PfäBlin
2016; Pramuka 2007; Sajatovic 2016; Tang 2015; Turan Gurhopur
2018; Yadegary 2015).
We assessed two dimensions of competence in treatment delivery.
First, we reviewed the competence in terms of the professional
training background of the personnel who delivered the
intervention; in web-based intervention programs we evaluated
the training background of the professionals who had designed
the intervention. Second, we reviewed the competence of the
measures used to assess the quality of actual treatment delivery.
Most studies reported the training background of the personnel
delivering the intervention (N = 21: Au 2003; Beretta 2014; Caller
2016; Ciechanowski 2010; DiIorio 2011; Dorris 2017; Edward 2019;
Gandy 2014; Lundgren 2006; Lundgren 2008; Helde 2005; Hosseini
2016; Leenen 2018; Meyer 2019; Orjuela-Rojas 2015; Pakpour
2015; PfäBlin 2016; Ring 2018; Ridsdale 2018; Sajatovic 2016;
Sajatovic 2018). Seven studies provided additional details for
training background (Brown 2019; Fraser 2015; Gilliam 2019; May
2002; Schröder 2014; Tang 2015; Thompson 2010), We rated
the risk of bias as low for this domain in these studies. Four
studies reported the use of measures to assess competence
(Pakpour 2015: assessment of empathy, use of open-ended
questions, etc; Ridsdale 2018: all courses were audio-recorded and,
of those, approximately 25% were chosen for the competence
evaluation; Sajatovic 2016: sessions were audio-recorded and non-
interventionist study staB evaluated competence; Thompson 2010:
supervision) The results of their analysis were reported in three
studies (Pakpour 2015; Sajatovic 2016; Ridsdale 2018). We rated
the risk of bias as low for competence in intervention delivery
in these studies that reported results of the assessment. We
sought clarification from all authors who had not reported the
use of measures to assess competence or the results thereof.
Six authors provided additional details about their attempts to
assess competence, with results (Gilliam 2019: session recordings
were reviewed for clinical supervision and quality assurance;
Lundgren 2006 and Lundgren 2008: regular supervision) or
without results (Gandy 2014: no measures to assess competence
were used; May 2002: regular supervision and video-taping of
some sessions; PfäBlin 2016: regular supervision; Sajatovic 2018:
sessions were assessed qualitatively for competence [rapport and
empathy, engagement, timing, etc.]). As a result, we judged risk of
incompetence to be low in three studies (Gilliam 2019; Lundgren
2006; Lundgren 2008), and competence to deliver the intervention
protocol to be unclear in all other studies.
In general, we had little information to judge risks of bias in
selective recruitment. Risk of selective recruitment was considered
low in 12 studies that reported a consecutive recruitment
procedure at the intervention site including screening of all
patients for eligibility (Beretta 2014; Caller 2016; Dorris 2017;
Gilliam 2019; Helde 2005; Pakpour 2015; PfäBlin 2016; Ridsdale
2018; Ring 2018; Sajatovic 2016; Sajatovic 2018; Tang 2015;
Thompson 2010). Risk of selective recruitment was considered high
in all studies whose recruitment procedure involved subjective
criteria (N = 2: Au 2003: subjective report of psychological distress;
Leenen 2018: excluded patients who were not able or willing
to function in group activities based on clinical judgment) or
advertisement (N = 9: DiIorio 2011; Fraser 2015; Gandy 2014;
Lundgren 2006; Lundgren 2008; May 2002; Meyer 2019; Rau 2006;
Schröder 2014) or convenience sampling (N = 1: Hosseini 2016).
Recruitment procedures were unclear in 11 studies (Brown 2019;
Ciechanowski 2010; Edward 2019; Hum 2019; Jantzen 2009; Lua
2013; Martinović 2006; Orjuela-Rojas 2015; Pramuka 2007; Turan
Gurhopur 2018; Yadegary 2015)
E;ects of interventions
See: Summary of findings 1 Psychological treatments compared
with usual or supportive care
We have listed our outcomes in Table 2, organized in alphabetical
order and categorized according to our operational definition of
psychological treatment types.
Health-related quality of life
Quality of Life in Epilepsy Inventory (QOLIE-10, QOLIE-31,
QOLIE-31-P, QOLIE-48, QOLIE-89)
Eleven studies (643 participants) contributed data to the meta-
analysis; they investigated comparable skill-based psychological
interventions and used the most common quality-of-life tool
(QOLIE-31/-31-P/-89) as their outcome measure (also see Summary
of findings 1). Seven studies used QOLIE-31 (Au 2003; Caller
2016; Ciechanowski 2010; Fraser 2015; Gandy 2014; Martinović
2006; Orjuela-Rojas 2015). Two studies used QOLIE-31-P (Leenen
2018; Tang 2015) and two studies used QOLIE-89 (Gilliam 2019;
Helde 2005); all four study authors provided raw data allowing
transformation to QOLIE-31 for the meta-analysis.
Meta analysis results
Among the 11 studies, two studies were of adolescents and adults
(Caller 2016; Helde 2005), one of adolescents and young adults
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(Martinović 2006), and eight of adults (Au 2003; Ciechanowski 2010;
Fraser 2015; Gandy 2014; Gilliam 2019; Leenen 2018; Orjuela-Rojas
2015; Tang 2015). We found statistically significant mean changes in
the total score and each subscale measure, except social function. A
positive mean change indicated a postintervention improvement.
1. Total score (11 RCTs, 643 participants): significant mean change
of 5.23 points (95% CI 3.02 to 7.44; P < 0.001; Chi2 P = 0.08; I2 =
41%); Analysis 1.1; Figure 4
2. Overall QoL (10 RCTs, 639 participants): significant mean change
of 5.95 points (95% CI 3.05 to 8.85; P = < 0.001; Chi2 P = 0.11; I2 =
37%); Analysis 1.2; Figure 5.
3. Energy and fatigue (10 RCTs, 642 participants): significant mean
change of 5.25 points (95% CI 1.56 to 8.93; P = 0.005; Chi2 P = 0.05;
I2 = 48%); Analysis 1.3.
4. Emotional well-being (10 RCTs, 643 participants): significant
mean change of 4.96 points (95% CI 0.70 to 9.21; P = 0.002; Chi2
P = 0.002; I2 = 66%); Analysis 1.4.
5. Seizure worry (10 RCTs, 632 participants): significant mean
change of 4.35 points (95% CI 1.35 to 7.35; P = 0.005; Chi2 P = 0.42;
I2 = 2%); Analysis 1.5.
6. Cognitive functioning (10 RCTs, 641 participants): significant
mean change of 4.18 points (95% CI 1.82 to 6.54; P < 0.001; Chi2
P = 0.69; I2 = 0%); Analysis 1.6.
7. Medication eBects (10 RCTs, 643 participants): significant mean
change of 3.16 points (95% CI 0.01 to 6.32; P = 0.05; Chi2 P = 0.62;
I2 = 0%); Analysis 1.7.
8. Social function (10 RCTs, 630 participants): non-significant mean
change of 3.09 points (95% CI −0.17 to 6.35; P = 0.06; Chi2 P = 0.68;
I2 = 0%); Analysis 1.8.
 















Heterogeneity: Tau² = 5.32; Chi² = 16.89, df = 10 (P = 0.08); I² = 41%
Test for overall effect: Z = 4.64 (P < 0.00001)
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Figure 5.   Forest plot of comparison: 1 QOLIE-31- Comparison of mean change from baseline, outcome: 1.2 QOLIE-31













Heterogeneity: Tau² = 7.62; Chi² = 14.23, df = 9 (P = 0.11); I² = 37%
Test for overall effect: Z = 4.02 (P < 0.0001)
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Funnel plots for analyses of QOLIE-31 total score and overall QoL
are provided in Figure 6 and Figure 7, respectively. Within both
plots, the Orjuela-Rojas 2015 study is clearly distinguishable from
the other studies, but we interpret that this visually diBerent result
is due to this study having the smallest sample size and the most
imprecise results (largest standard error) of all included studies,
and that there is no clear evidence of publication bias from visual
inspection of asymmetry of the plots.
 
Figure 6.   Funnel plot of comparison: 1 QOLIE-31- Comparison of mean change from baseline, outcome: 1.1
QOLIE-31- total score.











Psychological treatments for people with epilepsy (Review)









Cochrane Database of Systematic Reviews
Figure 7.   Funnel plot of comparison: 1 QOLIE-31- Comparison of mean change from baseline, outcome: 1.2 QOLIE-31
- overall QoL subscale.











We report the results of the 14 studies that used QOLIE-inventories
and could not be included in the meta-analysis in narrative
form. They were excluded because they were not skills-based but
education-only interventions (four studies: PfäBlin 2016, Ridsdale
2018; Beretta 2014, Lua 2013), or the uniqueness of the intervention
protocol (two studies: Meyer 2019; Pakpour 2015), or inadequate
data (DiIorio 2011; Hosseini 2016; Meyer 2019; Pramuka 2007;
Sajatovic 2016; Sajatovic 2018; Turan Gurhopur 2018; Yadegary
2015).
Seven studies reported significant improvements in the treatment
group when comparing the mean postintervention outcomes:
Hosseini 2016 reported a significant mean increase in the total
score for the intervention group (mean change 35.95 [SD 8.74]; P <
0.001) and a significant mean decrease for the control group (mean
change −8.07 [SD 8.91]; P < 0.001);
Lua 2013 (intervention mean 69.2 [SD 17.4] versus control mean
58.4 [SD 13.6]; P = 0.007);
Meyer 2019 (intervention mean 32.50 [SD 5.12] verses control mean
30.91 [SD 5.05]; P < 0.01 using intension-to-treat analysis);
Pakpour 2015 (intervention mean 62.14 [SD 13.21] versus control
mean 56.01 [SD 12.12]; P < 0.001 [adjusted for variables such as age
and gender]);
Sajatovic 2018 (SMART intervention mean 2.52 [SD 0.9] versus wait-
list control mean 2.99 [SD 08] in which higher scores indicated
worse quality of life; P < 0.001);
Turan Gurhopur 2018 (intervention mean increase 2.54 ± 0.238
versus control mean increase 2.26 ± 0.254, P < 0.002);
Yadegary 2015 (intervention mean 72.18 [SD 11.34] versus control
mean 53.49 [SD 15.97]; P < 0.001).
The remaining seven studies did not report a significant mean
postintervention diBerence in total scores between the treatment
and control groups:
Beretta 2014 (intervention mean 63.00 [SD 15.48] versus control
mean 65.04 [SD 14.38]; P value was reported to be non-significant,
without precise value);
DiIorio 2011 (intervention mean 33.77 [SD 7.96] versus wait-list
control mean 33.27 [SD 7.52]; P = 0.731);
PfäBlin 2016 (intervention mean 68 (SD 21) versus control mean 66
[SD 20], P value was reported to be non-significant, without precise
value);
Pramuka 2007 (intervention mean 67.3 [SD 2.6] versus control mean
65.0 [SD 2.8]; P value was reported to be non-significant, without
precise value);
Ridsdale 2018 (intervention mean 66.3 [SD 13.0] versus control
mean 65.5 [SD 14.0]; P = 0.195);
Sajatovic 2016 (intervention mean 2.38 [SD 0.60] versus control
mean 3.03 [SD 0,79]; P = 0.129);
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Schröder 2014 (intervention mean 50.55 [SD 3.69] versus control
mean 52.22 [SD 3.19]; P = 0.667).
The potential impact of the three studies that did not contribute
data to the meta-analysis was probably small (Hosseini 2016
[28 participants]; Yadegary 2015 [30 participants]; Pramuka 2007
[31 participants]), especially since two studies also reported
significantly higher postintervention HRQOL in the treatment over
the control groups (Hosseini 2016; Yadegary 2015).
Since most of the included studies had at least some bias issues, we
did not perform a sensitivity analysis to compare studies at low risk
of bias with studies at high risk of bias.
Other HRQOL outcome measures
Thirteen studies used other HRQOL outcome measures (Brown
2019; DiIorio 2011; Dorris 2017; Edward 2019; Hum 2019; Jantzen
2009; Lundgren 2006; Lundgren 2008; May 2002; Rau 2006; Ring
2018; Schröder 2014; Thompson 2010). We report the results in
narrative form.
The World Health Organization Quality of Life instruction, short
version (WHOQOL-BREF) was used in four studies (Hum 2019;
Lundgren 2006; Lundgren 2008; Schröder 2014). Lundgren 2006
and Schröder 2014 reported a non-significant mean diBerence
between groups (Lundgren 2006: intervention mean 58.36 [SD 9.66]
and the control mean 55.31 [SD 6.59], P value was non-significant
without precise value reported; Schröder 2014: intervention mean
75.9 [SD 15.04] versus control mean 78.62 [SD 17.39], P value
was non-significant without precise value reported). Hum 2019
and Lundgren 2008 reported significant improvement in the
intervention group (Hum 2019: P = 0.019; Lundgren 2008: P < 0.01)
but not in the control group; however, the significance level for a
group diBerence at postintervention was not specified (Hum 2019:
mean changes from baseline scores for the intervention group,
active control group, and wait-list control group were 6.88 [SD
2.6], 5.03 [SD 2.6], and 0.76 [SD 4.2], respectively; Lundgren 2008:
postintervention group mean 57.2 [SD 7.2] versus control group
mean 60.2 [SD 8.6]).
The Satisfaction with Life Scale (SWLS) was used by four studies
(Edward 2019; Lundgren 2006; Lundgren 2008; Thompson 2010).
Edward 2019 reported the mean scores at postintervention of the
intervention group (mean 24.4 [SD 7.83] versus the control group
25.3 [SD 7.44]) without mentioning the significance level. Lundgren
2006 reported a significant group diBerence at postintervention
(intervention group mean 23.28 [SD 4.58] versus control group
mean 13.85 (SD 5.98); P < 0.05). Lundgren 2008 did not specify
the significance level of the group diBerence at postintervention
(intervention group mean 21.8 [SD 6.3] versus control group mean
21 [SD 7.1]). Thompson 2010 reported a non-significant diBerence
between groups (21 [treatment mean] versus 18 [wait-list control
mean]; P = 0.090; SD was not reported).
Seven studies used diBerent HRQOL outcome measures:
Brown 2019 used the Childhood Epilepsy Quality of Life scale
(CHEQOL: intervention mean of 77.5 [SD 13.3] versus control mean
of 78.9 [SD 12.4]) and the KIDSCREEN-27 (intervention mean 50.4
[SD 10] versus control mean 47.5 [SD 7.6], but the significance level
was not significant);
Dorris 2017 used two measures for quality of life, both showed
non-significant postintervention mean between the intervention
and control groups; the Paediatric Quality of Life Inventory PedsQL
version 4.0 (intervention mean of 67.61 [SD 14.10] versus control
mean of 66.93 [SD 17.28]) and the Glasgow Epilepsy Outcome Scale
for Young Persons (GEOS-YP) (intervention mean 63.82 [SD 14.43]
versus control mean 66.83 [SD 11.85]);
Edward 2019 reported the postintervention mean of the SF-12
physical health score (PCS) (intervention group mean of 52.1 [SD
8.82] versus control mean of 47.8 [SD 11.8]) and the mental health
score (MCS) (intervention group mean of 47.3 [SD 8.65] versus
control mean of 46.8 [SD 10.6]) without mentioning the significance
level;
Jantzen 2009 reported that children and adolescents in the
treatment group showed a significant increase in the social
exclusion subscale in DISABKIDS, indicating better quality of life,
based on postintervention scores (P value was not provided; d = 0.3
[Cohen] Cohen 1988);
May 2002 reported non-significant postintervention mean between
groups using the Short-Form 36 mental component (intervention
mean 43.69 [SD 11.51] versus wait-list control mean 42.46 [SD
11.75]), and the physical component (intervention mean 50.39 [SD
9.37] versus wait-list control mean 52.00 [SD 8.7]; P = 0.075);
Ring 2018 employed the Epilepsy and Learning Disabilities
Quality of Life scale (ELDQoL). The comparison between the
intervention group postintervention mean and control group was
non-significant (mood scale intervention mean 26.01 [SD 8.74]
versus control mean 26.64 [SD 8.81]; behavior scale intervention
mean 15.65 [SD 6.51] versus control mean 16.28 [SD 6.77]);
Rau 2006 used the self-reported German questionnaire,
Gesundheitsbezogene Lebensqualität und psychosoziale
Auswirkungen der Epilepsie, (HRQoL and psychosocial
consequences of epilepsy (intervention mean 70.62 [SD 13.29]
versus wait-list control mean 77.25 [SD 15.0]; P = 0.075).
Psychiatric comorbidities outcome measures
Depression
Sixteen of the 36 studies included the level of depression as
an outcome measure; all of them indicated that there were no
statistical diBerences between the treatment and control groups
at baseline. We used postintervention means to compare the
diBerences between the two groups. Eight studies reported a
significant postintervention diBerence between the intervention
and control groups (Ciechanowski 2010; Fraser 2015; Gandy 2014;
Hum 2019; Martinović 2006; Schröder 2014; Tang 2015; Thompson
2010). Nine studies used more than one outcome measure (Caller
2016; Ciechanowski 2010; Gandy 2014; Gilliam 2019; Hum 2019;
Martinović 2006; Meyer 2019; Orjuela-Rojas 2015; Sajatovic 2016).
Two studies, which used two outcome measures reported both
significant and non-significant results (Ciechanowski 2010; Hum
2019). Eight studies reported non-significant results (Caller 2016;
Dorris 2017; Leenen 2018; May 2002; Orjuela-Rojas 2015; PfäBlin
2016; Ridsdale 2018; Sajatovic 2016). A lower mean score indicated
fewer depressive complaints.
Beck Depression Inventory and Beck Depression Inventory-II (BDI and
BDI-II)
In the six studies that used the BDI or BDI-II, four reported
significantly better postintervention mean depressive symptoms in
the treatment groups: Martinović 2006 (intervention mean 5.4 [SD
2.97] versus control mean 7.8 [SD 2.66]; P < 0.05); Schröder 2014
(intervention mean 15.84 [SD 13.00] versus control mean 18.37 [SD
10.23]; P = 0.01); Tang 2015 (intervention mean 6.90 [95% CI 4.49
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to 9.31] versus control mean 9.47 [95% CI 6.26 to 12.67]; P = 0.045);
Thompson 2010 (intervention mean 5.5 versus control mean 10.6; P
value < 0.01). Gilliam 2019 and Orjuela-Rojas 2015 reported a non-
significant diBerence (Gilliam 2019: intervention mean 12.8 [SD
11.9] versus control mean 12.3 [SD 9.9]; P value was not reported;
Orjuela-Rojas 2015: intervention mean 17.2 versus control mean
14.6; P = 0.58; SD was not reported).
Hospital Anxiety and Depression Scale (HADS) for assessing
depression (HADS-D)
Five studies used the HADS to assess depressive symptoms (Gandy
2014; Leenen 2018; Orjuela-Rojas 2015; PfäBlin 2016; Ridsdale
2018). Gandy 2014 reported significantly better postintervention
depressive symptoms in the treatment group (intervention mean
4.58 [SD 3.59] versus control mean 5.50 [SD 5.26]; P = 0.048), while
in Leenen 2018 (intervention mean 5.7 [SD 2.7] versus control mean
5.5 [SD 2.6]), the P value was non-significant, without a precise
value; Orjuela-Rojas 2015 (intervention mean 5.4 versus control
mean 5.2; P = 0.93; SD was not reported); PfäBlin 2016 (intervention
mean 9.0% ≥ 11 and control mean 5.5% ≥ 11; P = 0.432); and
Ridsdale 2018 (intervention mean 5.5 [SD 3.9] versus control mean
5.0 [SD 3.9], P value was non-significant, without precise value)
reported a non-significant diBerence.
Patient Health Questionnnaire-9 for accessing depression (PHQ-9)
Five studies used the PHQ-9 to assess depressive symptoms
(Caller 2016; Fraser 2015; Meyer 2019; Sajatovic 2016; Thompson
2010). Caller 2016 and Sajatovic 2016 reported a non-significant
diBerence in postintervention changes (Caller 2016: intervention
mean change −0.7 [SD 1] versus control mean change 1.2 [SD
1.2]; Sajatovic 2016: intervention group mean 9.70 [SD 5.55] versus
control mean 11.76 [SD 5.72], P = 0.25). Fraser 2015 and Meyer 2019
reported significantly lower depression scores in the treatment
group (Fraser 2015: intervention mean 6.3 [SD 5.5] versus control
mean 8.6 [SD 6]; P = 0.02; Meyer 2019: intervention mean 10.42 [SD
4.38] versus control mean 12.73 [SD 4.19]; P < 0.001). Thompson
2010 used the PHQ-9 to identify individuals with a major depressive
disorder at baseline, but did not provide postintervention data.
Neurological Disorders Depression Inventory for Epilepsy (NDDIE)
Four studies used the NDDIE to assess depressive symptoms (Caller
2016; Gandy 2014; Hum 2019; Meyer 2019). Gandy 2014 and Meyer
2019 found significantly reduced postintervention depressive
symptoms in the treatment group (Gandy 2014: intervention mean
14.3 [SD 3.4] versus wait-list control mean 16.48 [SD 3.81]; P =
0.045; Meyer 2019; intervention mean 14.35 [SD 3.4] versus control
mean 16.02 [SD 3.15]; P > 0.001). Hum 2019 reported a significant
decrease in scores across time for the intervention group (mean
change from baseline: 1.75 [SD 0.8], P = 0.023) and the active control
group (mean change from baseline: 1.71 [SD 0.8], P = 0.016), but
not the wait-list control group (mean change from baseline: 0.45
[SD 0.6], P = 0.654). Caller 2016 reported a non-significant diBerence
in depressive symptoms between groups (treatment mean change
from baseline −0.4 [SD 0.6] versus control mean change from
baseline 0.7 [SD 0.8]; P = 0.30.
Other depression outcome measures
Three studies that used other measures found significant eBects
in the treatment group for postintervention depressive symptoms.
Martinović 2006 used the Center for Epidemiological Study on
Depression scale (intervention mean 9.8 [SD 4.2] versus control
mean 13.6 [SD 4.64]; P < 0.05) and the Hamilton Depression Scale
(intervention mean 3.3 [SD 1.29] versus control mean 5.8 [SD
1.98]; P < 0.05). Hum 2019 used the Quick Inventory of Depressive
Symptomatology (QIDS) and found a significant decrease in scores
across time for the intervention group (P = 0.014) and the active
control group (P = 0.02), but not for the wait-list control group
(P = 0.085). However, the significance level of the comparison
of postintervention mean scores was not reported (intervention
group: 9.55 [SD 1.1], active control group: 10.63 [SD 1.0] and
wait-list control group 10.73 [SD 1.5]). Sajatovic 2016 used the
Montgomery and Asberg Depression Rating Scale (MADRS) and
found a significant treatment-by-time interaction eBect (P = 0.036),
and the comparison of postintervention group means (intervention
group mean 16.75 [SD 10.28] versus control group mean 22.94 [SD
11.81]) was non-significant (P = 0.09).
Four studies that used other measures found non-
significant diBerences in depressive symptoms between groups.
Ciechanowski 2010 used the Hopkins Symptom Checklist-20
(treatment mean change from baseline −0.18 [SD 0.7] versus control
mean change from baseline −0.48 [SD 0.7]; P = 0.09). May 2002
used the Depressive Mood Scale (intervention mean 13.63 [SD
8.99] versus wait-list control mean 12.22 [SD 8.86]; the P value
was non-significant, without precise value). Brown 2019 and Dorris
2017 used pediatric depression outcome measures and found non-
significant diBerences in depressive symptoms between groups.
Brown 2019 used the Children's Depression Inventory — Short (CDI-
S): intervention mean 45.6 (SD 6.9) versus control mean 44 (SD
4.8); Dorris 2017 used the Pediatric Index of Emotional Distress (PI-
ED): intervention group mean: 14.95 (SD 6.39) versus control group
mean: 13.39 (SD 6.69), P value was non-significant, without precise
value.
Suicidal ideation
While Ciechanowski 2010 reported a significantly smaller
proportion of participants with suicidal ideation at follow-up
(decreasing 24% in the intervention group and increasing 12% in
the usual care group; P = 0.025; post-treatment outcomes were not
reported), Orjuela-Rojas 2015 did not find a significant diBerence
in suicide risk between groups, using the Mini International
Neuropsychiatric Interview (intervention mean 1.1 versus control
mean 0.6; P = 0.42; SD was not reported).
Anxiety
Eight studies included the level of anxiety symptoms as an
outcome measure (Fraser 2015; Gandy 2014; Leenen 2018; Meyer
2019; Orjuela-Rojas 2015; PfäBlin 2016; Ridsdale 2018; Tang
2015). One study reported significant baseline diBerences between
the intervention (11.2) and control (8.3); P = 0.04 (Orjuela-
Rojas 2015). We used postintervention means to compare the
diBerence between the two groups. A lower mean score indicated
fewer anxiety complaints. Two studies reported a significant
postintervention diBerence between the intervention and control
groups (Meyer 2019; Tang 2015).
Beck Anxiety Inventory (BAI)
Among the eight studies that examined anxiety symptoms, only one
study, using the BAI, reported significantly fewer postintervention
anxiety symptoms between groups (intervention mean 9.73 [95%
CI 6.35 to 13.22) versus control mean 10.70 [95% CI 7.24 to 14.16];
P = 0.008 [Tang 2015]). None of the remaining studies, assessing
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anxiety with validated outcome measures, reported a significant
diBerence.
Hospital Anxiety and Depression Scale (HADS) for assessing anxiety
(HADS-A)
Gandy 2014 reported a non-significant postintervention diBerence
between groups (intervention mean 6.11 [SD 2.96] versus control
mean 7.45 [SD 3.78]; P = 0.089). Similar findings were also reported
by Leenen 2018 (intervention mean 5.2 [SD 3.5] versus control mean
6.1 [SD 4.2], P value was non-significant, without precise value);
PfäBlin 2016 (20.9% with HADS-A ≥ 11 in the intervention group
and 17.8% with HADS-A ≥ 11 in the control group; P value was
non-significant, without precise value); Ridsdale 2018 (intervention
mean 9.0 [SD 5.0] versus control mean 7.8 [SD 4.8], P = 0.917) and
Orjuela-Rojas 2015 (intervention mean 9.7 versus control mean 9.2;
P = 0.8). It is worth noting that in this study, the treatment group had
a significantly higher anxiety score at baseline compared to control
(11.2 versus 8.3; P value = 0.04).
Generalized Anxiety Disorder-7 (GAD-7)
While Meyer 2019 found a significant diBerence between groups
at postintervention in symptoms of anxiety using the Generalized
Anxiety Disorder-7 (intervention mean 7.74 [SD 4.3] versus control
mean 9.82 [SD 3.91]; P < 0.001), Fraser 2015 did not find a significant
diBerence between groups (intervention mean 5.4 [SD 6.6] versus
control mean 6.1 [SD 5.1]; P = 0.282).
Seizure-related outcomes
FiFeen studies included seizure-related variables as outcome
measures (Au 2003; Ciechanowski 2010; Gilliam 2019; Jantzen 2009;
Leenen 2018; Lundgren 2006; Lundgren 2008; May 2002; Pakpour
2015; Rau 2006; Ridsdale 2018; Ring 2018; Sajatovic 2016; Sajatovic
2018; Tang 2015). Sajatovic 2018 reported negative health events
(NHEs) which included seizure count but also other variables
such as epilepsy-related emergency room visits and injuries. All of
them reported no evidence of baseline imbalance between groups
except in Lundgren 2008, in which no statistics were provided, and
baseline imbalance was indicated from the raw data (treatment
group N = 10, seizure frequency = 414; active control group N =
8, seizure frequency = 33). However, this study reported that 50%
of participants in both the intervention and the active control
groups were seizure-free at postintervention. Five studies reported
a significant postintervention diBerence between the intervention
and control groups (Lundgren 2006; Lundgren 2008; May 2002;
Pakpour 2015; Tang 2015).
Three studies reported a significant postintervention reduction in
seizure frequency between groups:
May 2002 (seizures per month in six months: intervention mean 2.77
[SD 1.64] versus control mean 2.74 [SD 1.62]; P < 0.041);
Lundgren 2006 (seizures in one month: intervention mean 0.71 [SD
0.91] versus control mean 6.00 (SD 3.91); P < 0.001);
Tang 2015 (seizures in six weeks: intervention mean 5.9 [95% CI 2.88
to 8.92] versus control mean 7.33 [95% CI 3.46 to 11.21]; P = 0.018).
Twelve studies reported non-significant postintervention
diBerences between groups in seizure frequency: (Au 2003;
Ciechanowski 2010; Gilliam 2019; Jantzen 2009; Lundgren 2008;
Rau 2006; Ridsdale 2018; Sajatovic 2016), seizure recency (Ridsdale
2018), seizure severity (Gilliam 2019: seizure calendar; Leenen 2018:
National Hospital Seizure Severity Scale (NHS3): intervention group
mean 7.3 [SD 8.1] versus control group mean 8.4 [SD 9.3], P value
was non-significant, without precise value; Ring 2018: Epilepsy and
Learning Disabilities Quality of Life seizure severity scale (ELDQoL-
SSS): intervention group mean 22.48 [SD 9.55] versus control group
mean 23.07 [SD 9.70], P = 0.875).
Pakpour 2015 reported a significant postintervention reduction
in seizure severity using the Liverpool Seizure Severity Scale
(intervention mean 47.24 [SD 17.41] versus control mean 58.09 [SD
21.75]; P < 0.05).
Tang 2015 found no significant postintervention changes using the
Seizure Severity Index (intervention mean 2.55 [95% CI 2.06 to 3.03]
versus control mean 2.91 [95% CI 2.44 to 3.38]; P > 0.05).
Sajatovic 2018 also found no significant postintervention change
of seizure count (intervention mean −1.4 [SD 5.12] versus control
mean 5.5 [SD 0.62]; P = 0.60) and non-significant diBerences in
seizure severity (intervention mean 19.52 [SD 8.3] versus control
mean 17.91 [SD 7.8]; P = 0.06).
Lundgren 2006 and Lundgren 2008 measured seizure index (seizure
frequency x seizure duration in seconds), which was not a validated
outcome measure. With a comparable baseline seizure index,
Lundgren 2006 reported significant postintervention reduction.
Lundgren 2008 reported a significant diBerence in change scores
between the two groups.
D I S C U S S I O N
Despite our broad operational definition, psychological treatments
for people with epilepsy have been investigated in a relatively small
number of randomized controlled trials. We found 36 RCTs that fit
our operational definition, and investigated HRQOL as a primary or
secondary outcome parameter.
Summary of main results
Primary outcome measure
The Quality of Life in Epilepsy Inventory (QOLIE-10, QOLIE-31,
QOLIE-31-P, QOLIE-48, QOLIE-89) was the most commonly used
outcome measure for health-related quality of life (HRQOL), and
was used in 25 studies. Results from the meta-analysis (11 studies:
Au 2003; Caller 2016; Ciechanowski 2010; Fraser 2015; Gandy
2014; Gilliam 2019; Helde 2005; Leenen 2018; Martinović 2006;
Orjuela-Rojas 2015; Tang 2015) found significant postintervention
improvement for the total score and for six out of seven QOLIE-31
subscales (emotional well-being, energy and fatigue, overall QOL,
seizure worry, cognitive functioning, and medication eBects). The
mean improvement in the total score and one subscale measuring
overall QOL exceeded the minimally important change (MIC)
threshold established by Borghs 2012 for a small eBect size (d =
0.3 [Cohen]), indicating a clinically meaningful postintervention
improvement in HRQOL (MIC: total score: 4.73 points; QoL score:
5.22 points). In the remaining 14 studies that were not included in
the meta-analysis, seven reported significant diBerences between
the treatment and control groups at post-treatment measures
(Hosseini 2016; Lua 2013; Meyer 2019; Pakpour 2015; Sajatovic
2018; Turan Gurhopur 2018; Yadegary 2015), and seven reported
non-significant group diBerences at post-treatment measures
(Beretta 2014; DiIorio 2011; PfäBlin 2016; Pramuka 2007; Ridsdale
2018; Sajatovic 2016; Schröder 2014). Eleven studies used HRQOL
outcome measures other than the QOLIE inventories, but only
three studies found a significant diBerence between the treatment
and control groups at post-intervention, indicating significantly
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better HRQOL in the treatment groups (Hum 2019; Jantzen 2009;
Lundgren 2006).
Secondary outcome measures
Fewer than half of the studies (eight out of nineteen) examining
depressive symptoms reported a decrease in symptoms for
those receiving the treatment compared to control. Only two
studies out of eight examining anxiety levels found a significant
postintervention reduction in the treatment groups. A relatively
small proportion of the studies (5/14) investigating seizure-
related outcome measures reported a significant reduction at
postintervention in the treatment groups.
Overall completeness and applicability of evidence
The studies in this updated review evaluated complex
psychological treatments, typically applied in tertiary-care
settings, and involved participant groups with comparable
underlying epilepsy diagnoses, but diBering severities of
psychiatric and somatic comorbidities, and diverse cultural,
ethnic, and socioeconomic backgrounds. There were diBerences
between the included studies in their stated treatment methods,
goals, strategies, and theoretical underpinnings. Psychologists with
varying levels of experience delivered most of the treatments; team
eBorts including a wider range of specialists (doctors, nurses, social
workers, etc.) were involved in some educational interventions. In
some cases, the work of these therapists was carefully structured
and supervised, while some studies presumably relied on shorter
training courses.
We used 10 diBerent outcome measures to investigate our primary
outcome measure, i.e. HRQOL (QOLIE inventories, WHOQOL-
BREF, SWLS, DISABKIDS, SF-12/-36, PedsQL, GEOS-YP, CheQoL,
KIDSCREEN-27, ELDQoL). Hence, our eBorts to pool data were
hampered to some extent by the wide diversity of outcome
measures used in these trials. We addressed this by including as
many comparable outcome as possible. We therefore sought raw
data from authors that used the QOLIE inventories convertible
to QOLIE-31 (most commonly used in our included studies) and
analyzed the mean change from baseline. In addition, we focused
our meta-analyses on skills-based psychological interventions and
did not include education-only interventions. The studies which are
included in meta-analysis are representative of the whole evidence
base for skills-based psychological interventions. We have no
reason to think that the results from these meta-analyses would not
be applicable in similar settings and patient groups.
Certainty of the evidence
We pooled results only from studies measuring the same construct
(QOLIE-31, QOLIE-31-P, QOLIE-89) and limited meta-analysis to
fairly similar interventions, to avoid clinical heterogeneity. Overall,
the certainty of evidence of the meta-analysis was limited by a
serious risk of bias in some of the included studies (e.g. Orjuela-
Rojas 2015, with four high-risk and one unclear rating out of seven
'Risk of bias' parameters). Since most of the included studies had
at least some bias issues, we did not perform a sensitivity analysis
comparing studies with low risk of bias versus studies with high risk
of bias. Given that the evidence directly answered our healthcare
question, the results were precise enough, and fairly consistent
across studies, and we found no evidence of publication bias or
a dose-response gradient in the included studies, we considered
there was no reason to further downgrade the certainty of the
evidence. As the eBect was not large, neither was there reason to
upgrade the certainty of the evidence. Interpreting these findings
with the GRADE approach, we are therefore moderately confident
in the eBect estimate that skills-based psychological interventions
may enhance overall quality of life in people with epilepsy.
We identified RCTs and quasi-RCTs to include in this review,
based on our operational definition of psychological interventions,
regardless of the nature of the control group. The heterogeneity
of control groups (e.g. usual care, wait-list control, other
psychological or educational intervention, pharmacotherapy, etc.)
may have influenced the interpretation of the eBect of skills-based
psychological interventions for people with epilepsy because they
may have been attenuated by another evidence-based treatment
(e.g. using sertraline for the treatment of depression in epilepsy in
the control group, used by Gilliam 2019). As the number of included
studies increases, we may take this into consideration and regroup
our analyses in future updates.
In the process of evaluating the risks of bias, we considered two
biases that are naturally inherent in the context of psychological
intervention trials. The first bias was blinding of participants
and the professionals who deliver the intervention. Although two
studies managed to blind both participants and the professionals
providing treatment (Martinović 2006 by using an active skills-
based intervention control group, and Ring 2018 by using a cluster-
randomized design), we considered this as a reasonable bias in
psychological trials. Secondly, we rated all studies that included
self-selection, e.g. through advertisement, web-based fora, study
flyers, in the process of participant recruitment as having a high risk
of bias for selective recruitment. We agreed that this is a high risk of
bias for research design, but we could understand the reason from a
clinical perspective, because patient volunteering may oFen reflect
motivation to treatment. We therefore also considered this to be a
reasonable bias in psychological trials.
Potential biases in the review process
The identification of relevant studies fitting our broad operational
definition of psychological treatments was challenging. As outlined
in the review protocol, we searched a wide variety of databases,
including trial registers, and scanned reference lists of relevant
systematic reviews. Two review authors independently evaluated
all studies and referred to the wider group of review authors
or the Epilepsy Review Group with any unresolved questions.
Although this whole process was carried out carefully, we cannot
discount the possibility that we may have missed a relevant study,
or misjudged an included study or a study outcome. Since this
review will be periodically updated, we will in future updates
include any missed relevant studies, and correct misjudgments of
included studies or study outcomes that come to our attention.
Even though many of the included studies were published despite
finding non-significant results, we cannot discount the potential
risk of publication bias. However, the research community did not
make us aware of trials that had been stopped or not published
because of non-significant findings.
Three members of our review author team had also co-authored
three of the included studies (Gandy 2014; Ridsdale 2018; Tang
2015). Following the strict standards of the Cochrane review
process, we felt that this contributed a necessary critical expertise
with the implementation of RCTs in this area of research, rather
than an increased risk of bias. Gandy and Goldstein were not
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involved in the actual review process. Since Tang had been involved
in the review process, a second author with no conflict of interest
(MR) assessed eligibility and risks of bias for her study.
Agreements and disagreements with other studies or
reviews
The results of this review reinforced the conclusions of a recent
systematic review of psychological treatments for epilepsy, which
suggested that cognitive behavioral therapy and mindfulness-
based interventions had consistently demonstrated significant
improvements in HRQOL in prospective uncontrolled, as well as in
controlled study designs (Tang 2014).
This review is in keeping with a systematic review of cognitive
behavioral therapy for depression in people with epilepsy, which
suggested that interventions tailored toward improving depression
were possibly eBicacious (Gandy 2013). Our results are also in line
with the previous Cochrane Review focusing on seizure frequency
as a primary outcome parameter, in that we could draw no reliable
conclusions about the eBicacy of psychological treatments in
controlling seizures (Ramaratnam 2008).
From our review of randomized controlled trials investigating
psychological treatments, we have identified the following two
research problems in this area.
The feasibility of using randomized trial designs to study
psychological interventions has been repeatedly challenged,
primarily because the possibility of realistically balancing
prognostic factors, on average, across intervention groups is
questionable. The psychological (and psychopathological) make-
up of most participants is regarded as being too multifaceted for
this endeavor to be successful. In addition, these trial designs
usually include pre- and postintervention outcome measurements
only and are therefore limited in their ability to capture
process-related outcomes. (Tschuschke 2005). Technology-focused
outcome measures, such as electronic monitors and ecological
momentary assessment (EMA) may provide systematic (i.e.
equidistant) and frequent (e.g. daily) response data on symptoms,
mood, and behavior. Such process-oriented variables may
provide insight in nonlinear and complex dynamics of human
change processes and therefore allow for more individualized
psychotherapeutic management (Modi 2017).
Another important contributing factor to the eBectiveness of
psychological treatments is the therapeutic relationship between
recipient and therapist (Baldwin 2013). However, no RCT
investigating psychological treatment for epilepsy included this
relationship as a variable.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
We found moderate-certainty evidence that skills-based
psychological interventions benefited adults with epilepsy in
quality of life. The eBect in the intervention groups was significantly
better than in the control groups (using usual care, social
support, counseling as usual, or selective serotonin reuptake
inhibitors). Unfortunately, we found few interventions focused on
quality of life in children and adolescents. Only one study (Ring
2018) investigated an intervention in individuals with intellectual
disability (IQ < 70). These findings therefore can not be generalized
to this population.
Implications for research
Increasing overall quality of reporting
In many cases, the quality of the study design and its
implementation appeared to be better than the actual publication
suggested. There are mechanisms available to raise the quality of
reporting (e.g. submitting manuscripts of RCTs with a CONSORT
checklist [Schulz 2010]). Adherence to the CONSORT guidelines and
use of the CONSORT checklist may not only increase the eBort by
study authors and review authors, but it may also raise the quality
of reporting in this resource-intensive field of research. The quality
of reporting may be improved with small changes, such as including
the descriptor 'assessor-blinded' in the title, since depending
on the study design, this may be the only type of blinding
that is feasible in this area of research. Adhering to CONSORT
guidelines may be made diBicult by a journal's word limitation
policies. If that is the case, pertinent details about study design
should be submitted as supplementary materials published online.
Publication of research designs prior to conducting a study is
now required by many journals, which increases transparency. The
CONSORT group has developed an extension for trials assessing
nonpharmacologic treatments to acknowledge and help navigate
the specific challenges that are not addressed in the original
CONSORT guidelines (Boutron 2008).
Furthermore, specific information about participant screening and
selection will allow clinicians to assess the applicability of an
intervention to their clinical setting or to modify an intervention
for their patient population. We encourage the reporting of
non-significant study results, since they also make important
contributions to the concerns of the whole scientific community.
Increasing comparability by using common and meaningful
HRQOL outcome measures
Investigators are encouraged to ensure that their outcome
measures match the treatment goal of the investigated
intervention (e.g. self-management, coping, etc.) (Modi 2017);
HRQOL may constitute a secondary outcome measure. Despite
diverse treatment goals and outcomes, the broad use of the
standardized QOLIE inventories would increase comparability of
studies investigating psychological treatments for children and
adults with epilepsy.
Since many psychological treatments involve patient-oriented goal
setting, it would be interesting to explore if the extended Quality
of Life in Epilepsy-31-P would provide a more accurate reflection
of the treatment eBects than the use of the 'non-personalized'
QOLIE-31, due to the individually-weighted calculation of scores
for the individual's subjective evaluation. This exploration would
require the correlation of this extended version with quantitative
and qualitative clinical data in trials investigating psychological
treatments.
We could not include any pediatric RCTs in the meta-analysis, due
to a lack of epilepsy-specific HRQOL outcomes. Future pediatric
studies should incorporate validated HRQOL measures that qualify
as common data elements.
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To help with the interpretation and evaluation of clinical rather
than statistical relevance of outcomes, we recommend that all
studies using HRQOL outcome measures for which a minimum
clinically important change has been determined, include the
percentage of participants whose results reached a minimum
clinically important change, with confidence intervals.
If a minimum clinically important change has not been established,
providing eBect sizes would help readers to assess the clinical
meaning of statistical results.
Increasing overall quality of study designs
In order to increase the overall quality of study designs,
adequate randomization and allocation concealment, and blinded
outcome assessment should be pursued when conducting RCTs
investigating psychological treatments for people with epilepsy. As
attrition is oFen high in this type of research, which requires active
participation, an intention-to-treat analysis (or other appropriate
statistical analysis accounting for follow-up data) should be carried
out, and reasonable power calculations should be conducted to
determine appropriate sample sizes. For active and immediate
control groups, supportive therapy, social support, or regular
counseling can be used as a control group for the eBects of
attention, which allows blinding of the participants to their
treatment arm (Lundgren 2006; Martinović 2006; Tang 2015). To
facilitate the attribution of treatment eBects, the use of anti-
seizure medications (ASMs) and the resulting changes should be
recorded and reported. There are measures available that would
allow for the evaluation of treatment fidelity, such as recording and
scoring sessions, which should also be used and reported. Besides
treatment fidelity, the quality of actual treatment delivery (i.e. the
clinical skills of the therapist) should also be actively monitored and
reported.
Due to limitations of self-report measures, future study designs
could complement these measures with objective measures, e.g.
hospital stays and emergency room visits, sick leaves and injuries,
as well as biomarkers, such as functional Magnetic Resonance
Imaging (fMRI), quantitative EEG analyses, etc. However, the
validity of a number of fMRI studies has recently been questioned,
which may have a large impact on the interpretation of weakly-
significant neuroimaging findings (Eklund 2016).
In order to allow for a better assessment of the sustainability of
study results, study designs should include a follow-up assessment
of outcome measures at least three months aFer treatment
discontinuation.
Increasing overall generalizability
Impaired intellectual function or disability or both are more
common in people with epilepsy than in the general population,
especially among people with early-onset epilepsy. Investigating
the applicability of using skills-based psychological interventions
or educational interventions in these populations could therefore
provide important clinical insights. There was only one included
study (Ring 2018) focused on using a skills-based psychological
intervention for individuals with ID (IQ < 70). We recommend
examining this subsample of people with epilepsy as a direction for
further research.
Increasing implementation e;orts
While an increasing number of clinical trials have investigated the
eBicacy of psychological interventions for people with epilepsy,
only a smaller number of these interventions have outlasted the
funding of the clinical trial period, and an even smaller number
of interventions have been integrated into usual-care pathways in
locations other than the original study site. Future funded studies
may require a section and plan describing how implementation
science addresses moving a successful intervention into clinical
practice. In order to increase these implementation eBorts, it seems
essential to a) create training curricula, b) negotiate with insurance
companies about acknowledging and reimbursing psychological
treatments as part of usual care, and last but not least c) investigate
the feasibility of replicating psychological intervention protocols
in non-research settings and in particular in poorly-resourced
environments where most of the world's population resides.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Prospective, randomized, assessor-blinded, controlled trial comparing group CBT (ZMILE) to WLC on
QOL, seizure frequency and self-efficacy. Outcome measures were obtained at baseline (3 months prior
to intervention) and postintervention (3 months after intervention).
Participants Inclusion criteria: at least 2 seizures per month, with subjectively-reported psychological distress
Exclusion criteria: active serious medical disorders, psychotic features, severe mental deficiency and a
history of neurosurgery within the last year
17 adults were enrolled; 8/9 were allocated to CBT (ZMILE)/WLC. The mean ages were 38.3 (SD 7.0)
years in CBT and 41.4 (SD 7.7) years in WLC. The durations of epilepsy in years were 20.3 (SD 7.9) in CBT
and 26.7 (SD 13.6) in WLC. 8/5 participants in CBT had complex focal seizure/secondary generalization.
1/8/4 participants in WLC had simple focal seizure/complex focal seizure/secondary generalization.The
mean weekly seizure frequency at baseline was 3.71 (SD 1.82) in CBT and 3.48 (SD 2.23) in WLC
The study was conducted in the Neurology Clinic of the Queen Elizabeth Hospital, Hong Kong. The
dates when the study was conducted were not stated. The study was partially supported by the Queen
Elizabeth Hospital Research Grant; no conflict of interest reported.
Interventions The intervention group (ZMILE) received a total of 8 x 2-hour sessions of group CBT, conducted week-
ly for 8 weeks. Following a structured format, the intervention was provided by 2 trained clinical psy-
chologists, with the following components: understanding stress and its relationship to seizures, re-
laxation training, cognitive restructuring, identification of seizure-provoking situations, systematic de-
sensitization, stress management, and communication skills. Participants were also asked to complete
homework assignments between the sessions on relaxation, recording of negative thoughts, and cop-
ing methods
Outcomes Outcomes: QoL, self-efficacy, and seizure frequency, measured with the QOLIE-31, ESES, seizure fre-
quency (average over 3 months of weekly self-report)
Time points measured:
1) Baseline (3 months before treatment)
2) Postintervention (3 months after the last treatment session)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Allocation was performed using a matched design
Au 2003 
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Allocation concealment
(selection bias)





High risk Insufficient information
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk There was no attrition
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias High risk Professionals who delivered the interventions were clinical psychologist
trained in CBT and seizure management technique, so the risk of bias was low
in this dimension of treatment competency. However, there was no informa-
tion on how treatment competency was monitored so the risk of bias in this
dimension was unclear. The risk of bias is unclear in terms of treatment fideli-
ty as no adherence measures were mentioned. All participants recruited had
subjectively reported psychological distress, inadequate seizure control and at
least 2 seizures per month; but there were no details on how these participants





Methods Unblinded, randomized, controlled study comparing a participant-tailored educational plan (Treat-
ment) in adults with epilepsy and chronic comorbidity to UC on drug-related problems and quality of
life. Outcome measures were obtained at baseline, 1 month and 6 months post-baseline
Participants Inclusion criteria: adults with epilepsy and the following criteria: the presence of at least 1 chronic clini-
cal condition requiring medical treatment; clinically-relevant AEs attributable to the present treatment,
clinically-relevant drug interactions, or both; possible modification of the treatment schedule to elimi-
nate AEs or risky drug interactions
Exclusion criteria: adults with a non-modifiable treatment schedule, who were unable to understand or
comply with an educational plan, unable or unwilling to release a written informed consent
174 adults randomized. 91/83 participants were allocated to Treatment/UC. The age ranged from 18 to
70+ in both groups. 65/17 participants in Treatment and 69/9 participants in UC had focal epilepsy/gen-
eralized epilepsy; the remainder were unclassifiable. The seizure frequency per month in the preceding
6 months ranged from 0 to 5+ in both groups. 60/51 participants had ≤ 2 comorbidities, and 27/29 par-
ticipants had ≥ 3 comorbidities in Treatment/UC; the remaining were not specified
The study was carried out in San Gerardo University Hospital. Consecutive participants were random-
ized from December 2009 to December 2011. All follow-up was completed in June 2012. This clinical tri-
al have been funded by the Italian Drug Agency (AIFA Study Protocol Code FARM77RW2S), which pro-
vided research grants for all the participating centres. The author received research grants from Sig-
ma-Tau, Janssen-Cilag,Kedrion Pharma, Eisai. MPC received speaker's or consultancy and/or research
Beretta 2014 
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grants from Cyberonics, UCB, Eisai, Novartis, Janssen-Cilag, GSK. CF received research grants from Mer-
ck Serono and Pfizer.
Interventions The treatment consisted of an educational plan (1 hour counseling), delivered by treating physician to
the participant on an individual basis. The plan comprised the following components: The cause and
nature of any AEs or drug interactions; the tolerability profile of each drug present in the schedule, il-
lustrated as a simple list, including the commonest AEs, presented in decreasing order of frequency;
the clinical manifestations (if any) associated with the current drug interactions; any contraindication
to the use of over-the-counter drugs that may potentially interfere with the current treatment sched-
ule; the reasons for, and the potential benefits of the suggested treatment change; an encouragement
to withdraw any drug that may potentially interfere or be contraindicated. The educational plan was
administered at admission and in the same form after 1 month, as a reminder
Outcomes Drug-related problems (particularly drug interactions), QoL, measured with the (QOLIE-31
Time points measured:
1) Baseline
2) 1 month after baseline
3) 6 months after baseline
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A centralized, computer-generated allocated sequence was used for the ran-
domization. No evidence to suggest selection bias
Allocation concealment
(selection bias)
Low risk Information was sought and provided in the study protocol. Assignment to the





High risk Neither the participants nor the physicians providing the intervention were
blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 1/91 in Treatment and 1/83 in UC withdrew during the study
Selective reporting (re-
porting bias)
Low risk Unpublished data (QOLIE-31 raw data) were sought and provided. No evidence
to suggest reporting bias after review of study protocol
Other bias Low risk Risk of bias for treatment infidelity, competency in training background of the
professionals who delivered the intervention and selective recruitment were
low. There were no measures to monitor the quality of treatment delivery, so
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Study characteristics
Methods A blinded randomized controlled trial comparing 6 months of behavioral counseling intervention
(Treatment) in children with epilepsy to TAU on physical activity, depressive symptoms and QoL
Participants Inclusion criteria: Children aged 8 – 14 years with a diagnosis of epilepsy as confirmed by a neurologist;
with at least 1 seizure in the previous 12 months; ambulatory; fluency in English or French; intellectual
functioning at grade ≥ 3 level as judged by parents; and access to a computer
Exclusion criteria: Participants with additional diagnoses of psychogenic seizures or autism were not
included
115 adults randomized. 56/59 participants were allocated to intervention/TAU
The mean age of the participants was 11.4 years (± 1.9). 6/17/28/23 participants in intervention and
9/11/28/24 participants in TAU had simple focal/complex focal/generalized tonic-clonic/absence
seizures. The duration of epilepsy was 4.2 years (± 3.2) in the intervention group and 3.8 years (± 3.2) in
the TAU group. The study was carried out at 2 study sites in Canada: McMaster site and Ottawa site. Re-
cruitment occurred between January 2012 and March 2017. This work was financially supported by the
Ontario Brain Institute EpLink section (PI: GM Ronen), the Innovation Fund of the Alternative Funding
Plan for the Hamilton Academic Health Sciences Organization (PI: GM Rone ), and the Children's Hospi-
tal Academic Medical Organization Innovation Fund of the Children's Hospital of Eastern Ontario, Ot-
tawa (Local PI: Daniela Pohl). No conflict of interest reported.
Interventions Counseling sessions were conducted by trained research assistant (McMaster site) or the study re-
search coordinator (Ottawa site). Counseling sessions were 15 mins long and occurred weekly for
weeks 1 – 4, bi-weekly for weeks 6 – 12, and monthly (booster sessions) for weeks 16 – 24. The aims of
these sessions were to develop motivation as well as to learn and implement self-regulatory skills to
support behavior change. All participants were given the goal to reach a level of PA consistent with the
number of steps associated with meeting Canadian PA guideline recommendations by the end of the 6-
month period
Outcomes Physical activity, Childhood Epilepsy Quality of Life scale (CHEQOL), KIDSCREEN-27, Children's Depres-
sion Inventory—Short (CDI-S)
Time points measured:
1) Baseline (2-week period)
2) 16 weeks after baseline
3) 28 weeks after baseline
4) 52 weeks after baseline
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Separate balanced block randomization schemes were established for each
activity group, and an allocation ratio of 1:1 was used
Allocation concealment
(selection bias)
Low risk The research coordinator at the McMaster study site conducted this process





High risk The author clarified that the participants were not blinded
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All outcomes
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk The author clarified 16 dropouts i.e. 14% attrition
Selective reporting (re-
porting bias)
Low risk Reviewing the publication does not reveal selective reporting
Other bias Unclear risk Altogether unclear risk for infidelity to intervention protocol, competence to






Methods Assessor-blinded, randomized, controlled trial comparing a group receiving HOBSCOTCH (H: Home-
Based Self-management and Cognitive Training Changes lives), HOBSCOTCH plus memory training (H
+) and care as usual (Control) on quality of life, mood, objective and subjective neurocognitive func-
tions. Outcome measures were obtained at baseline and postintervention follow-up (8 weeks)
Participants Inclusion criteria: epilepsy, with or without uncontrolled seizures, with subjective memory complaints
(QOLIE-31 cognition subset questions ≤ 7) who provided informed consent.
Exclusion criteria: severe mental disability, estimated IQ < 70, visual impairment precluding reading
and writing, and those without reliable phone access
66 participants (age 16 to 65 years). 22 were randomized to each of H, H+, and Control. A total of 17 par-
ticipants withdrew. H/H+ were combined in the analysis (N = 29) compared with Control (N = 20). The
mean age in H/H+ was 49.3 (± 9.2) and 41.4 (± 11.2) in Control. There were 19 women in H/H+ and 13
women in Control. 17 participants in H/H+ and 13 participants in Control had received epilepsy surgery
The study was conducted at Dartmouth-Hitchcock Epilepsy Center between January 2013 and June
2014. The study was funded by the Center of Disease Control and Prevention, National Center for
Chronic Disease Prevention and Health Promotion, Special Interest Projectwithin theManaging Epilep-
syWell (MEW) network 3U48DP001935-04S3 and U48DP005018. Dr. Jobst has received research support
from Neuropace, Inc., and NIH and is currently on the advisory committee of Neuropace. None of this is
related to this work.
Interventions An epilepsy specialized Advanced Registered Nurse Practitioner or Registered Nurse trained as 'mem-
ory coaches', delivered the intervention. The intervention program was structured into 8 weekly 45-
to 60-minute sessions, with the first session in a group format and the subsequent 6 sessions conduct-
ed over the telephone, followed by a final in-person review session with outcome assessment. Partici-
pants randomized into H/H+ groups were offered an intervention based on self-efficacy principles, in-
cluding organizational skills, seizure management, and social skills. It also comprised problem-solving
therapy and behavior modification strategies, focused on cognitive symptoms. Participants in the H+
group were also required to participate in cognitive training, using a Nintendo handheld console and
the Brain Age program, with tasks consisting of multiple working memory exercises. The total time of
training was equal to 20 to 40 minutes of daily training. Participants in the control group received usual
care
Outcomes Primary outcome measure was change in quality of life (QOLIE-31). 
Caller 2016 
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Secondary outcome measures were mood (PHQ-9), neuropsychological status (RBANS), self-report
cognitive function (FACT-Cog), self-perceived executive function (BRIEF-A), and patient satisfaction (a
satisfaction survey)
Time points measured:
1) Baseline (after randomization)
2) 8 weeks after baseline
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)









High risk Participants were not blinded to the treatment they received
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk A total of 17/55 (25.8%) dropouts. Treatment group H (7/22; 31.8%), Treatment
group H+ (8/22; 36.4%), Control (2/22; 9.1%)
Selective reporting (re-
porting bias)
Low risk No evidence of selective reporting within publication
Other bias Unclear risk Low risk in terms of the training component of treatment competence and se-
lective recruitment. But there was no information on how the quality of treat-
ment delivery was ensured and so the risk of bias was unclear for the treat-






Methods Assessor-blinded, randomized controlled trial evaluating the long-term effect on improving depressive
symptoms between a home-based collaborative care intervention for adults with epilepsy and depres-
sion (PEARLS) and TAU control group. Outcome measures were obtained at baseline through 12-month
follow-up
Participants Inclusion criteria: ICD-9 epilepsy diagnosis and significant depression based on PHQ-9 score ≥10
Exclusion criteria: pregnant women, bipolar or psychotic disorder, active psychiatric treatment, sub-
stance abuse history based on questionnaire, cognitive impairment based on screening test
Ciechanowski 2010 
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80 adults were recruited; 40 were randomized to PEARLS and 40 to TAU, stratified by whether or not
seizures were reported in the preceding 6 months
The mean ages were 43.3 years (SD 11.0) in PEARLS, and 44.4 (SD 11.1) TAU. 23/29 were women in
PEARLS/TAU. In the past 6 months prior to recruitment, 29/30 participants had at least 1 seizure in
PEARLS/TAU. In the month prior to recruitment, 11/12 participants had seizures with LOC and 14/18
participants had seizures without LOC in PEARLS/TAU
The study was conducted in the University of Washington Regional Epilepsy Center, USA. Recruitment
took place between April 2007 and April 2008. The study was funded by the Prevention Research Cen-
ters Program and Epilepsy Program of the Centers for Disease Control and Prevention and the Univer-
sity of Washington Health Promotion Research Center (U48DP000050) and the CHAMMP (Center for
Healthcare Improvement for Addictions, Mental Illness and Medically Vulnerable Populations) at Har-
borview Medical Center, Seattle WA; no conflict of interest reported.
Interventions PEARLS is a home-based, multimodal depression intervention. Participants received PST by mas-
ters-level trained social workers who participated in PEARLS training (pearlsprogram.org). PST is a
skill-enhancing behavioral depression treatment addressing problems that cause and maintain de-
pression symptoms. PST was modified in this study to emphasize social and physical activation. Par-
ticipants were scheduled for 8 x 50-minute in-home sessions in weeks 1 to 3, 5, 7, 11, 15, and 19. From
week 19 until study end (12 months), participants received monthly 5- to 10-minute telephone calls
from the therapist for PHQ-9 administration, and assessment of their use of PST. Therapists reported to
the study psychiatrist regularly; psychiatrist would call participants to clarify clinical issues (e.g. suici-
dal ideation)
The TAU group received no active treatment, but physicians of participants assigned to the TAU arm re-
ceived a letter reporting the depression diagnosis and encouraging depression treatment as clinically
appropriate




2) 6 months (by phone)
3) 12 months (by phone)
4) 18 months (by phone)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random assignment and block randomizations were
used. No evidence to suggest selection bias
Allocation concealment
(selection bias)





High risk Participants were not blinded to the treatment they received
Blinding of outcome as-
sessment (detection bias)
Low risk Assessors were blinded
Ciechanowski 2010  (Continued)
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Low risk 8/5 and 7/11 were missed in the 6-month/12-month follow-up in PEARL and
TAU, respectively. The attrition rates (20%/12.5% for 6-month follow-up and
15%/27.5% for 12-month follow-up for PEARL and TAU, respectively) were
higher than the authors’ expectation (i.e. 10%) but lower than our cut-oB for
long-term studies (i.e. 20%)
10 (25%) and 12 (30%) were lost at the 18-month follow-up in PEARL and TAU,
respectively. Although the attrition rates were comparable for the 2 groups,
they were higher than the authors’ expectation, and higher than our cut-oB for
long-term studies. The risk of bias was therefore high for 18-month follow-up
Selective reporting (re-
porting bias)
High risk Unpublished data were sought and provided. Postintervention suicidal
ideation was missing. Evidence to suggest reporting bias
Other bias Unclear risk Unclear risk for selective recruitment, treatment fidelity and competence to
deliver the intervention. Low risk for training background (competence) of per-





Methods Unblinded, quasi-randomized, controlled trial comparing a 6-week online epilepsy self-management
program (WebEase) to WLC in adults with epilepsy. Outcomes are medication adherence, perceived
and sleep quality. Outcome measures were obtained at baseline, 6 weeks and 12 weeks after random-
ization
Participants The protocol for the study and all recruitment notices were reviewed and approved by the Emory Uni-
versity institutional review board prior to beginning recruitment. Participants for this study were re-
cruited though epilepsy-based websites and forums, online clinical research matching services, and re-
ferrals from health care professionals.
Inclusion criteria: adults aged 18 or older, with a diagnosis of epilepsy, had been on antiseizure medica-
tion for at least 3 months, had access to Internet, willing to participate and had not participated in We-
bEase before, spoke and read English. Participants for this study were recruited through epilepsy-based
websites and forums, online clinical research matching services, and referrals from healthcare profes-
sionals.
194 adults were recruited. 97 were allocated to each group. A secondary review of eligibility yielded 148
participants who were retained for analysis (70 in WebEase; 78 in WLC). The mean age was 41.8 years in
WebEase and 40.0 in WLC. 48/61 were women in WebEase/WLC. 42/52 participants had seizures in the
past 30 days in WebEase/WLC. The mean number of seizures in 30 days prior to recruitment was 10.8
(SD 32.9) in WebEase and 9.3 (SD 25.9) in WLC. The number of participants who reported tonic-clonic/
complex focal/simple focal/absence of seizures were 25/22/8/4 in WebEase and 29/18/12/6 in WCL. The
dates when the study was conducted were not stated. This study was supported by the CDC Epilepsy
Program in the National Center for Chronic Disease Prevention and Health Promotion under Coopera-
tive Agreement 1U48-DP001909-01. The contents of this article are solely the responsibility of the au-
thors and do not necessarily represent the official views of the CDC. No conflict of interest was report-
ed.
Interventions WebEase is a theory-based, interactive, Internet-based self-management program for people with
epilepsy. WebEase incorporates concepts and principles of social cognitive theory, the transtheoretical
model of behavior change, and motivational interviewing. The WebEase program lasted for 6 weeks.
Participants spent 2 weeks in each of the 3 modules (medication, stress, sleep) that constitute the core
of WebEase. The program was designed to correspond with a person’s stage of change. Regular weekly
DiIorio 2011 
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reminders were sent to participants until the end of 6 weeks. Participants received an Amazon giF card
at the end of their participation in the study.
Outcomes MAS, PSS, ESI-R, PSQI, ESMS, Epilepsy Knowledge Profile, QOLIE-10
Time points measured:
1) Baseline prior to randomization
2) 6 weeks after randomization
3) 12 weeks after randomization
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Quasi-randomization by assigning participants alternately
Allocation concealment
(selection bias)





High risk Participants were not blinded to their treatment; personnel were blinded since
this was a web-based intervention
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk The assessors were not blinded at any assessment, based on information pro-




High risk 22/70 and 12/78 missed the second assessment in WebEase and WLC, respec-
tively. 18/70 and 33/78 missed the third assessment in WebEase and WLC. The
attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk Unpublished data (QOLIE-10 outcomes) were sought and provided. No evi-
dence to suggest reporting bias
Other bias High risk Low risk of bias for treatment infidelity as this was a web-based intervention.
Training background of personnel developing the WebEase intervention was
rated as low risk for incompetence. Risk of bias is high for selective recruit-





Methods Assessor-blinded, randomized, controlled trial comparing group intervention (PIE) and WLC in children
and adolescents with epilepsy (aged 12 - 17 years) on quality of life and epilepsy knowledge. Outcome
measures were obtained at baseline, postintervention (6 weeks), 3- and 6-month follow-up
Participants Inclusion criteria: children and adolescents aged between 12 and 17 years with a diagnosis of epilepsy
(controlled or refractory), able to speak, read, and write English, and who attended mainstream school-
ing
Dorris 2017 
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Exclusion criteria: formal diagnosis of Learning Disability, suicidal ideation and/or scored ≥ 40 on the
BDI-Y and BAI-Y, had a diagnosis of non-epileptic seizures only. 83 participants randomized. 40/43 were
allocated to PIE/WLC, respectively. The mean age in years was 14.4 (range 12 - 17) and 14.3 (range 12 -
17) in PIE and WLC, respectively. There were 26/24 female participants in PIE/WLC, respectively. 12/19
had focal seizures; 25/29 had generalized clonic/tonic clonic seizures; 4/5 had myoclonic seizures,
16/16 had absence seizures, 0/1 had tonic seizures, in PIE and WLC, respectively. All participants were
recruited across 7 tertiary pediatric neuroscience centres in the UK. Recruitment took place over a
four-month period from April to July 2015. The study was financially supported by UCB Pharma (award
number: G0002101) and a monetary award from Yorkhill Children's Foundation; no conflict of interest
reported.
Interventions PIE was a group-based self-management intervention, based specifically on initial consumer survey
findings. The intervention was conducted in a 6-week group setting co-led by a clinical psychologist
and epilepsy nurse, which met once a week for 6 weeks for 120 minutes. Topics included medical (med-
ication adherence, managing medical appointments, ketogenic diet) and sleep hygiene self-manage-
ment aspects of epilepsy in addition to psychosocial issues such as driving, development of coping
strategies for anxiety or low mood through strategies such as problem-solving, and techniques based
on CBT and mindfulness
Outcomes PedsQL™ version 4.0, GEOS-YP, EKP-G, SSEC-C, Brief - Illness Representations Questionnaire (B-IPQ), PI-
ED, CHI-ESQ -Caregiver and young person self-report versions
Time points measured:
1) Baseline





Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomly allocated to the intervention or control conditions










High risk Participants were not blinded to their treatment; personnel who facilitated the
intervention were not blinded to the allocation of participants
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 3/40 and 11/43 missed the second assessment in PIE and WLC, respective-
ly.The attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk Reviewing the publication does not reveal selective reporting
Dorris 2017  (Continued)
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Other bias Low risk Low risk for infidelity to intervention protocol, since the intervention protocol
was manualized, training sessions were provided by the authors, weekly su-
pervision sessions were provided and audio recordings of each session were
checked for fidelity. Fidelity was considered high. No evidence to suggest se-
lective recruitment bias. Competence in delivery of intervention delivery was





Methods A quasi-randomized trial comparing group intervention (brief education intervention on lifestyle self-
management) and control in adult (aged > 18) with epilepsy. Outcome measures were obtained at
baseline (at the time of recruitment) and 6 months after intervention
Participants The participating sites were two large hospitals in Melbourne, Australia, one public and one private. Pa-
tients recruitment was conducted in year 2015.
Inclusion criteria: only adults (> 18 years) who had been diagnosed with epilepsy were eligible. People
with history of seizures from causes other than epilepsy, such as acute trauma, were not included in
this study unless the comorbidity existed in addition to a diagnosis of epilepsy. Furthermore, as docu-
ments were available only in English, people with limited English comprehension were excluded. Once
the 60 participants had been recruited, they were contacted again and allocated to the intervention or
control group. Random allocation to groups was used; but if a participant was unable to attend the in-
tervention face-to-face session, they were placed into the control group by the researcher responsible
for participant group allocation
60 participants were recruited (male N = 31). N = 37/23 were allocated to control/intervention. The av-
erage age was 40.4/39.9 years in the control/intervention group. All 60 participants were analyzed at
time point 1, and 35 were analyzed at time point 2 (18 in control and 17 in intervention group).
This study was supported by St Vincent's Private Hospital Melbourne. The funder did not participate in
the research process. No conflict of interest was reported
Interventions Self-Management and Lifestyle Education for Adults Living with Epilepsy was a theory-informed, ev-
idence-based and peer-reviewed education package developed specifically for the purpose of this
study. The development was based on the framework of the SDT. SDT is centered on supporting peo-
ple's natural tendencies to behave in ways that promote and maintain their health. The education
package was divided into 4 education modules: managing epilepsy and medical care; socializing on a
budget; leading a healthy lifestyle; and emotional self-management. Including these topics address-
es some key triggers that can bring on a seizure in people with epilepsy. The facilitators were clinical
nurse specialists in neurosciences, who were trained by a research team member qualified in SDT and
training in the module content, and had received instructions on how to conduct sessions
Outcomes SF-12, SWLS, CD-RISC, MMAS-8
Time points measured
1) Baseline (at the time of recruitment, no information on whether it was before or after randomization
2) 6 months after the intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Edward 2019 
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Random sequence genera-
tion (selection bias)
High risk Random allocation to groups was used; but if a participant was unable to at-
tend the intervention face-to-face session, they were placed into the control
group by the researcher responsible for participant group allocation
Allocation concealment
(selection bias)





High risk Neither the participants nor the personnel who delivered the intervention
were blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 6/23 (26%) and 19/37 (51%) missed the second assessment in intervention and
control group, respectively. The attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk No evidence to suggest reporting bias. Study protocol not yet provided upon
request
Other bias Unclear risk Risk of bias for the training dimension in treatment competency was low as
professionals who delivered the intervention received targeted training. But
risk of bias for competency on treatment delivery and treatment fidelity were





Methods Unblinded, randomized, controlled trial comparing group intervention (PACES) and WLC in people with
epilepsy on self-management and quality of life. Outcome measures were obtained at baseline (after
randomization), postintervention (8 weeks) and 6 months follow-up
Participants Inclusion criteria: adults, age 18 and above, with an established diagnosis of epilepsy for at least 6
months, able to speak, read, and write English, and reasonably cognitively intact (MoCA); aged ≥ 21
Exclusion criteria: severe mental illness or psychosis, or known cognitive impairment (IQ < 70)
92 participants randomized. 46 were allocated to each group; 41/38/37 and 42/40/39 were analyzed
in PACES and WLC, respectively, at baseline/postintervention (8 weeks), and 6-month follow-up. The
mean age was 44.9 (SD 12.5) and 45.4 (SD 12.6) in PACES and WLC, respectively. There were 23 women
in each group. 8/7 had simple focal seizures; 20/23 had complex focal; 9/7 had secondarily generalized
seizures; 14/20 had tonic-clonic seizures; 2/3 had myoclonic seizures, 6/4 had absence seizures, 2/2 had
other seizures, in PACES and WLC, respectively
All participants were recruited through the UW Regional Epilepsy Center and Swedish Epilepsys Center,
both in Seattle, USA. Recruitment took place from 2010 to 2013. This work was financially supported by
the Centers for Disease Control and Prevention SIP 12-09, grant no. DP002273; no conflict of interest re-
ported.
Interventions PACES was a group-based, psycho-educational intervention, based specifically on initial consumer sur-
vey findings. The intervention was conducted in an 8-week group setting of 6 to 8 adults, co-led by a
psychologist and trained peer with epilepsy, which met 1 evening a week, at a hospital, for 75 minutes.
Fraser 2015 
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Topics included medical, psychosocial, cognitive, and self-management aspects of epilepsy, in addi-
tion to community integration and optimizing epilepsy-related communication
Outcomes ESMS, ESES, QOLIE-31, PHQ-9), and the GAD-7
Time points measured:
1) Baseline (after randomization)




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A random-number generator was used for randomized assignment. No evi-
dence to suggest selection bias
Allocation concealment
(selection bias)





High risk Participants and personnel were not blinded to the treatment they received or
provided
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk The dropout rate was 16/92 (17.4%) overall; 9/46 (19.6%) in the Intervention




Low risk No evidence of selective reporting bias within study, or after review of docu-
mentation of outcome measures used in the study
Other bias High risk Unclear risk of bias for treatment infidelity and competence in delivering the
intervention. Training background of personnel delivering the intervention
was rated as low risk for incompetence. Risk of bias is high for selective recruit-





Methods Unblinded, randomized, controlled trial comparing individual CBT to WLC in people with epilepsy on
mood-related symptoms. Outcome measures were obtained at baseline, post-treatment and 3-month
follow-up
Participants Randomized 59 adults aged 18 - 65, had a formal diagnosis of epilepsy according to the ILAE criteria,
had an IQ of ≥ 80 (at least low average) according to the National Adult Reading Test, were fluent in Eng-
lish and provided written informed consent.
Gandy 2014 
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Exclusion criteria: psychotic disorder, suicidal, severe personality disorder, about to undergo epilepsy
surgery, primary health concern and reason for seeking psychological support related to chronic illness
other than epilepsy (e.g. MS)
31 and 28 participants were randomly enrolled to CBT and WLC. The mean age in years was 41 (SD 12;
range 19 - 66) in CBT, and 38 (SD 13; range 20 - 63) in WLC. 9/13 participants had refractory epilepsy in
CBT/WLC. The mean duration of epilepsy in years was 15 (SD 13; range 5 - 37) in CBT, and 9 (SD 13; range
5 - 32) in WLC. The mean number of AEDs was 2 (SD 0.8; range 0 - 4) in CBT, and 2 (SD 1; range 1 - 4) in
WLC. 14/21 participants had focal epilepsy; 6/4 participants had generalized epilepsy in CBT/WLC. 13/10
participants had a history of previous illness in CBT/WLC. The estimated IQ was 104 (SD 10; range 84 -
118) in CBT, and 106 (SD 10; range 81 - 122) in WLC
Participants were recruited from the Comprehensive Epilepsy Service at the Royal Prince Alfred Hospi-
tal, in Sydney, Australia. A minority (N = 7) were recruited through advertisements about the study by
Epilepsy Action Australia. Recruitment took place between January 2011 and December 2011. Dr Mile-
na Gandy was supported by the generous scholarships of the National Health Research Council of Aus-
tralia and the Molly McDonnell Foundation of the Epilepsy Society of Australia for this research. Prof.
Louise Sharpe is supported by an NHMRC Senior Research Fellowship. The authors also acknowledged
the Epilepsy Action Australia for advertising the study and providing seizure diaries for participants. No
conflicts of interest was reported.
Interventions The CBT program included 9 individual sessions: 1 x 1- to 2-hour assessment session for formulation of
treatment goals, and 8 weekly, individualized 1-hour therapist-client sessions, with elements including
home-based practical tasks, behavioral activation, CBT model, anxiety management, and communi-
cation skills about their illness. The intervention was delivered by postgraduate doctorate-level intern
psychologists under the supervision of senior clinical psychologists (> 10 years of experience). All ther-
apists and supervisors attended a 1-day workshop; a strict adherence checklist was completed by all
therapists, who attended weekly supervision with senior clinical psychologists
Outcomes NDDI-E, the HADS, QOLIE-31
Time points measured:





Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A list of random numbers, using the Bernoulli function, was generated and
used consecutively for randomization. No evidence to suggest selection bias
Allocation concealment
(selection bias)





High risk Participants were not blinded to their treatment
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Outcome assessment was not blinded, based on information provided by
study authors
Gandy 2014  (Continued)
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High risk 12/31 (39%) and 5/28 (18%) withdrew from the study at 3-month follow-up. At-
trition rate was considered high
Selective reporting (re-
porting bias)
Low risk Unpublished data were sought and provided. No evidence to suggest selective
reporting
Other bias High risk Although there was regular supervision with adherence checklist, results for
treatment adherence were not available so the risk of bias was unclear. The
professionals who delivered the interventions received training specifically on
the use of treatment, so the risk of bias was low in this dimension of treatment
competency. But there was no measures to monitor treatment delivery, so the
risk of bias was unclear for the competency to deliver the intervention. Risk






Methods A randomized trial to compare depression and multiple secondary health outcomes of sertraline and
CBT in persons with current major depression and active epilepsy. Outcome measures were obtained
at baseline (before randomization), week 8 (during intervention) and week 16 (immediately after inter-
vention)
Participants Inclusion criteria: age 21 - 75 years, diagnosis of epilepsy confirmed by a board-certified neurologist
with subspecialty training in epilepsy, occurrence of an absence, focal with impaired awareness, or
generalized motor seizure within the past 12 months while taking a recommended dose of an approved
antiseizure medication, score of > 14 on the CES-D, diagnosis of current major depressive episode on
the MINI, and able to read and understand study documents based on investigators' assessment
Exclusion criteria: suicidal attempt within the past year, current alcohol or other substance abuse dis-
order, history of bipolar depression or psychotic disorder, pregnant or lactating, prior hypersensitivity
reaction to sertraline, progression central nervous system disorder (such as tumor or multiple sclero-
sis), significant medical illness such as hepatic or renal disorder (serum creatinine < 3 mg/dl)
Out of 1020 individuals prescreened in clinic, 140 participants were randomized to sertraline group (N
= 72) and CBT (N = 68); mean age at enrollment was 39.6 years; 77 were women; 127 (90.7%) had not re-
ceived prior treatment for depression. There was no statistically significant difference in demograph-
ic characteristics and baseline measures. 49 in both groups completed treatment as assigned. 23 (32%)
did not complete the sertraline treatment; 19 (28%) did not complete the CBT treatment.
All subjects were recruited from the general neurology and subspecialty epilepsy clinics at Columbia
University and Washington University, as well as through announcements in local periodicals. The
dates were not specified. This work was funded by the National Institute for Neurological Disorders and
Stroke (R01NS040808). No conflict of interest was reported.
Interventions A 16-week intervention intended to eliminate depression was administered. Each participant's physi-
cian continued epilepsy management. Either sertraline or CBT was the treatment for depression.
Sertraline treatment: sertraline was initiated at 50 mg a day, and increased by 50 mg at 2-week inter-
vals as needed for a CES-D score > 14, up to a maximum dose of 200 mg a day
CBT: administered by licensed therapist using standardized manual-based Beck guidelines in a 1-hour
session each week. The therapist completed a weekly written assessment to document the compo-
nents of CBT used in each session (authors provided us further information that there was weekly clini-
cal supervision in group format, the group included several experienced CBT therapists and each meet-
ing lasted about 90 minutes; supervision was also provided on as-needed basis; but the record for such
Gilliam 2019 
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meeting to ensure adherence to treatment protocol was no longer available). If approved by the par-
ticipant, CBT sessions were taped for quality monitoring. Participants were encouraged to attend all
session in person, but a minority of the sessions could be performed by telephone in consideration of
transportation limitations
Outcomes Primary outcome: the proportion of participants achieving remission from depression based on MINI
Secondary outcomes: BDI, CES-D, suicidal module of the MINI, QOLIE-89, AEP, seizure rate and severity
based on seizure calendars
Time point measures for depression severity (BDI and CES-D), seizures and treatment side effects:
1) Baseline (prior to randomization)
2) 2-week interval between clinic visit until treatment completion at 16 weeks
Time point measures for all other outcome measures:
1) Baseline (prior to randomization)
2) 4-week interval following baseline assessment until treatment completion at 16 weeks
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk The randomization code was generated by a computer program by a non-in-
vestigator. The code was kept in a locked computer in a secure room. Only a






High risk There was no blinding of participants and personnel as confirmed by the au-
thors
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Reasearch assistants who were aware of the intervention implemented the
study procedures. They did not attempt to blind research assistants collecting
outcome data because they were unable to ensure blinding based on their pi-




High risk The attrition rate was 23/72 (31.9%) and 19/68 (27.9) in the sertraline and CBT
groups, respectively. The attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk The authors reported all data at baseline, 8-week and 16-week measurements;
although the interval data were not reported in the publication, they were not
intended to be treated as treatment outcome based on the hypotheses
Other bias Low risk Although there was regular supervision with adherence checklist, results for
treatment adherence were not available (confirmed by author) so the risk of
bias was unclear. Risk of bias in both dimensions of treatment competency for
training and delivery were low. risk of bias was low in selective recruitment
Gilliam 2019  (Continued)
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Study characteristics
Methods Assessor-blinded, randomized controlled trial comparing a nurse-led intervention (Intervention) for
adults with epilepsy to a UC control arm, on epilepsy-related quality of life. Outcome measures were
obtained before randomizations and after 2 years
Participants Randomized 114 participants with a definite diagnosis of epilepsy and ASM for more than 1 year, ≥ 1
seizure during the previous year, the ability to cooperate, and understand written and oral informa-
tion, and who provided written informed consent. 58/57 and 56/54 participants were randomized/ana-
lyzed in Intervention and UC, respectively. The mean age was 35.3 years (range 16 - 69) in Intervention,
and 39.5 (range 16 - 67) in UC. There were 32 women in each group. 18/32/34/3/4/13/0 participants in
Intervention, and 18/34/30/5/3/13/1 participants in UC, had simple focal/complex focal/secondarily
generalized tonic-clonic/absence/myoclonic/primarily generalized tonic-clonic/unclassified seizures.
8/2 participants had major seizures (convulsive seizure with reduced consciousness) more frequent-
ly than once a month in Intervention/UC; 14/12 had minor seizure more frequently than once a week.
The mean duration of epilepsy was 19 years in both groups. 20/28/9 participants in Intervention, and
12/38/4 participants in UC had 1/2/3 or more AEDs
All participants were outpatients in the Neurological Clinic in Trondheim, Norway. Recruitment took
place from February 2001 to March 2002. The study was supported by a grant from GlaxoSmithKline,
Norway; no conflict of interest reported.
Interventions Intervention comprised a 1-day group education program (5 - 11 participants/group). General informa-
tion about different aspects of living with epilepsy was provided by a multidisciplinary team consisting
of the nurse, a neurologist, a social worker, and a clinical neurophysiologist. Extended nurse follow-up
and counseling was provided after the group session for continuity of care (nurse’s presence in neurol-
ogist consultations; the nurse called the participants every 3 months to ensure consultation and to ad-
dress individual needs; the importance of compliance with medical regimen was emphasized)
The UC group was offered conventional treatment according to individual needs
Outcomes QOLIE-89
Time points measured:
1) Baseline (before randomization)
2) 2 years after randomization
100-mm VAS scale (general satisfaction with the follow-up by the Neurological Clinic during the last 2
years)
Time points measured:
1) 3 months after the final interview (2 years after randomization)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Allocation concealment was ensured
Helde 2005 
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High risk Neither participants nor service providers were blinded, based on information
provided by study authors
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 1/58 and 2/56 withdrew from the study. No evidence to suggest attrition bias
Selective reporting (re-
porting bias)
Low risk Unpublished data (QOLIE-89 raw data) were sought and provided. No evidence
to suggest selective reporting
Other bias Low risk Low risk for selective recruitment and training background (competence) of
personnel delivering the intervention. Treatment fidelity and competence to





Methods Assessor-blinded, quasi-randomized, controlled trial comparing individual CBT and WLC in people with
epilepsy, on quality of life. Outcome measures were obtained at baseline and 2-month follow-up
Participants Randomized 56 participants (age 18 and above) with willingness to participate, epilepsy diagnosis
for at least 1 year, with primary generalized tonic-clonic epilepsy and uncontrolled seizures that were
diagnosed by a neurologist, no other chronic illness, and not enrolled in any other research. 28/23
and 28/24 were randomized/analyzed in Intervention and WLC, respectively. The mean age was 29.08
(SD 8.06) and 32.75 (SD 10.89) in Intervention and WLC. There were 10 women in Intervention and 12
women in WLC. The mean duration of epilepsy in years (was 18.17 (SD 12.74) in Intervention, and 15.2
(SD 8.89) in WLC, respectively.
Exclusion criteria: immigrants, missing more than 1 intervention session, recent tragic life events (such
as loss of life, divorce, etc.)
All participants were diagnosed with epilepsy at the Nour and Kashani Hospitals in Isfahan, Iran. The
dates when the study was conducted were not stated. The study was financially supported by the uni-
versity's research deputy; no conflict of interest was reported.
Interventions Intervention comprised 5 group sessions, each separated by 4 days. The structure of the motivation-
al interviewing sessions was extracted from the book Motivational Interviewing Group Intervention for
each session. Motivational interviewing is a strategy for fortification and enhancement of internal mo-
tivation, for changing through thought exploration, identification, and overcoming doubts and dual-
ism. Aspects of the group intervention included being hopeful to overcome issues, decreasing social
isolation, helping others to solve their problems, and learning that others may have to grapple with the
same issues
The WLC was offered conventional treatment, according to individual needs
Outcomes QOLIE-89
Time points measured:
1) Baseline (before randomization)
Hosseini 2016 
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2) 2 months after the intervention and randomization
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk The described procedure remained unclear, but suggested quasi-randomiza-
tion by assigning participants alternately
Allocation concealment
(selection bias)





High risk Participants and personnel were not blinded to the treatment they received
and provided
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk The dropout rate in the treatment group was 5/28 (17.9%). Attrition was con-
sidered high. Furthermore, the reason for exclusion (missing > 1 treatment ses-
sion) indicated that the model of analysis was not ITT
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias High risk Unclear risk of bias for treatment infidelity and competence in delivering the
intervention. Training background of personnel delivering the intervention
was rated as low risk for incompetence. Risk of bias is high for selective recruit-





Methods Unblinded, controlled trial comparing a mindfulness-based CBT program (UPLIFT) to epilepsy informa-
tion and self-management program (EpINFO) or WLC in adults with epilepsy and symptoms of depres-
sion. The study aimed to explore the efficacy of UPLIFT in reducing depression and improving quality of
life
Participants Inclusion criteria: > 18 years of age, resided in the province of Ontario, access to a computer, Internet,
and phone, diagnosed with epilepsy for a minimum of 1 year, experienced some depressive symptoms
as reflected by a minimum score of 12 on the CESD-R, reading comprehension score > 7 on an EQAO
Junior Division Assessment of Reading (www.eqao.com/en) or a listening comprehension assessment
score > 18 on the WIAT-III.
55 adults were enrolled. 20, 24 and 11 participants were allocated to UPLIFT, EpINFO and WLC, re-
spectively. The mean age was 36.9 (± 2.9)/37.2 (± 2.6)/29.4 (± 2.3) years in UPLIFT, EpINFO and WLC,
respectively. 4 (UPLIFT), 9 (EpINFO) and 8 (WLC) participants were women. 3/2/12/3 participants in
UPLIFT had generalized/focal/mixed/unknown seizures, 2/5/13/4 participants in EpINFO had gener-
alized/focal/mixed/unknown seizures, 1/1/6/3 participants in WLC had generalized/focal/mixed/un-
known seizures. Patients were referred from local epilepsy clinics and community epilepsy agencies in
Ontario, Canada, The dates when the study was conducted were not stated. This research was finan-
Hum 2019 
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cially supported by EpLink – The Epilepsy Research Program of the Ontario Brain Institute (OBI); no
conflict of interest reported.
Interventions The program UPLIFT (Thompson 2010) taught coping strategies during each session with skill-building
exercises for participants to complete in between sessions. The intervention was delivered by phone by
a licensed mental health professional and a person living with epilepsy during 1-hour sessions, deliv-
ered once a week for 8 weeks
Outcomes The QIDS, NDDIE, and the psychological health subscale of the WHOQOL-BREF scale
1) Baseline
2) 6 months postintervention
3) 1 year postintervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomly assigned (stratified by age and sex) using an on-
line random-number generator to 1 of 3 groups
Allocation concealment
(selection bias)





Unclear risk Altogether unclear risk of performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk Attrition was 24.6%
Selective reporting (re-
porting bias)
Low risk We have not received the study protocol. As far as we can tell from the publica-
tion, there is no selective reporting of outcome measures
Other bias Unclear risk Altogether unclear risk of infidelity to treatment protocol, incompetence to de-





Methods Unblinded, quasi-randomized controlled trial comparing the FLIP&FLAP epilepsy intervention group
(IG) for children and adolescents with epilepsy to a WLC on HRQOL and the children's ability to explain
epilepsy to others. Outcome measures were obtained at baseline and 6 months after treatment
Participants Inclusion criteria: diagnosis of epilepsy, taking antiseizure medication, sufficient German literacy, will-
ingness of the child and at least 1 carer to participate in the education-program
Jantzen 2009 
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192 families enrolled; 105 were enrolled to IG, and 87 were enrolled to WLC. At baseline, the final sam-
ple include 67 in IG, and 74 in WLC. Written consent was obtained from parents; children gave oral con-
sent to participate
Mean ages in years were 11.6 (SD 3.0; range 6 - 17) in IG, and 11.7 (SD 2.5; range 6 - 16) in WLC. Mean du-
ration of seizures in years were 4.7 (SD 4.0) in IG, and 5.6 (SD 3.7) in WLC. 19/15/4/13/3/11 participants
in IG and 22/15/7/3/1/10 participants in WLC had tonic-clonic/complex focal/simple focal/absence/my-
oclonic /unclassified seizures. 42 (IG) and 48 (WLC) participants were seizure-free for > 6 months. 29 in
IG and 39 in WLC were receiving monotherapy
The study took place in the University of Luebeck, Germany; participants were recruited from 10 spe-
cialized German epilepsy centres, between autumn 2003 and spring 2005. The work was financially
supported by JanssenCilag GmbH (Neuss, Germany) as well as the Friedrich Bluhme and
Else Jepsen StiFung (Luebeck). No conflict of interest reported.
Interventions The intervention group could be held as a 2-day (14 hours per course) or a 2½ day (16 hours per course)
continuous session in group format (5 - 8/group). The intervention was delivered by healthcare profes-
sionals, such as nurses, social workers, doctors, or psychologists; 2 trainers were required per course.
The following domains were included: disease knowledge, disease-related emotions, communication,
self-responsibility, self-management, participation, and educational insecurity. One of the main aims
was to help children to conceptualize their seizures. By watching the film and receiving age-appropri-
ate information, the participants were enabled to understand their seizures and to develop a more ade-
quate self-concept
Outcomes DISABKIDS modular HRQOL questionnaire, disclosure of epilepsy, seizure-free episode
Time points measured:
1) Baseline (immediately before intervention for IG and at recruitment for WLC)
2) Follow-up assessment (6 months after intervention)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Grouping was based on participant's time of application - those who applied
for the first course were assigned to IG, while those who applied for the second
course were assigned to WLC
Allocation concealment
(selection bias)





High risk Participants and therapists were not blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk The attrition was < 10% in all subgroups of the sample
Selective reporting (re-
porting bias)
Low risk No evidence for selective reporting within publication
Jantzen 2009  (Continued)
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Methods Assessor-blinded randomized, controlled trial comparing a multicomponent self-management group
intervention (MCI) and TAU in adults with epilepsy on self-management and quality of life. Outcome
measures were obtained at baseline, 3- and 6-month follow-up.
Participants Inclusion criteria: adults, aged 18 and above, diagnosed with epilepsy and using AED, able to under-
stand Dutch, and who were willing and able to use eHealth devices
Exclusion criteria: people with epilepsy who were not willing or able to function in group activities and
clinical judgment
104 participants randomized. 52/48 were allocated to MCI/TAU, respectively. The mean age in years was
40.0 (SD 13.1) and 43.5 (SD 15.4) in MCI and TAU, respectively. There were 24/28 women in each group,
respectively. The mean duration of epilepsy was 20.3/19.9 years in MCI/TAU, respectively, and the mean
seizure frequency at baseline 4.5/5.8 in MCI/TAU, respectively
All participants were recruited trough the Academic Centre for Epileptology in Maastricht. Recruitment
took place from March 2014 to December 2015. This study was funded by the Netherlands Organization
for Health Research and Development (ZonMw), grant application number 836011018; no conflict of in-
terest reported.
Interventions MCI was a group-based self-management education program with e-Health interventions directed at
improving self-efficacy, so improving the self-management skills of people with epilepsy. The MCI con-
sisted of 5 weekly group sessions of 2 hours each, followed by a 2-hour booster session after 3 weeks
and was delivered by 2 nurse practitioners. All group sessions consisted of 2 components: education
and practicing goal-setting skills. In the educational part, participants were sharing and discussing
strategies about 3 topics: 1) self-monitoring and self-monitoring using (e-Health) tools; 2) risk-evalua-
tion and management; and 3) shared decision-making/concordance. The goal-setting component of
the intervention is based on Aspinwall and Taylors' 5 stages of proactive coping.







Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk The randomization scheme was distributed to the researcher in sealed en-
velopes during the first visit, prior to baseline
Leenen 2018 
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High risk Participants were not blinded to their treatment; personnel who facilitated the
intervention were not blinded to the allocation of participants
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk The author clarified "the data analyst was not involved in the intervention and




Low risk 6/52 and 9/50 missed the second assessment in CBT (ZMILE) and TAU, respec-
tively.The attrition rate was considered low
Selective reporting (re-
porting bias)
Low risk No evidence to suggest reporting bias
Other bias High risk The intervention protocol was manualized and training sessions were provid-
ed by the authors. The author clarified that forms were used to record if all ses-
sions adhered to the intervention protocol and that fidelity was high. Howev-
er, no competence measures were used. It is therefore altogether unclear risk
for competence to deliver the intervention. High risk for selective recruitment
bias as unspecified "inability" to function in group activities or "clinical judg-
ment that they would not be able to comprehend topics discussed within the





Methods Randomized, controlled, open-label trial comparing an SMS-based epilepsy education program (IG) to
a paper-based epilepsy education program as control (CG) in individuals with epilepsy on epilepsy-re-
lated quality of life. Outcome measures were obtained at baseline and after intervention (3 months af-
ter randomization)
Participants Inclusion criteria: adults (aged 18 or above), epilepsy, on regular treatment, able to either write, read,
or understand and communicate in Malay or English language, capable of completing questionnaires
(either written or verbal), mobile phone owners, and active users, provided written consent
144 randomized, 72 into each group; 71 in IG and 65 CG were included in the final analysis. The mean
age of all participants was 30.5 (SD 11.8) years. There were 38 and 33 women in IG and CG, respective-
ly. 13 participants in IG and 16 in CG had a duration of epilepsy between 6 and 12 months, 15/16 partic-
ipants in IG/CG had duration of > 120 months. 36/36 and 40/32 in IG/CG had generalized seizures/focal
seizures.
The study was conducted in the Neurology Clinics of 3 public hospitals in the states of Terengganu, Pa-
hang, and Kelantan in Malaysia. The dates when the study was conducted and sources of funding were
not stated; no conflict of interest reported.
Interventions The intervention for both the IG and CG included a printed epilepsy education module. It was based on
the Modular Service Package Epilepsy (MOSES), and was modified to suit the sociodemographic back-
grounds of participants in the East Coast Peninsular Malaysia (May 2002; Ried 2001). 11 parts were in-
cluded: 1) basic knowledge, 2) history and statistics, 3) living with epilepsy, 4) diagnosis, 5) treatment
and therapy, 6) prognosis, 7) self-control, 8) myth and facts, 9) psychosocial aspects, 10) laws and acts,
and 11) reference. All participants were instructed to read 1 part a week at home, based on the sched-
ule provided in the user manual.
Lua 2013 
Psychological treatments for people with epilepsy (Review)









Cochrane Database of Systematic Reviews
IG received an add-on SMS-based mobile epilepsy education system (MEES) throughout the 3 months.
3 parts were included: 1) epilepsy education module, 2) drug-taking reminder, and 3) clinic appoint-
ment reminder. During the period, 2 simple SMS messages, generated from each printed education
module, were automatically delivered to participants every 4 days; they also received SMS reminders
once a month for their medication and their appointment, based on individual schedules. MEES al-
lowed participants to send queries and comments about their healthcare services or their illness by
SMS to a specific number, to be addressed by researchers
Outcomes Malay Quality of Life Inventory in Epilepsy-30 (MQOLIE-30)
Time points measured:
1) Baseline (at recruitment)
2) 3 months (after intervention)
Notes Data were sought but not provided
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk An interactive voice response system was used for randomization. No evidence
to suggest selection bias
Allocation concealment
(selection bias)





Unclear risk No information provided about blinding of personnel delivering the interven-
tion
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 1/72 (1%) and 7/72 (10%) withdrew from the study (both < 20%, which was our
cut-oB). No evidence to suggest attrition bias
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting






Methods Unblinded, randomized, controlled trial comparing ACT to ST in adults with epilepsy on quality of life
and seizure control. Outcome measures were obtained at baseline, postintervention, 6 months and 12
months following the end of interventions
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Participants 27 participants (aged 27 - 55 years) with epilepsy, who were institutionalized or day-workers in a centre
of epilepsy in South Africa participated; all of them were able and willing to participate, had a minimum
of 4 seizures during the past 3 months, and had a verified diagnosis of epilepsy using EEG
14/13 participants were randomly allocated to ACT/ST, respectively; 7 women in each group. 4 and 5
participants in ACT and ST needed an interpreter. 10/1/2/4 participants in ACT and 9/0/1/7 participants
in ST had generalized tonic-clonic seizures/myoclonic jerks/complex focal seizures/absence seizures
Exclusion criteria: signs of an ongoing progressive illness
The study took place in Epilepsy, South Africa, and the Department of Neurology, University of Cape
Town. The dates when the study was conducted and source of study funding were not stated; no con-
flict of interest reported.
Interventions The treatment included an ACT (ACT plus behavioral techniques for seizure management) and ST.
The design involved 4 sessions, comprised 1 individual session (1½ hours), 2 group sessions (3 hours
each), followed by 1 individual session (1½ hours). All participants were subsequently provided indi-
vidual boosters, and followed up for an additional session at 6 and 12 months (1 hour each). The boost-
er sessions were conducted after the follow-up measures were taken. Total therapy time over the 12-
month study was 11 hours. The ACT protocol can be downloaded at www.contextualpsychology.org
and www.ACT-Forum.se.
Participants in the ACT learned to improve their valued living by building a broader behavioral reper-
toire in valued life directions. Therapeutic components included techniques to build psychological
flexibility around the chain of seizure behaviors, self as context, defusion, acceptance, contact with
present moment, committed action, and empowerment. The patterns of seizures were discussed, as
they occurred as obstacles to valued living. Participants were required to make records of seizure pat-
terns, in terms of antecedents, seizure responses, and consequences. Individualized seizure manage-
ment techniques (e.g. counter-measures) were taught.
The ST goal was to provide an equal amount of professional attention in a supportive environment. The
therapists were instructed to give no active advice. The intervention was delivered by 2 clinical psy-
chologists from Uppsala University, Sweden (first and second authors) trained in ACT, and with experi-
ence in behavioral treatment of epilepsy








Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Allocation concealment was ensured, according to information provided by
study authors
Lundgren 2006  (Continued)
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High risk Participants and personnel were not blinded to the treatment they received or
provided
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk There were no dropouts
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias High risk Low risk for incompetence of personnel delivering the intervention, but no
measure to check adherence was used. Risk of bias is therefore unclear for
treatment fidelity. Risk of bias is high for selective recruitment as advertise-





Methods Unblinded, randomized controlled trial comparing ACT to yoga in adults with epilepsy on seizure con-
trol and quality of life. Outcome measures were obtained at baseline, postintervention, 6 months and
12 months following the end of interventions
Participants Inclusion criteria:adult (18 years or older), ability and willingness to participate in the program, a mini-
mum of 3 seizures during the past 3 months, and an EEG-verified diagnosis of epilepsy
Recruited 18 adults (aged 18 - 55) from an outpatient clinic for epilepsy in southwest India. 10 and 8
were allocated to ACT and yoga, respectively. The mean age was 21.9 years in ACT and 25.8 years in yo-
ga; 3 women in each group. 6 and 5 participants required an interpreter for the treatment in ACT and
yoga, respectively. 6 in each group had generalized tonic-clonic seizures; 2 and 1 had myoclonic jerks in
ACT and yoga, 3 and 2 had complex focal seizures in ACT and yoga, 1 had absence seizures in yoga. The
dates when the study was conducted and the sources of funding were not stated; no conflict of interest
reported.
Interventions Refer to Lundgren 2006 for the structure and intervention details of ACT
The yoga training for epilepsy had 2 main features: stimulating activity that the participants considered
meaningful, and using yoga techniques to decrease the risk of epileptic seizures and promote well-be-
ing. The program focused on 3 different physical dimensions and 2 psychological dimensions to unite
the mind, body, and soul. The yoga teacher and the participants discussed barriers to living a life they
considered important. Accepting private events and living meaningful lives were essential parts of the
treatment. The teacher used metaphors, direct instructions, and encouragement to help the partici-
pants to be active in areas considered important. Examples of such domains were: relationships, work,
health, and leisure time
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)










High risk Participants and personnel were not blinded to the treatment they received
and provided
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk There were no dropouts
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias High risk Low risk for incompetence of personnel delivering the intervention, but no
measure to check adherence was used. Risk of bias is therefore unclear for
treatment fidelity. Risk of bias is high for selective recruitment as advertise-





Methods Blinded, randomized, controlled trial comparing CBI to counseling as usual (TAU) in adolescents with
epilepsy on depressive symptoms. Outcome measures were obtained at baseline, 6-month and 9-
month follow-up
Participants Inclusion criteria: newly-diagnosed epilepsy (either focal or generalized, at least 2 unprovoked seizures
within a period of not longer than 12 months), subthreshold depression (as defined by Hamilton De-
pression Scale, scores 6 to 8), normal intelligence
Exclusion criteria: epilepsy caused by progressive cerebral lesion, mental retardation, a diagnosis of
depression, psychotic symptoms, schizophrenia, bipolar disorder, social phobia, agoraphobia, or panic
disorder according to DSM-IV
32 participants were included in the study. All participants attended either elementary or high-school
classes depended on age. 16 were randomized into BCI and TAU. The final sample analyzed was 30, as 1
participant in each group withdrew after randomization.
Martinović 2006 
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The mean age was 17.2 (SD 2.5; range 13 - 19) years in the CBI and 17.6 (SD 2.2; range 13 - 19) in TAU.
There were 9 girls in each group. 6/5 (CBI) and 9/10 (TAU) participants had generalized seizures/focal
seizures. 7/9 and 8/6 participants were receiving monotherapy/polytherapy in CBI/TAU. 5 in CBI and 7
in TAU were drug-resistant. The mean IQ was 104 (SD 14.6; range 87 - 130) in CBI and 102 (SD 15.8; range
85 - 132) in TAU
All participants were recruited from general practices in Belgrade and its surrounding areas. They were
then referred to the Outpatient Department of Epilepsy, located at the Institute of Mental Health. The
dates when the study was conducted were not stated. There was no statement on conflicts of interest
in the publication.
Interventions CBI was applied as part of an individual treatment plan, aimed at analyzing and modifying distorted
automatic thoughts related to negative depressive thinking. It was delivered in group format with 7 to 8
participants/group, administered in 8 sessions during the first 2 months, and then in 1 session a month
during the next 4 months. Participants in CBI learned to recognize and correct all main types of cogni-
tive errors: catastrophic, over-generalization, personalization, and selective abstraction. Sessions con-
sisted of activity plans, relaxation, identification and correction of thought distortions through cogni-
tive restructuring, role playing, development of social skills, and problem-solving. All participants ran-
domized to CBI were instructed to note, in a treatment diary, the occurrence of negative thoughts and
counter-measures taken (positive thoughts). Negative and positive thoughts were rated on a 4-point
scale
TAU was administered in the same number of sessions and formats. It consisted of therapeutic coun-
seling without elements of CBI








Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A computer-generated list of numbers was used for randomization. No evi-
dence to suggest selection bias
Allocation concealment
(selection bias)





Low risk Both the participants and the therapists who delivered the treatment (CBI
and TAU) were unaware of the study hypotheses. They were told that they
would be provided with or deliver psychological means to improve coping
with epilepsy. No evidence to suggest performance bias
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 1 dropout in each group. No evidence to suggest attrition bias
Martinović 2006  (Continued)
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Selective reporting (re-
porting bias)
High risk Results of the following parameters were unavailable: 1) familial risk factors, 2)
environmental risk factors, 3) the rating of positive and negative thoughts on a
4-point scale, 4) seizure control. Unpublished data were sought but not provid-
ed






Methods Assessor-blinded, randomized, controlled trial comparing the Educational Epilepsy Program MOSES
(Modular Service Package Epilepsy) to a WLC in adults with epilepsy on quality of life, self-esteem, de-
pressive symptoms, epilepsy knowledge and coping, seizure frequency, as well as epilepsy-specific dai-
ly living restrictions, fears, mobility, and leisure. Outcome measures were obtained at baseline and 6
months after intervention
Participants Inclusion criteria: epilepsy, regardless of syndrome, duration, or severity
Exclusion criteria: mental retardation, acute psychiatric illness, non-epileptic seizures only
Enrolled 383 people. The final sample included 242 participants (aged 16 - 80), 113 received MOSES and
129 were allocated in WLC. The mean age was 37.5 (SD 13.7; range 16 - 77) years in MOSES, and 38.4
(SD 13.5; range 16 - 80) years in WLC. There were 65/73 women in MOSES/WLC. The duration of epilepsy
ranged from 1 to 54 years in MOSES and 1 to 61 years in WLC. 23/71/3 participants MOSES and 20/81/0
participants in WLC had generalized epilepsy/focal epilepsy/focal and generalized signs. The rest had
an undetermined type of epilepsy, or no data were available. 45/46/58/3/1/5 participants in MOSES,
and 57/56/59/11/0/3 participants in WLC had simple focal seizures/complex focal seizures/tonic-clonic
seizures/absence seizures/myoclonic seizures/tonic seizures. The rest were undetermined. 23/35 par-
ticipants had no seizures in the past 6 months in the MOSES and WLC groups. 38/39 had 1 to 5 seizures
in the past 6 months; 21/30 had > 1 seizure a month; 17/22 had > 1 seizure a week; 11/1 had > 1 seizure a
day. 110 participants in MOSES and 125 in WLC received treatment with antiseizure medication
Participants were drawn from 22 epilepsy centres in Germany, Austria, and Switzerland. The dates
when the study was conducted were not stated. The study was supported by Sanofi-Synthelabo; no
conflict of interest reported.
Interventions The aims of MOSES were to improve participants’ knowledge about epilepsy, its consequences, diag-
nostic and therapeutic measures, and to improve participants’ understanding of psychosocial and oc-
cupational problems. The participants were encouraged to cope actively with their disease, to live with
as few limitations as possible, to participate in the treatment process, and to gain more self-esteem.
The program focused on enhancing the self-help potentials of the participants, and on promoting the
participants to become 'experts' in dealing with their epilepsy. As results, a reduction of psychosocial
problems and an improvement of quality of life were expected. The program included 9 units: living
with epilepsy, epidemiology, basic knowledge, diagnostics, therapy, self-control, prognosis, psychoso-
cial aspects, and network. To cover the program, ∼14 lessons (60 minutes each) were necessary. In this
study, MOSES was offered as a 2-day course (course details were not specified)
Outcomes SF-36, Rosenberg self-esteem scale, Depression Scale (D-S), Restrictions in Daily Living Due to Epilepsy,
Epilepsy Knowledge Profile, Coping with Epilepsy and Adaptation, seizure frequency, and contented-
ness of drug therapy, evaluation of the MOSES program
Time points measured:
1) Baseline
2) 6 months after completion of the course
May 2002 
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Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random sequence generation was ensured, according to information provid-
ed by study authors
Allocation concealment
(selection bias)






High risk Participants were not blinded, according to information provided by study au-
thors
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk 133/383 withdrew after randomization; of the remaining 250, 8 were excluded
due to violation of study protocol. 242 were included in the final sample. Attri-
tion rate was considered high
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias High risk As professionals who delivered the intervention had to have had at least 2
years of experience caring for people with epilepsy (social worker, nurse, med-
ical doctor etc.) and received additional theoretical and practical training and
supervision to deliver the MOSES intervention, we rated risk of bias as low
in this dimension of treatment competence. Regular supervision (no results
available), no adherence checklist, some sessions were video-taped (no results
available). Risk of bias is therefore unclear for treatment fidelity and compe-
tence in treatment delivery. Risk of bias is high for selective recruitment as ad-





Methods A parallel-group, pragmatic randomized controlled trial of an Internet-based cognitive-behavioral ther-
apy (Emyna), offered adjunctively to care as usual (CAU), to improve depression among people with
epilepsy. Outcome measures were obtained at baseline, 3 months, 6 months and 9 months through a
secure, encrypted online survey service
Participants Inclusion criteria: age of at least 18; diagnosis of active epilepsy (defined by having taken AEDs with-
in the past 5 years or having experienced seizures within the past 10 years); diagnosis of a current de-
pressive disorder (confirmed by telephone-administered diagnostic interview administered by trained
research associates); at least moderate depression severity (PHQ-9 > 9); ability to read and speak Ger-
man; with Internet access.
Exclusion criteria: antidepressant medication was newly prescribed or changed within 1 month prior to
inclusion; currently in psychotherapy; had been diagnosed with bipolar disorder, schizophrenia, or oth-
Meyer 2019 
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er psychotic disorder, or borderline personality disorder; acute suicidality was confirmed in telephone
interview
Participants were recruited consecutively by outpatient clinics in epilepsy centres and other hospitals
as well as Internet forums, social media (e.g. Facebook), and health insurance brochures. 543 individ-
uals were interested in participating in the study, 483 provided consent, 283 were not eligible based
on inclusion/exclusion criteria. Finally, 200 met inclusion criteria and were randomized into control
group (N = 100) or intervention (N = 100). The mean age of the total sample was 40.3 (SD = 13.12); 73
were male. 73, 60 and 60 participants in CAU+Emyna and 81, 66, and 57 participants in CAU completed
3-month, 6-month and 9-month postintervention assessment, respectively.
Participants were recruited consecutively via outpatient clinics in epilepsy centers and other hospitals
as well as Internet forums, social media (e.g. Facebook), and health insurance brochures between Ju-
ly 2016 and May 2017. This research was funded by Gaia, Germany, a research-focused small-to-medi-
um enterprise that specializes in e-health interventions and regularly participates in publicly funded
research. The authors reported potential conflicts of interest as below: B.M., M.W., and F.S. are affiliat-
ed with Gaia, the company that funded this trial and that developed, owns, and operates the Internet
intervention evaluated in it. B.M. is employed full-time as Chief Scientific Office, M.W. is Chief Execu-
tive Officer and founder of Gaia, and F.S. is employed full-time as a research associate. None of the au-
thors who are not employed by Gaia (M.H., S.A., K.B., J.S., Y.N.) has received any remuneration from Ga-
ia. M.H. has received speaker honoraria and/or consultancy fees from Bial, Desitin, Eisai, LivaNova, No-
vartis, Shire, and UCB within the past 3 years. S.A. has received speaker honoraria and/or consultancy
fees from Bial, Desitin, Eisai, LivaNova, and UCB within the past 3 years. The other authors (K.B., J.S.,
Y.N.) declare that they have no competing interests.
Interventions The intervention was named 'Emyna', inspired by the Greek word "emyna", denoting 'defense', and
alluding to the idea that the program might help people with epilepsy to defend themselves against
some of the adverse emotional effects brought about by epilepsy. Emyna is a fully-automatic Internet
intervention that requires no clinician support. It conveys CBT techniques and exercises to people with
epilepsy and can be accessed over a period of 180 days. Program content is presented in interactive
'simulated dialogues' in which participants navigate through the program by reading brief text pas-
sages or listening to audio recordings and then selecting one of several response options.
Outcomes Primary outcome - depressive symptom severity
PHQ-9, NDDIE
Secondary outcomes and additional measures
GAD-7, DASS-21, WSAS, QOLIE-10, Seizure frequency by self-report, illness-related sick day oB work in
the previous 3 months, number of days hospitalized in the previous 3 months, positive/negative ad-
verse events attributed to intervention by INEP-ON
TIme point measured:
1) Baseline
2) 3 months after intervention
3) 6 months after intervention
4) 9 months after intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomization was performed by the principal investigator (PI; Y.N.) using a
computer-generated sequence to assign the allocation sequence
Meyer 2019  (Continued)
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Allocation concealment
(selection bias)
Low risk The PI did not have knowledge of participant characteristics prior to perform-
ing the randomization, because participants were enrolled by trained research





High risk Participants were not blinded to whether they were receiving the intervention,
but the intervention was delivered using a fully automatic Internet interven-
tion that requires no clinician support, so performance bias is considered low
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 27/100 (27%) in the CAU+Emyna and 19/100 (19%) in the CAU-only dropped
out at 3 months post-assessment. The attrition bias was considered high
Selective reporting (re-
porting bias)
Low risk No evidence to suggest reporting bias
Other bias High risk Low risk of bias for treatment infidelity as this was a web-based intervention.
Training background of personnel developing the Emyna intervention was rat-
ed as low risk for incompetence. Risk for selective recruitment was high as In-





Methods Assessor-blinded, quasi-randomized, controlled trial comparing group CBT with SSRIs treatment of
MDD in adults with TLE on mood and quality of life. Outcome measures were obtained at baseline, 6
weeks (during treatment), and 12 weeks (immediately after treatment)
Participants Inclusion criteria: adults (aged over 18), diagnosed with MDD according to the criteria of the DSM-IV,
diagnosed with TLE according to the criteria of the ILAE, literate; individuals on antidepressant treat-
ments were allowed to participate only if they had been on stable doses for > 8 weeks, and still showed
signs of significant depression
Exclusion criteria: high risk of suicide that required hospitalizations, abused or dependent on drugs,
history of head trauma within 6 months prior to the recruitment, any condition that would prevent un-
derstanding the study or the psychotherapeutic process, such as mental retardation, psychosis, deliri-
um, or dementia, previous CBT
The 15 participants were assigned to CBT (N = 7) and SSRIs (N = 8) according to the participant's ability
to attend the weekly session. There was 1 woman in the CBT and 4 in the SSRI group. The mean age was
33.8 years in CBT, and 43.1 years in SSRI. The duration of epilepsy/age at seizure onset was 12.4/21.4
years in CBT, and 22.3/20.7 years in SSRIs. The average number of seizures a month was 5.2 in CBT, and
4.6 in SSRI. 3 participants in each group had a comorbid anxiety disorder
The study was conducted at the National Institute of Neurology and Neurosurgery in Mexico City. Re-
cruitment took place between January 2013 and December 2013. This work was undertaken at theN-
ational Institute of Neurology and Neurosurgery with support from the Department of Neuropsychiatry
and by an author's research scholarship from the Consejo Nacional de Ciencia y Tecnologia (CONACYT).
No conflicts of interest was reported.
Interventions The CBT sessions comprised 1 weekly 90-minute session for 12 consecutive weeks. The components
and structure of CBT were based on Crail-Melendez 2013. Therapeutic elements included the basics
Orjuela-Rojas 2015 
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and relationship of depression and epilepsy, identification of emotions, modification of activities to
improve mood, identification and reviewing of thought records, automatic thoughts, introduction of
thought distortions, learning alternative thoughts, introduction of the concept of core beliefs, down-ar-
row techniques, etc.
According to the study protocol, the SSRI group received treatment with a SSRI (sertraline or citalo-
pram) for 12 weeks, based on the protocol suggested by the American Psychiatric Association in their
practice guidelines for depression, in which titration is done at week 6, after the second evaluation
Outcomes BDI, HADS, QOLIE-31, MINI
Time-points measured
1) Baseline
2) 6 weeks during treatment
3) 12 weeks (immediately after treatment)
Notes Original data were sought and provided by study authors
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Group assignment was not random. Allocation to CBT group was based on par-









High risk Participants and personnel were not blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 2/7 (28.5%) in CBT and 1/8 (12.5%) in SSRI lost to follow-up. We considered the
overall attrition rate (20%) high for this short-term intervention
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias Unclear risk Unclear risk for treatment infidelity, selective recruitment and the competency
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Methods Unblinded, randomized controlled multicenter trial comparing MI with UC in adults with epilepsy on
their drug adherence, drug-taking behaviors, seizure severity and HRQOL. Outcome measures were ob-
tained at baseline, 3 months, and 6 months following delivery of the intervention
Participants Inclusion criteria: adults (aged 18 or above), diagnosis of epilepsy according to the ILAE criteria, inde-
pendent in daily living activities or were responsible for taking their medications, prescribed AEDs
Exclusion criteria: rapidly progressing neurological or medical condition, were not prescribed AEDs, di-
agnosis of an intellectual disability, major cognitive impairment (MMSE < 23), unable to read and write
Persian
Recruited 275 adults with epilepsy. 137 and 138 were randomly assigned to MI and UC, respectively.
The mean age was 41.37 (SD 16.25) years in MI, and 39.86 (SD 15.01) years in UC. There were 45 in MI
and 49 women in UC. 41 (MI) and 96 (UC) were on polytherapy. 55/34/48 in MI and 60/38/40 in UC had
idiopathic/cryptogenic/symptomatic epilepsy. 60/38/32 in MI and 64/39/30 in UC had focal seizures/
generalized seizures/absence seizures; the rest were unknown in either group
The study involved 8 neurologic clinics from Qazvin (N = 2) and Teheran (N = 6). Recruitment took place
between June 2014 and February 2015. The source of funding was not mentioned in the publication.
The authors declared no conflicts of interest.
Interventions MI intervention was a multifaceted program, designed to enhance medication adherence behavior and
clinical outcomes in participants with epilepsy. 3 weekly, individual face-to-face sessions, each lasting
for 40 to 60 minutes, were provided. Participants were encouraged to express their experiences, values,
readiness, and confidence for behavior change during the intervention. The MI techniques used to re-
solve barriers and encourage participants to take medications regularly used open-ended questions,
affirmations, reflective statements, and summaries to elicit change talk. The participants also received
a drug diary calendar to help them monitor their plan on medication adherence. All sessions were de-
livered on an individual basis, by a male health psychologist with 10 years of experience working with
medication adherence in people with chronic diseases, who had received 60 hours of training of MI in
Qazvin and Tehran
All participants, in both MI and UC, received standard care consistent with 'treatment as usual' for pa-
tients with epilepsy
Outcomes MARS, AED serum levels, BMQ, PBC, behavioral intention, self-monitoring, action planning, coping
planning, SRBAI, LSSS, and QOLIE-31
Time points measured:
1) Baseline before randomization
2) 3 months after intervention
3) 6 months after intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A computer-generated code based on random-number sequence with stratifi-
cation by the study sites was used. Randomization was performed by indepen-




Unclear risk Insufficient information was provided
Pakpour 2015  (Continued)
Psychological treatments for people with epilepsy (Review)














High risk Insufficient information on the blinding of participants was provided
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 4/275 dropouts at follow-up. Attrition rate was considered low
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias Low risk Low risk for the training component of treatment competence, quality of treat-
ment delivery and selective recruitment. There was no information on how





Methods Assessor-blinded, randomized, controlled trial comparing a group receiving individual counseling pro-
vided by an EN and WLC in people with epilepsy on satisfaction with treatment. Outcome measures
were obtained at baseline and 6-month follow-up
Participants Inclusion criteria: adults (age 16 and above) with epileptic seizures, who were referred to an epilepsy
outpatient clinic, and who agreed in writing to participate in the study
Exclusion criteria: incapable of responding to the questionnaire (language or learning difficulties), only
non-epileptic seizures
187 participants; 92 and 95 were randomized, 67 and 76 were analyzed in EN and WLC. The mean age
was 42.6 (± 14.8), and 44.9 (± 15.0) in EN and WLC group. There were 34 women in EN and 45 women in
WLC. The mean duration of epilepsy was 20.7 (± 16.8) in EN, and 23.5 (± 17.1) in WLC 2 outpatient clin-
ics that specialized in epilepsy participated. The dates when the study took place were not stated. The
study was financially supported by UCB Pharma; no conflict of interest reported.
Interventions The 2 certified ENs ('epilepsy specialist assistant' or 'epilepsy specialist counselor') who provided the
intervention had received a 1-year part-time training, with blended e-learning, attendance periods,
homework, visits to specialized epilepsy institutions, and train-the-trainer training, in order to engage
in patient-education programs. Participants of the EN group were offered time for counseling, and ad-
vice during their routine visit. The EN handed out a short questionnaire in order to assess participants'
major needs. The questionnaire covered the following topics: epilepsy, therapeutic issues, risks and
adverse effects of medication and other therapies, pregnancy, problems in daily life with seizures, con-
sequences of seizures for driving, employment, the job, school and families, and social issues, and an
open-ended question for topics not listed. The nurses provided leaflets and other written information
about driving regulations, pregnancy, social support, and self-support groups.
Participants of the control group had routine care only
Outcomes Primary outcome measure was satisfaction of participants with information and support
Secondary outcome measures were satisfaction with patient–doctor relationship, organization of
treatment, epilepsy knowledge, coping, and restrictions in daily life.
Pfä;lin 2016 
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HADS and global Quality of Life (item from QOLIE-31)
Time points measured:
1) Baseline (before randomization)
2) 6 months after baseline
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random allocation by a computer-generated block randomization list
Allocation concealment
(selection bias)





High risk WLC group design. The epilepsy nurse was a new service, added to the stan-
dard service of the outpatient clinics
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Questionnaires were returned anonymously to the Society for Epilepsy Re-




High risk Dropout rate in EN group: 27%; dropout rate in WLC group: 20%
Selective reporting (re-
porting bias)
Low risk HADS scores were available as a supplementary table, online
Other bias Low risk Low risk for selective recruitment and the training component of treatment
competence. Unclear risk for treatment fidelity and competence in delivering
the intervention. There was regular supervision but no results available as the





Methods Unblinded, randomized, controlled trial comparing a psychoeducational program (Treatment) to TAU
in participants with epilepsy on epilepsy-related quality of life, self-efficacy, locus of control, and per-
sonality. Outcome measures were obtained at baseline, and 1-month and 6-month follow-up
Participants Inclusion criteria: adults (18 or above) with a diagnosis of epilepsy made by a neurologist, ability to un-
derstand and participant in the consent process
Exclusion criteria: not specified
55 adults were enrolled. 31 and 24 were allocated to Treatment and TAU, respectively. The mean ages
were 48.89 years (SD 14.3) in Treatment, and 48.1 years (SD 14.3) in TAU. The mean ages at first seizure
were 22.5 years (SD 16.7) in Treatment, and 20.32 years (SD 13.1) in TAU.
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Participants were recruited at a university hospital-based regional epilepsy centre (from August 2003
to April 2005), and the VA Pittsburgh Healthcare System Neurology Clinic (from May 2004 to May 2005).
This work was supported by the Centers for Disease Control and Prevention (CDC) as a Special Interest
Project of the University of Pittsburgh Prevention Research Center on Healthy Aging through CDC Coop-
erative Agreement U48/CCU320171. The authors acknowledge the ongoing financial and administrative
support of the Epilepsy Program of the Centers for Disease Control
Interventions The treatment was delivered in group format (6 to 12 per group), with weekly 2-hour sessions, for 6
consecutive weeks. Participants were reimbursed USD 10 for each intervention they attended, and USD
20 for completion of baseline or follow-up questionnaires. The curriculum and materials were devel-
oped with a multidisciplinary team (epilepsy centre neuropsychologist, an epilepsy nurse, a rehabil-
itation psychologist, an exercise physiologist, and a behavioral interventionist). Therapeutic compo-
nents included a mixture of psychoeducation, medical information, and advocacy topics, framed in the
self-management activities of self-evaluation, self-monitoring, stimulus control, and self-reward, plus
peer support. The topics for the 6 weekly treatment were 1) taking charge of your medical care, 2) tak-
ing charge of your self-advocacy, 3) taking charge of stress, 4) taking charge of your schedule and goals,
5) taking charge of your relationships, and 6) taking charge of your future. Group interventions were co-
led by 2 licensed psychologists and a research associate, with a guest lecture on medical issues, by an
epilepsy nurse clinician.
Those in the TAU maintained their regular schedule of follow-up appointments with their neurologists
and the epilepsy nurse in the clinic





Notes Data were sought but not provided
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A table of random number was used to generate a randomization sequence.
No evidence to suggest selection bias
Allocation concealment
(selection bias)





High risk Participants and investigators who led the group were not blinded to group as-
signment
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 12/31 (38%) in the Treatment, and 5/24 (21%) in the TAU groups withdrew af-




High risk Baseline scores for both groups, and data for 6 months after baseline assess-
ment for the TAU group were unavailable. Data were sought but not provided
Pramuka 2007  (Continued)
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Methods Assessor-blinded, quasi-randomized, controlled multicenter trial comparing a group educational pro-
gram for children and their parents (FAMOSES) and WLC in children with epilepsy on knowledge, cop-
ing, and treatment outcome. Outcome measures were obtained at baseline and 3-month follow-up
Participants Inclusion criteria: children with epilepsy, able to read and write in German, parents of children with
epilepsy, whether or not they could read and write German
Exlusion criteria: children with non-epileptic seizures only, and their families
70 children (8 - 13 years) and 159 parents were enrolled. 82/55 and 77/48 parent were allocated/an-
alyzed in the FAMOSES and WLC groups, respectively. 38/31 and 32/19 children were allocated/ana-
lyzed in the FAMOSES and WLC groups, respectively. The mean ages in years were 10.8 (SD 1.8) and 10.3
(SD 1.8) in FAMOSES and WLC. There were 18 girls in FAMOSES and 12 girls in WLC. The mean durations
of epilepsy in years were 5.4 (SD 3.6) years in FAMOSES and 4.3 years (SD 3.1) in WLC. 15/12 had focal
epilepsy; 6/3 had generalized epilepsy; 6/1 had epilepsy with focal and generalized features; 2/1 had
non-classified epilepsy; 2/2 did not provide information about their epilepsy in FAMOSES/WLC. 15/11
had further illnesses in FAMOSES/WLC. 28/17 took at least 1 AED in FAMOSES/WLC
The participating 9 institutions in Germany were Epilepsy Center Bethel, Bielefeld, Epilepsy Center
Berlin-Brandenburg, Epilepsy Center Kleinwachau, Epilepsy outreach clinic, Regensburg, pediatric
practice Dr. Bettendorf, Epilepsy Center Vogtareuth, Epilepsy Center Raisdorf, Epilepsy Center Kork,
and the pediatric clinic Links der Weser, Bremen. Recruitment took place from January 2003 to January
2004. Sources of funding and conflicts of interest were not reported.
Interventions FAMOSES is an educational program developed by an interdisciplinary project group to improve knowl-
edge, coping, and treatment outcome, emotional and practical adaptation to the condition. The ed-
ucational program comprised 1 group session (14 hours) for children (4 to 6 children) and 1 separate
group session for parents (6 to 10 adults)
The WLC group was offered conventional treatment according to individual needs
Outcomes KINDL (Gesundheitsbezogene Lebensqualität und psychosoziale Auswirkungen der Epilepsie/Health-
related Quality of Life and psychosocial consequences of epilepsy), epilepsy knowledge, seizure fre-
quency, contentment with therapeutic regimen, missed school days, evaluation of FAMOSES by partici-
pants
Time points measured:
1) Baseline (before randomization)
2) 3 months after the intervention (FAMOSES)/baseline (WLC)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Unclear in publication. According to information sought from authors, the al-
location depended on the participants' application to the 1st or 2nd available
course and the availability of places in the chosen course
Rau 2006 
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Allocation concealment
(selection bias)
High risk Unclear in publication. According to information sought from authors, the allo-





High risk Blinded to final assessor only. Neither participants nor service providers were
blinded
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk The participating research institutes that assessed the data received an




High risk 76.4% of all study participants returned the questionnaires (parents: 78.6%;
children: 71.4%; FAMOSES (children): 18,4%; WLC (children): 40,6%)
Selective reporting (re-
porting bias)
Low risk All outcomes were reported at all measured times
Other bias High risk Not enough information to evaluate fidelity to the intervention protocol and
selective recruitment. However, infidelity to the intervention protocol is un-
likely, since the intervention is manualized and personnel delivering the in-
tervention received prior training and supervision as part as the standardized
FAMOSES training procedures. Selective recruitment bias is present as families





Methods Assessor-blinded, randomized, controlled trial comparing the Educational Epilepsy Program SMILE
(UK) (Self-management education for people with poorly controlled epilepsy) to TAU in adolescents
and adults with epilepsy on quality of life, seizure frequency and recency, psychological distress, im-
pact and stigma of epilepsy, self-mastery, medication adherence, and adverse effects. Outcome mea-
sures were obtained at baseline and 6 and 12 months after randomization
Participants Inclusion criteria: epilepsy, aged ≥ 16 years, prescribed antiseizure medication, reporting at least 2
seizures (of any type) in the previous year, able to answer questionnaires in English
Exclusion criteria: nonepileptic seizures, acute illness or substance misuse, serious psychiatric illness or
a terminal condition, or if they were currently participating in other epilepsy-related research
Enrolled 407 people. The final sample included 404 participants (aged 16 - 85), 205 received SMILE and
199 were allocated to TAU. The mean age was 42.5 (SD 14.3; range 16 - 85) years in SMILE (UK), and
40.8 (SD 14.0; range 17 - 82) years in TAU. There were 115/104 women in SMILE (UK)/TAU. The dura-
tion of epilepsy ranged from 8 to 32 years in SMILE (UK) and in TAU. 52/58 participants had < 1 seizure a
month in the past 12 months in the SMILE (UK) and TAU groups. 147/138 had ≥ 1 per month in the past
12 months; as per inclusion criteria all participants received treatment with antiseizure medication.
The trial was run from King’s College London, UK. Participants were drawn from specialist epilepsy clin-
ics at eight hospitals in London and South East England. PWE were recruited from specialist epilepsy
clinics between December 2013 and August 2016.
This research was independent and funded by the National Institute for Health Research (Health Tech-
nology Assessment, 09/165/01 — Self-Management education for adults with poorly controlled epILEp-
sy [SMILE] A Randomized Controlled Trial); no conflict of interest reported.
Ridsdale 2018 
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Interventions The intervention was based on MOSES with the aims to communicate information and to encourage
participants to share their own experiences with others. Participants were given a workbook contain-
ing course content to use during the sessions and to take home (see May 2002 for further information).
Groups included 5 - 14 participants. The course was 16 hours over 2 consecutive days, delivered by an
epilepsy nurse specialist and an EEG technician
Outcomes QOLIE-31-P with added Patient-specific weightings, seizure frequency scales, seizure recency (number
of days since last seizure), HADS, Impact of Epilepsy, Stigma of Epilepsy, and Self-Mastery and Control
Time points measured:
1) Baseline
2) 6 months after randomization (only QOLIE-31-P, seizure frequency and recency, and Impact of
Epilepsy)
3) 12 months after randomization
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Randomization was provided by an online system managed by the King’s Clini-





High risk Participants were not blinded to their treatment; personnel who facilitated the
intervention were not blinded to the allocation of participants
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Research staB who completed follow-up assessments and the participants’




High risk 51/205 and 39/199 missed the second assessment in SMILE and TAU, respec-
tively.The attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk No evidence to suggest reporting bias
Other bias Low risk Low risk for infidelity to intervention protocol, since the intervention protocol
was manualized. A fidelity implementation found that trainers within the tri-
al delivered the intervention according to protocol, with good adherence and
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Methods Blinded, cluster-randomized, controlled trial comparing a nurse-led competency framework (EpAID) to
TAU in adults with epilepsy and ID on seizure severity and QoL
Participants Inclusion criteria: The presence of a developmental ID with an IQ of ≤ 70. A diagnosis of epilepsy with
a history of at least 1 seizure in the 6 months preceding recruitment into the trial (not considered by
those managing the epilepsy to have been a non-epileptic seizure)
Exclusion criteria: The presence of a rapidly progressive physical or neurological illness. Alcohol or drug
dependence
Enrolled 312 people from 17 research clusters. 184 received EpAID and 128 were allocated to TAU. The
mean age was 39.6 (SD 13.3; range 18.1 - 65.5) years in EpAID, and 37 (SD 12.5; range 18.4 - 63.5) years
in TAU. There were 85/67 women in EpAID/TAU. The age at epilepsy diagnosis was 5.6 (± 7.6) and 7.3
(± 9.9) in EpAID/TAU, respectively. 15/20/1/10 participants had focal/generalized/undetermined/spe-
cial epilepsy syndromes in EpAID, 15/28/7/4 participants had focal/generalized/undetermined/special
epilepsy syndromes in TAU
Participants were drawn from 17 individual cluster sites from across England, Scotland and Wales. The
first site recruited in September 2014 and the final site recruited in September 2015.This trial was fund-
ed by the NIHR Health Technology Assessment programme; no conflict of interest reported.
Interventions The experimental intervention was the Learning Disability Epilepsy Specialist Nurse Competency
Framework. This provides guidelines describing a structure and goals to support the delivery of epilep-
sy care and management by LD-trained nurses. The guidelines were developed by the UK ESNA in asso-
ciation with the UK Royal College of Nursing. A key element of the competency framework is that it is
not a manualized treatment guideline for epilepsy but rather a list of what management a nurse should
be able to deliver at their given level of competence. Within these constraints, nurses delivered their in-
terventions at a frequency determined by clinical need, through home visits, telephone clinics and vis-
its to the local primary care or ID team base as appropriate. When nurses considered that it was appro-
priate, and as described in the competency framework, they also delivered epilepsy education to pa-
tients and carers. In addition, interactions with other clinicians, for example participants’ primary care
health service, local community ID health team and/or local neurology service were facilitated by the
nurses as and when they considered clinically appropriate. Nurses delivered the intervention on an as-
needed basis for 24 weeks
Outcomes ELDQoL-SSS, injuries associated with seizures, the level of distress manifested by the patient, as per-






Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomization of the clusters was undertaken independently by KCTU using
block randomization with fixed block sizes
Allocation concealment
(selection bias)
Low risk The author clarified "allocation was undertaken by the King's College clinical
trials unit who knew nothing about the sites. None of the research team were




Low risk To minimize expectations of the participants, their carers and families and the
clinical staB at each cluster, they were not informed that there were 2 arms in
the trial (an ‘active’ arm and a TAU arm), nor were they informed which arm
Ring 2018  (Continued)
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All outcomes of the study they had been randomized to. Clinicians in both arms were aware
that they were part of a treatment trial and all had received direct training
from a senior nurse
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk The author clarified "research assistants involved in outcome assessments





Low risk Attrition was 13%
Selective reporting (re-
porting bias)
Low risk We have not received the study protocol. As far as we can tell from the publica-
tion, there is no risk of selective reporting
Other bias Low risk Unclear risk of infidelity to intervention protocol and incompetence to carry
out the intervention. Training background of personnel was competent/expert
level, i.e. low risk of bias in this dimension of competence. No risk of selective
recruitment
Appropriate analysis used for the cluster-randomized design (linear mixed-
effects model which compares individuals within the treatment and control





Methods Unblinded randomized, controlled trial comparing a 12-week Targeted Self-Management for Epilepsy
and Mental Illness (TIME) program to TAU in adults with epilepsy and comorbid mental illness on de-
pression symptom severity. Outcome measures were obtained at baseline, 12 weeks (postintervention)
and 16 weeks after baseline assessment
Participants Inclusion criteria: adults aged 18 or older, with a diagnosis of epilepsy and a DSM IV diagnosis of schiz-
ophrenia, schizoaffective disorder, bipolar disorder, or chronic/recurrent major depressive disorder,
confirmed with the MINI, who spoke and read English.
44 adults were recruited. 22 were allocated to each group. The mean age was 52.0 years in TIME and
45.1 in TAU. 13/12 were women in TIME/TAU. The mean seizure frequency in the past 30 days in TIME/
TAU was 3.7/8.8. The number of participants who reported generalized/focal/unclassified seizures were
16/5/1 in TIME and 14/6/2 in TAU. The mean duration of epilepsy was 27.6/25.4 in TIME/TAU.
Interventions The TIME intervention stresses information-sharing in a way that is accessible to participants with
epilepsy and comorbid mental illness and fosters motivation for active self-management. Topics ad-
dressed include a summary of facts vs myths about mental illness and epilepsy, developing an action
plan for concurrently coping with mental illness and epilepsy, personal goal-setting, stress manage-
ment, and training to communicate with care providers.The final TIME intervention was operational-
ized in 2 steps. Step 1: 12 group-format, in-person 60- to 90-minute sessions (up to 8 participants per
group), collaboratively delivered by a nurse educator–peer educator dyad. Step 2: Following the group
sessions, participants had 2 telephone maintenance sessions (spaced approximately 2 weeks apart)
with the peer educator and 2 telephone sessions (spaced approximately 2 weeks apart) with the nurse
educator. Phone sessions emphasized support and ongoing self-management. Nurse educators provid-
ed brief linkage (information sharing, opportunity for questions) to the participants' clinical providers.
The study took place at Case Western Reserve University Prevention Research Center; the time when
the study was conducted was not stated. This publication was supported by the Grant or Cooperative
Agreement Number U48DP001930 (SIP12-057) under the Health Promotion and Disease Prevention Re-
Sajatovic 2016 
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search Centers Program, funded by the Centers for Disease Control and Prevention; no conflict of inter-
est reported.
Outcomes MADRS, BPRS, PHQ-9, GAF, WHODAS-II, 30-day self-reported seizure frequency, QOLIE-10, PSQI, ESES,
MSPSS, ISMI, 10-item ESS
Time points measured:
1) Baseline




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomization was allocated using a computer-generated list
Allocation concealment
(selection bias)
Low risk Randomization using a computer-generated list that was only available after





High risk Participants were not blinded to their treatment; personnel who facilitated the
intervention were not blinded to the allocation of participants
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 3/22 and 6/22 missed the second assessment in TIME and TAU, respective-
ly.The attrition rate was considered high
Selective reporting (re-
porting bias)
Low risk Results for ESES, MSPSS, ESS, and ISMI are missing in the publication but were
provided by the principal investigator. The study protocol mentions: Adher-
ence:TRQ, Substance use: ASI which are not reported in the publication. The
main author clarified: "We ended up not using/reporting the ASI data because
of concern with data quality and/or complexity of the scale."
Other bias Low risk Low risk for infidelity to intervention protocol or incompetence in delivery of
intervention. Fidelity to the TIME intervention and competence were assessed
quantitatively (for example, duration and content covered) and qualitatively
(for example, participant–interventionist interaction) at each session. Nonin-
terventionist study staB evaluated acceptability of each fidelity dimension. Im-
mediate feed-back and course correction were established as needed. Any de-
viation was addressed in debriefing sessions conducted immediately after the
intervention. While the results were not mentioned in the publication, the au-
thor clarified: "We had a relatively high degree of fidelity and if there was any
“driF” observed during a session it was addressed during the mandatory de-
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Study characteristics
Methods A randomized controlled trial to test a self-management intervention for people with epilepsy (SMART)
that specifically focused on high-risk subgroups of people who have recently experienced seizures or
epilepsy-related complications
Participants Study participants were drawn from the community with assistance from the local Ohio Epilepsy Asso-
ciation, MetroHealth System, a regional safety net healthcare provider, the Lois Stoke Veterans Admin-
istration, and University Hospitals of Cleveland Neurological Institute, a tertiary care centre. Specific
date was not mentioned.
Inclusion criteria:
Aged 18 or above, having at least 1 negative health event (NHE) within the past 6 months, able to pro-
vide written consent and participate in study procedures
Exclusion criteria:
Immediate risk of self-harm, dementia, pregnant, unable to read/understand English
139 individuals were assessed for eligibility, 19 were excluded based on inclusion/exclusion criteria,
120 were randomized. 60 and 60 were randomized into the SMART and WLC, respectively. 60, 53 and 51
in the SMART group and 60, 58 and 52 in the WLC were analyzed in the baseline, 10-week and 24-week
follow-ups, respectively
This study was supported by a grant from the Centers for Disease Control and Prevention SIP 14-007
1U48DP005030.
The authors declared potential conflicts of interest as below: M.S. has received research grants from
Otsuka, Alkermes, Merck, Janssen, Reuter Foundation, WoodruB Foundation, Reinberger Founda-
tion, National Institute of Health, and the Centers for Disease Control and Prevention; is a consultant
to Bracket, Otsuka, Supernus, Neurocrine, Health Analytics, and Sunovion; and has received royalties
from Springer Press, Johns Hopkins University Press, Oxford Press, and UpToDate. C.T. has research
grants from the National Science Foundation, Biogen, and Philips Healthcare. S.L. has research grants
from the National Institute of Health and within the past 3 years has been a speaker for Sunovion. The
other authors have no conflicts of interest to report.
Interventions SMART has 8 sessions conducted over approximately 8 - 10 weeks, SMART is operationalized in 2 steps.
In step 1, 1 group-format, in-person 60- to 90-minute session (up to 10 participants), was collaborative-
ly delivered by a nurse educator-peer educator dyad. Peer educators were individuals with epilepsy
with at least 3 lifetime NHEs. Following the in-person session, there were 7 group-format sessions de-
livered by the Internet on personal computer tablets using posters/graphics and emphasizing interac-
tive discussion. The online communication system used was Adobe Connect, secure Web conferenc-
ing software. In step 2, following the group sessions, participants had 6 telephone maintenance ses-
sions with the peer educator and the nurse educator alternating calls. Nurse- and peer-educator calls
were intended to be brief (no more than 10 - 15 mins) and followed a semiscripted structure in which
the nurse- or peer-educator asked participants how they were doing with attempting to meet their per-
sonal care plan
Outcomes Primary outcome:
Self-reported NHEs in the 6 months prior to the study enrollment and during the 6-month RCT
Secondary outcome:
PHQ-9, MADRS, QOLIE-10, SF-36, LSSS, ESES, MSPSS, ESMS, ESS
TIme point measured:
1) Baseline (immediately prior to randomization)
Sajatovic 2018 
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2) 10-week (shortly after the completion of the SMART sessions)
3) 24-week (6-month follow up)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated 1:1 randomization was based on a randomized block de-
sign with random block sizes
Allocation concealment
(selection bias)






High risk Participants were not blinded to their treatment; personnel who facilitated the
intervention were not blinded to the allocation of participants
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 7/60 and 2/60 missed the 10-week assessment in SMART and WLC, respective-
ly. The attrition rate was considered low
Selective reporting (re-
porting bias)
Low risk No evidence to suggest reporting bias
Other bias Low risk Low risk for infidelity to intervention protocol. Noninterventionist study staB
evaluated fidelity quantitatively (i.e. duration and content covered) and quali-
tatively (i.e. participant-interventionist interaction) at each session. The fideli-
ty checklist contained 7 items using a yes/no format (completed by noninter-
ventionist study staB) that assessed whether the interventionists adhered to
study content (1 item), format (1 item), rapport and empathy with group par-
ticipants (2 items), peer educator engagement (1 item), and timing/schedule
planning (2 items). If there were any "no" responses on the fidelity checklist,
these were addressed at a debriefing held immediately after the SMART ses-





Methods Assessor-blinded, randomized, controlled trial comparing an online psychological intervention for de-
pression (Deprexis) to a WLC in adults with epilepsy. The study aimed to evaluate the feasibility and ef-
ficacy of the program on depressive symptoms and quality of life. Outcome measures were obtained at
baseline and 9 weeks after baseline (after intervention)
Participants Inclusion criteria: self-reported epilepsy diagnosis (externally validated based on an epilepsy-specific
inventory, the PESOS questionnaire), self-reported depressive symptoms
Exclusion criteria: acute suicidal ideation, diagnosis of psychosis, bipolar disorder, or suicidality, insuf-
ficient time to take part in the online program for 9 weeks
Schröder 2014 
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78 adults were enrolled. 38 and 40 were randomized to Deprexis and WLC, respectively. The mean age
was 35.03 years (SD 9.99; range 18 - 57) in Deprexis and 40.03 (SD 11.85; range 22 - 77) in WLC. 27 and 32
were women in Deprexis and WLC. AEDs were well tolerated/badly tolerated by 17/20 participants in
Deprexis and 19/20 participants in WLC. 1 participant in each group was not taking any AEDs. 26/12 par-
ticipants in Deprexis had ≤ 1 seizure a month, and 27/13 in WLC had > 1 seizure a month. 15/18/5 partic-
ipants in Deprexis and 22/14/4 participants in the WLC had 1/2/≥ 3 different seizure types
Participants in WLC group were, on average, significantly older than participants in the intervention
group (P = 0.048). To take this group difference into account, the variable 'age' had been entered as a
covariate in the statistical analyses. Participants were recruited by a patient database from the Epilep-
sy Center Alsterdorf, Germany, and postings in moderated epilepsy-specific online forums. Recruit-
ment took place between May 2012 and July 2013. Sources of funding were not stated; no conflict of in-
terest reported.
Interventions This trial used the Internet-based program Deprexis, which is aimed at reducing symptoms of depres-
sion. It predominantly comprised elements of CBT, such as cognitive restructuring and behavioral ac-
tivation, and complemented these with mindfulness and acceptance exercises, among others. Users
interacted with the program by a simulated dialogue, in which they were continuously asked to select
one of several response options, and were presented with subsequent content that aimed to match
their expressed preferences and requirements. Depending on reading speed and each user’s individual
path through the program, each module lasted for approximately 10 to 60 mins. The participants could
log in for a duration of 9 weeks
Outcomes BDI-I, WHOQOL-BREF, QOLIE-31
Time points measured:
1) Baseline
2) 9 weeks after the baseline
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Allocation was done in consecutive order, using a computer-generated ran-
domized number table. No evidence to suggest selection bias
Allocation concealment
(selection bias)





High risk Since the intervention was delivered by an Internet platform, the provision
was considered blinded; this conclusion was discussed with and agreed by
study authors. However, the participants could not be blinded to their group
status
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 14/38 (Deprexis) and 8/40 (WLC) withdrew from the study. The overall attrition
rate was 28%, which was higher than the expected rate (25%), as stated in the




Low risk Unreported data were sought and provided by study authors. Comparison
with registered protocol showed that some outcome parameters had original-
Schröder 2014  (Continued)
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ly been planned, but due to a change of protocol, had not been collected dur-
ing the course of the study
Other bias High risk Low risk of bias for treatment infidelity as this was a web-based intervention.
Training background of personnel developing the website was rated as low
risk for incompetence. Risk of bias is high for selective recruitment as adver-





Methods Assessor-blinded, randomized, controlled trial comparing a mindfulness-based therapy (MT) to a
placebo attention social support (SS) in adults with epilepsy on quality of life, mood and anxiety symp-
toms, and seizure control. Outcome measures were obtained at 6-week pre-intervention baseline and 6
weeks postintervention
Participants Inclusion criteria: adults (aged 18 or above) with drug-resistant epilepsy according to ILAE definition
Exclusion criteria: primary diagnosis of organic mental disorder, psychotic disorders, psychogenic
nonepileptic seizures, learning disability, or mental retardation
61 adults were enrolled. 30 and 31 were randomly allocated to MT and SS. The mean age was 34.77
years (SD 10.26) in MT and 35.47 (SD 11.22) in SS. There were 14 women in each group. The mean dis-
ease duration in years was 20.43 (SD 9.95) in MT and 18.93 (SD 11.08) in ST. 36.7%/23.3%/36.7%/3.3% of
the participants in MT and 40%/40%/16.7%/3.3% of the participants in SS were under AED monother-
apy/2 drugs/3 drugs/4+ drugs. The total number of seizures in 6 weeks pre-intervention was 9.83 (SD
9.78) in MT, and 9 (SD 11.79) in SS. 40%/36.7% of participants in MT/SS had experienced seizures within
the past week
Participants were recruited from the Neurology Outpatient Clinic in the Prince of Wales Hospital, the
teaching hospital of the Chinese University of Hong Kong. The study took place between September
2011 and January 2013. The study was not funded by any organization. The authors had reported no
conflicts of interest.
Interventions Intervention comprised an active treatment: MT, and a placebo attention control, SS. Intervention was
delivered in group format (7 to 8/group) with 4 x 2½-hour biweekly sessions, conducted by the same
clinical psychologist. All participants received an identical educational package with basic knowledge
and management of epilepsy, including layman terms of the etiology and types of seizure, sleep hy-
giene, and the importance of drug adherence and regular exercise. The MT protocol was based on sev-
eral guiding references on mindfulness for participants with chronic diseases. The concept of mind–
body connection that is rooted in the Chinese culture was emphasized. Therapeutic components, such
as mindfulness techniques (e.g. mindful eating, body scan), the concept of acceptance, and coping
with seizure-related disturbances (i.e. auras and postictal physical and psychological reactions) were
included. Participants had experiential, progressive training on mindfulness techniques during ses-
sions.
No direct intervention was provided in the SS group. It was designed to create a supportive atmosphere
for sharing of illness experiences and self-help strategies with the same contact hours (10 hours) and
format as the MT group
Outcomes QOLIE-31-P, BAI, BDI, seizure frequency, SSQ
Time points measured:
1) Baseline (6 weeks before intervention)
2) Follow-up (6 weeks after the intervention)
Tang 2015 
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Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomization was used. No evidence to suggest selection bias
Allocation concealment
(selection bias)






High risk All participants were told that they were provided 'supportive treatment'; they
were not aware of the experimental/control design of the study. Investigator
who led the group was not blinded to group assignment
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 1 participant in the SS group withdrew. No evidence to suggest attrition bias
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias Low risk Low risk for selective recruitment and the training component of treatment
competence. Unclear risk for treatment fidelity and competence in delivering





Methods Unblinded, controlled trial comparing a home-based depression intervention (UPLIFT) to WLC in adults
with epilepsy and symptoms of depression. The study aimed to explore the efficacy of UPLIFT in reduc-
ing depression, increasing knowledge, skills, and self-efficacy, and improving quality of life. Outcome
measures were obtained at baseline, interim (8 weeks after intervention, postintervention time point
for UPLIFT), and post-test (16 weeks after intervention, postintervention time point for WLC; repeated
measure for UPLIFT)
Participants Inclusion criteria: adults diagnosed with epilepsy for > 1 year, had depressive symptoms as indicated by
a score of > 13 on the CES-D, but not severe depression (< 38 on CES-D), who were English-speaking and
willing to be audio-taped
Exclusion criteria: active suicidal ideation and cognitive impairment (i.e. ≤ 20 on the telephone MMSE)
53 adults were enrolled. 26 and 27 were allocated to the UPLIFT and WLC, respectively. The mean/me-
dian age was 36.4/34.0 years in UPLIFT and 35.4/31.0 in WLC. 20 (UPLIFT) and 23 (WLC) were women. 13
participants in UPLIFT and 19 in WLC had a seizure in the 4 weeks prior to enrollment. 10 participants
in UPLIFT and 9 in TAU had a major depressive disorder with mean/median CES-D scores of 25.7/24.5 in
UPLIFT and 27.33/30.0 in WLC
Recruitment and screening were coordinated by the physicians and nurses at the participating hos-
pital-based epilepsy clinic (names of the specific clinic was not provided in the publication) from
Thompson 2010 
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June 2007 to November 2008. Funding was made possible by Cooperative Agreement U48 DP 000043
through the Emory Prevention Research Center, from the Centers for Disease Control and Prevention
(CDC). There was no statement regarding potential conflicts of interest in the publication.
Interventions Intervention was delivered either by telephone or web in group-conferencing format, with weekly 1-
hour sessions for 8 consecutive weeks. The UPLIFT acronym refers to both mindfulness (using practice)
and CBT (learning to increase favorable thoughts) which formed the basis of the intervention materials.
The telephone and web intervention contained the same elements and structure. Each session includ-
ed a check-in, instruction, skill-building, and discussion, with homework between sessions that was
reviewed in the next session. Therapeutic components included knowledge about depression, epilep-
sy, CBT, mindfulness, and skills related to CBT and mindfulness. Participation in the sessions involved
skills practice, discussion, and group exercises based on session’s main topics. CBT-related topics in-
cluded thought monitoring, identifying cognitive distortions, self-esteem, problem identification, goal-
setting, and identifying supports. Relaxation exercises, including a body scan and progressive muscle
relaxation, were used for coping and to facilitate awareness of the body. Mindfulness activities consist-
ed of attention to breath, sights, and sounds, and other meditations
All sessions were co-facilitated by a layperson with epilepsy and a student research assistant in the
Master of Public Health program, supervised by a licensed clinical psychologist
Outcomes mBDI, BDI, PHQ-9, knowledge and skills, DCSES, SWLS, BRFSS, SCS
Time points measured:
1) Baseline (0 week, baseline)
2) Interim (8 weeks postintervention for the first telephone and web UPLIFT)
3) Post-test (16 weeks postintervention for the first telephone and web UPLIFT and 8 weeks postinter-
vention for the WLC)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Detailed information on method of randomization was unavailable
Allocation concealment
(selection bias)





High risk Neither the participants nor the project staB were blinded to the group assign-
ment
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 13 persons lost from the study (3 attended 1 session; 10 attended none). The
authors did not provide details of the dropouts in each group (13/53 = 24.5%).
In addition, the number of participants in the telephone group (N = 13) and
web group (N = 12) participating in UPLIFT did not match the total number of
UPLIFT (N = 26) reported. Evidence of attrition bias noted for this short-term
intervention
Thompson 2010  (Continued)
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Selective reporting (re-
porting bias)
High risk Outcome parameters were unavailable for the post-test time point, except BDI
and mBDI. Results of PHQ-9 and self-compassion were unavailable for all time
points. Evidence of selective reporting noted. Unpublished data were sought
but not provided
Other bias Low risk Low risk of bias for treatment infidelity as this was a web-based intervention.
Training background of personnel developing the UPLIFT intervention was rat-





Methods A randomized controlled study. The objective was to evaluate the efficacy of the Modular Education
Program for Children with Epilepsy and Their Parents on disease management
Participants Inclusion criteria:
aged between 7 and 18, had epilepsy for at least 6 months, having no mental deficiency, being literate,
agreeing to participate in the study
Exclusion criteria were not stated clearly
The records of the previous year were examined by the authors in order to reach the number of appro-
priate cases in the study, 100 children were identified who were followed in the Pediatric Neurology
Polyclinic for epilepsy without mental deficiencies. 50 were randomized into the experimental group
and 50 into the control group. After randomization, 8 families from the experimental group refused to
participate
Study conducted between January and June 2014. Participants were recruited from a pediatric neurol-
ogy polyclinic of a university hospital in Antalya, Turkey (Akdeniz University Hospital Pediatric Neurolo-
gy Polyclinic). This research was supported by the Akdeniz University Scientific Research Projects Man-
agement Unit. The authors declare no conflict of interest in this study.
Interventions The intervention has 8 modules, 4 for children (1. Knowledge about epilepsy, 2. Epilepsy and me, 3.
Seizure management and 4. Epilepsy and social life) and 4 for parents (1. Knowledge about epilepsy,
2. Epilepsy and my child, 3. Seizure management, and 4. Epilepsy and social life). The teaching materi-
als and methods used in the modules are as follows: slides, the Guide to Living with Epilepsy for Chil-
dren and Parents, videos (occurrence of epileptic seizure; management of seizure moments; manage-
ment of seizures at home, on vacation, at school; using medicine, and living with epilepsy), role play-
ing, demonstration and implementation of certain activities, brainstorming, discussion, question and
answer, drawing pictures, and narration. The modular education program was introduced to the chil-
dren and parents one-to-one in a quiet place. The modular education program was taught on week-
days with a total duration of 16 hours. All the children participating in this study and all the parents had
the same training, but each participant was interviewed separately. No training was given to the con-
trol group during the study, but in order to determine the effectiveness of the training, the same num-
ber of follow-ups was carried out in the control group
Outcomes Outcome measures for children:
EKTC, SSEC-C, QOLIE-48
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2) Post-test 1 (immediately after training)
3) Post-test 2 (1 month later)
4) Post-test 3 (3 months later)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk In a closed envelope, papers numbered from1 to 100 are placed. The child and
his/her parents who are interested in participating in the study are asked to
choose one of these numbers from the envelope. 1 - 50 children and their par-










High risk Neither the participants nor the project staB were blinded to the group assign-
ment
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk 8/50 families from the intervention group refused to participate after random-
ization; none withdrew from the control. No evidence to suggest attrition bias
re final dropout rate
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting






Methods Randomized, controlled trial comparing a self-management training program (Intervention) with a UC
control group in adults with epilepsy on epilepsy-related quality of life. Outcome measures were ob-
tained at baseline and 1 month after intervention
Participants Inclusion criteria: adults with epilepsy for at least 1 year, using antiseizure medication, had at least 1
seizure in the past year, able to read and write, were willing to participate
Exclusion criteria: conditions in which intensive care was needed, enrolled in other research studies,
were absent from each training session
60 participants (aged between 18 and 65) were recruited. 30 were randomly assigned to each of inter-
vention and UC. 9/12/7/2 participants in intervention and 12/8/5/5 participants in UC were aged 18 to
25/26 to 35/36 to 45/46 to 65, respectively. 14 (intervention) and 15 (UC) were women. 2/1 participants
Yadegary 2015 
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in intervention and 28/29 in UC had focal seizures/generalized seizures. 17 participants had a seizure
in the last month in both groups. 20/10 participants in intervention and 23/7 participants in UC had
monotherapy/polytherapy
The study took place in a teaching hospital in Zanjan, Iran. The dates when the study was conducted
were not stated.
Interventions The intervention was delivered in group format (5 to 6 participants per group) with 4 x 2-hour sessions
within 1 month. Participants were phoned before every session to encourage them to attend. The in-
tervention materials consisted of 2 parts. The first part (1st session) included medical aspects of epilep-
sy, e.g. definition of epilepsy, description of seizures, types of seizures, observation and classification
of its causes, and diagnosis of epilepsy. Participants also received instructional booklet with the con-
tent. The second part (2nd to 4th session) was designed to promote self-management; details included
medication management, information management, safety management, lifestyle management, and
seizure management. All materials were presented using PowerPoint presentations
The UC control group received only the routine clinical care, and were contacted through 2 short phone




2) 1 month after intervention
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A table of random numbers was used. No evidence to suggest selection bias
Allocation concealment
(selection bias)





High risk Insufficient information was provided
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk Insufficient information was provided
Selective reporting (re-
porting bias)
Low risk No evidence to suggest selective reporting
Other bias Unclear risk Unclear risk for selective recruitment, treatment fidelity and all dimensions of
treatment competence
Yadegary 2015  (Continued)
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ACT: acceptance and commitment therapy; AE: adverse event; AED: anti-epilepsy drug; AEP: Adverse Events Profile; ARNP: advanced
registered nurse practitioner; ASI: ASM: anti-seizure medication; BDI: Beck Depression inventory; B-IPQ: brief illness reports questionnaire;
BMW: beliefs about medication questionnaire; BPRS: brief psychiatric rating scale; BRFSS: behavioral risk factor surveillance system;
CBI: cognitive behavioral intervention; CBT: cognitive behavioral therapy; CD-RISC: Connor-Davidson resilience scale; CDI-S: children's
depression inventory - short; CEQOL: childhood epilepsy quality of life; CES-D: Centers for Epidemiological Studies - depression; CHI-
ESQ: Commission for Health improvement - experience of service questionnaire; DASS-21: depression and anxiety stress scale; EEG:
electroencephalography; EKP-G: epilepsy knowledge profile - general; EKSP: epilepsy knowledge scale for parents; EKTC: epilepsy
knowledge test for children; ELDQOL-SSS: epilepsy and learning disability quality of life - seizure severity scale; EN: epilepsy nurse; EQAO:
education, quality and accountability oBice; ESES: epilepsy self-eBicacy scale; ESI-R: revised epilepsy stress inventory; ESMS: epilepsy
self-management scale; ESS: epilepsy stigma scale; GAD: generalized anxiety disorder; GAF: global assessment functioning; GEOS-YP:
Glasgow epilepsy outcome scale for young people; GSES: generic self-eBicacy scale; HADS: hospital anxiety and depression scale; HAMS:
Hamilton anxiety rating scale.;SCL: Hopkins symptom checklist; ID: intellectual disability; ILAE: International League Against Epilepsy; ISMI:
internalized stigma of mental illness scale; ITT: intention-to-treat; LOC: loss of consciousness; LOCS: locus of control scale; LSSS: Liverpool
seizure severity scale; MADRS: Montgomery Asberg depression rating scale; MAS: medication adherence scale; MCMI: Millon clinical
multiaxial inventory; MINI: mini international neuropsychiatric interviews scale; MMAS: Moriskey medication adherence scale; MOCA:
Montreal cognitive assessment; MDD: major depressive disorder; MQOLI: Malay quality of life in epilepsy; MS: multiple sclerosis; MSPSS:
multidimensional scale of perceived social support; NDDI-E: neurological depressive disorders inventory - epilepsy; NHE: negative health
event; NHS3: national hospital seizure severity scale; PA: Physical Activity; PAASS: parents anxiety about seizure scale; PEDsQL: pediatric
quality of life; PBC: perceived behavioral control; PESOS: performance, sociodemographic aspects, subjective estimation; PHQ: patient
health questionnaire; PI-ED: pediatric index - emotional distress; PHQ: patient health questionnaire; PST: problem-solving treatment; PSQI:
Pittsburgh sleep quality index; PSS: perceived stress scale; PWE: people with epilepsy; QIDS: quick inventory of depressive symptoms;
QoL: quality of life; QOLIE: quality of life in epilepsy; SCS: self-compassion scale; SDT: self-determination theory; SIDAED: side eBects
of anti-epileptic drugs; SRBAI: self- index; reported behavioral automaticity index; SSEC-C: seizure self-eBicacy scale for children; SSQ:
seizure severity questionnaire; SSRIs: selective seratonin uptake inhibitors; ST: supportive therapy; SWLS: satisfaction with life scale; TAU:
treatment as usual; TLE: temporal lobe epilepsy; UC: usual care; UPCC: Utrecht proactive coping confidence; WHO-DAS: World Health
Organization disability assessment schedule; WHOQOL-BREF: World Health Organization quality of life - brief; WIAT: Weschsler individual
achievement test; WLC: wait-list control; WPSI: Washington psychosocial seizure inventory; WSAS: work and social adjustment scale;
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Albert 2019 No HRQOL outcome measures
Aliasgharpour 2013 No HRQOL outcome measures
Cazares 2017 No HRQOL outcome measures
Chadi 2018 No HRQOL outcome measures
Dahl 1985 No HRQOL outcome measures
Dash 2015 No HRQOL outcome measures
Davis 1984 No HRQOL outcome measures
DiIorio 2009 No HRQOL outcome measures
Eshiet 2019 No HRQOL outcome measures
Helgeson 1990 No HRQOL outcome measures
Li 2016 No HRQOL outcome measures
McLaughlin 2011 No HRQOL outcome measures
Mills 1999 No HRQOL outcome measures
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Study Reason for exclusion
Modi 2016b No HRQOL outcome measures
Modi 2016c No HRQOL outcome measures
Mohamadpour 2017 No HRQOL outcome measures
Olley 2001 No HRQOL outcome measures
Peterson 1984 No HRQOL outcome measures
Pfäfflin 2012 No HRQOL outcome measures
Ridsdale 2000 No HRQOL outcome measures
Tajrishi 2015 No HRQOL outcome measures
Tan 1986 No HRQOL outcome measures
Thompson 2015 No HRQOL outcome measures
Yoo 2015 No HRQOL outcome measures
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Guided self-help interventions for mental health disorders in children with neurological conditions:
study protocol for a pilot randomized controlled trial
Methods A pilot randomized controlled trial will be conducted. Participants will be randomized to receive
guided self-help for common mental health disorders or to a 12-week wait-list control. The wait-list
control group will receive the intervention after a waiting period of 12 weeks
Participants 18 patients with neurological conditions and mental health disorders attending specialist neurolo-
gy clinics at a National UK Children's Hospital. Exclusion criteria are limited to those at significant
risk of harm to self or others, the presence of a primary mental health disorder other than anxiety,
depression or disruptive behavior (e.g. psychosis, eating disorder, obsessive-compulsive disorder)
or intellectual disability at a level meaning potential participants would be unable to access the in-
tervention
Interventions Participants in the treatment group will receive 10 sessions of guided self-help delivered over the
telephone
Outcomes The primary outcome measure is reduction in symptoms of mental health disorders
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Study name A home-based, primary-care model for epilepsy care in India: Basis and design
Methods A randomized trial aims to determine whether treatment adherence to antiepileptic drugs is better
with home-based care or with routine clinic-based care. The secondary aims are to compare the ef-
fects of the 2 care pathways on seizure control and quality of life
Participants The estimated number of participants in each arm was 91; to make up an anticipated attrition rate
of 30%, the total number of recruitment will be 240. People over 1-year-old with active epilepsy
were invited to enroll in the trial regardless of prior treatment status. People with febrile seizures,
neonatal seizures, single seizures not fulfilling the current operational definition for epilepsy, and
acute symptomatic seizures associated with head injury, stroke, and toxic, metabolic, and acute
infective conditions were excluded. Participants will be randomized into either 'clinic-based' or
'home-based' arm by a computer-generated, simple randomization scheme
Interventions Clinic-based arm: (n = 120, age range 1 - 80) are asked to attend monthly clinics at the Government
District Hospital for review visits and drug dispensing
Home-based arm: (n = 120, age range 1 - 67) receive an interventional package comprising the fol-
lowing: a) delivery of AEDs, b) education and counseling about self-management, social function-
ing, and stigma abrogation, c) adherence monitoring; all provided at home on a monthly basis by
study personnel with qualification equivalent to ANMs. During the first home visit, the study pur-
pose is explained, and information about drugs, including frequency and timings of drug-taking,
are provided. A comprehensive brochure, a seizure diary, and prescription record are also supplied.
During subsequent monthly visits, study personnel hold continued discussions regarding self-man-
agement; impart psychosocial education about schooling, marriage, and employment; inquire
about medication side-effects; verify seizure diaries; and supply the scheduled stock of AEDs
Outcomes Primary outcome: adherence, appraised at monthly intervals by pill counts and vernacular version
of the SRMS and BMQ
Secondary outcomes: quality of life appraisal by the PIES scale and several seizure-related parame-
ters including monthly seizure frequency, time to first seizure (in days) after enrollment, and pro-
portion of participants experiencing seizure freedom for the duration of study
Starting date Starting on 07 December 2017; the duration of the trial will be for 24 months
Contact information Dr. Josemir W. Sander, Department of Clinical & Experimental Epilepsy. Email: l.sander@ucl.ac.uk
Notes  
Singh 2019 




D A T A   A N D   A N A L Y S E S
 
Comparison 1.   QOLIE-31- Comparison of mean change from baseline





Statistical method Effect size
1.1 QOLIE-31- total score 11 643 Mean Difference (IV, Random, 95% CI) 5.23 [3.02, 7.44]
1.2 QOLIE-31 - overall QoL subscale 10 639 Mean Difference (IV, Random, 95% CI) 5.95 [3.05, 8.85]
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Statistical method Effect size
1.3 QOLIE-31 - energy and fatigue
subscale
10 642 Mean Difference (IV, Random, 95% CI) 5.25 [1.56, 8.93]
1.4 QOLIE-31 - emotional well-being
subscale
10 643 Mean Difference (IV, Random, 95% CI) 4.96 [0.70, 9.21]
1.5 QOLIE-31 - seizure worry subscale 10 632 Mean Difference (IV, Random, 95% CI) 4.35 [1.35, 7.35]
1.6 QOLIE-31 - cognitive functioning
subscale
10 641 Mean Difference (IV, Random, 95% CI) 4.18 [1.82, 6.54]
1.7 QOLIE-31 - medication effects
subscale
10 643 Mean Difference (IV, Random, 95% CI) 3.16 [0.01, 6.32]
1.8 QOLIE-31 - social function sub-
scale
10 630 Mean Difference (IV, Random, 95% CI) 3.09 [-0.17, 6.35]
 
 














Heterogeneity: Tau² = 5.32; Chi² = 16.89, df = 10 (P = 0.08); I² = 41%
Test for overall effect: Z = 4.64 (P < 0.00001)



























































































IV, Random, 95% CI
11.32 [4.30 , 18.34]
6.60 [-0.11 , 13.31]
4.40 [-1.76 , 10.56]
7.11 [2.97 , 11.25]
3.59 [-2.40 , 9.58]
-0.29 [-6.87 , 6.29]
0.64 [-3.79 , 5.07]
6.03 [1.83 , 10.23]
12.96 [5.88 , 20.04]
9.11 [-8.02 , 26.24]
3.32 [-0.32 , 6.96]
5.23 [3.02 , 7.44]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours UC or SC Favours psychological tx
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Analysis 1.2.   Comparison 1: QOLIE-31- Comparison of mean













Heterogeneity: Tau² = 7.62; Chi² = 14.23, df = 9 (P = 0.11); I² = 37%
Test for overall effect: Z = 4.02 (P < 0.0001)




















































































IV, Random, 95% CI
15.46 [5.15 , 25.77]
8.20 [-0.38 , 16.78]
3.62 [-4.80 , 12.04]
10.06 [3.55 , 16.57]
0.91 [-6.48 , 8.30]
2.97 [-4.65 , 10.59]
-0.80 [-7.07 , 5.47]
5.89 [0.53 , 11.25]
16.82 [-0.76 , 34.40]
7.75 [3.11 , 12.39]
5.95 [3.05 , 8.85]
Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours UC or SC Favours psychological tx
 
 
Analysis 1.3.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 15.97; Chi² = 17.16, df = 9 (P = 0.05); I² = 48%
Test for overall effect: Z = 2.79 (P = 0.005)




















































































IV, Random, 95% CI
10.97 [1.49 , 20.45]
10.00 [0.20 , 19.80]
2.65 [-5.96 , 11.26]
13.24 [5.99 , 20.49]
8.55 [-0.12 , 17.22]
-6.02 [-14.74 , 2.70]
0.07 [-7.18 , 7.32]
2.43 [-5.06 , 9.92]
11.87 [-9.82 , 33.56]
4.84 [-0.72 , 10.40]
5.25 [1.56 , 8.93]
Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours UC or SC Favours psychological tx
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Analysis 1.4.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 28.59; Chi² = 26.14, df = 9 (P = 0.002); I² = 66%
Test for overall effect: Z = 2.28 (P = 0.02)




















































































IV, Random, 95% CI
17.73 [7.86 , 27.60]
10.90 [-0.23 , 22.03]
11.93 [3.14 , 20.72]
8.67 [3.52 , 13.82]
8.04 [-0.52 , 16.60]
-5.02 [-13.04 , 3.00]
0.32 [-6.08 , 6.72]
-0.30 [-6.82 , 6.22]
0.57 [-19.37 , 20.51]
-0.30 [-5.94 , 5.34]
4.96 [0.70 , 9.21]
Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours UC or SC Favours psychological tx
 
 
Analysis 1.5.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 0.43; Chi² = 9.16, df = 9 (P = 0.42); I² = 2%
Test for overall effect: Z = 2.84 (P = 0.005)




















































































IV, Random, 95% CI
11.51 [-9.83 , 32.85]
9.70 [-0.00 , 19.40]
5.64 [-7.06 , 18.34]
5.54 [-0.46 , 11.54]
5.82 [-6.57 , 18.21]
-6.14 [-15.30 , 3.02]
1.68 [-6.27 , 9.63]
3.80 [-3.58 , 11.18]
22.60 [-6.22 , 51.42]
6.72 [-1.95 , 15.39]
4.35 [1.35 , 7.35]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours UC or SC Favours psychological tx
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Analysis 1.6.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 0.00; Chi² = 6.45, df = 9 (P = 0.69); I² = 0%
Test for overall effect: Z = 3.48 (P = 0.0005)




















































































IV, Random, 95% CI
10.52 [-2.15 , 23.19]
2.80 [-5.79 , 11.39]
2.05 [-6.50 , 10.60]
3.68 [-2.16 , 9.52]
1.48 [-7.63 , 10.59]
2.99 [-4.97 , 10.95]
1.02 [-4.46 , 6.50]
9.06 [3.73 , 14.39]
9.17 [-12.62 , 30.96]
4.05 [-3.27 , 11.37]
4.18 [1.82 , 6.54]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours UC or SC Favours psychological tx
 
 
Analysis 1.7.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 0.00; Chi² = 7.21, df = 9 (P = 0.62); I² = 0%
Test for overall effect: Z = 1.96 (P = 0.05)




















































































IV, Random, 95% CI
9.62 [-8.86 , 28.10]
11.00 [-4.31 , 26.31]
7.36 [-4.26 , 18.98]
9.04 [-0.54 , 18.62]
-2.58 [-13.11 , 7.95]
-5.23 [-16.79 , 6.33]
3.38 [-4.93 , 11.69]
3.83 [-4.59 , 12.25]
-7.29 [-38.30 , 23.72]
1.96 [-3.95 , 7.87]
3.16 [0.01 , 6.32]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours UC or SC Favours psychological tx
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Analysis 1.8.   Comparison 1: QOLIE-31- Comparison of mean change













Heterogeneity: Tau² = 0.00; Chi² = 6.58, df = 9 (P = 0.68); I² = 0%
Test for overall effect: Z = 1.86 (P = 0.06)




















































































IV, Random, 95% CI
9.76 [-6.90 , 26.42]
3.90 [-7.25 , 15.05]
2.67 [-13.06 , 18.40]
4.94 [-3.10 , 12.98]
2.16 [-8.47 , 12.79]
-4.02 [-13.58 , 5.54]
0.91 [-7.34 , 9.16]
10.36 [1.82 , 18.90]
5.80 [-24.30 , 35.90]
-0.01 [-8.58 , 8.56]
3.09 [-0.17 , 6.35]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours UC or SC Favours psychological tx
 
 
A D D I T I O N A L   T A B L E S
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Clinic Group 8 weekly 2-hour
sessions
N = 17 adults with at














Individual 8 50-min in-
home sessions
















Clinic Individual 1 x 1- to 2-hour
assessment ses-
sion + 8 weekly
1-hour sessions

















per week for 16
weeks
N = 98 adults (age 21 -




























Group 8 weekly 1-hour
sessions
N = 55 adults with
epilepsy and depressive
symptoms








































































































































thinking + behavioral acti-
vation












Individual 5 modules with
no fixed se-
quence, each
lasting for 60 -
180 min
N 154 adult (> 18) with











Clinic Group 12 weekly 90-
min sessions
N = 15 adults with







Individual 9 weekly mod-




























Group 8 weekly 1-hour
sessions
N = 53 adults with
epilepsy and depression







and sleep hygiene, cop-
ing strategies and prob-
lem-solving techniques








Clinic Group 6 weekly 120-
min sessions
N = 69 children and ado-

















Clinic Group 8 weekly 75-
min sessions
N = 83 adults with
epilepsy





















































































































































Clinic Group 5 weekly 2-hour
sessions fol-




N = 87 adults with







ercises (with focus on cop-
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and epilepsy), stress man-










Clinic Group 12 weekly 60- to
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N = 111 adults with at
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NR Clinic Group 4 weekly 120-
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Clinic Group 5 sessions in 20
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N = 56 adults with
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Clinic Individual 3 weekly 40- to
60-min sessions














min sessions + 2
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sessions + 2 x
1-hour boost-
ers at 6 and 12
months
N = 27 (Lundgren 2006)
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Clinic Group 6 weekly 2-hour
sessions
N = 55 adults with
epilepsy
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oped based on the self-de-
termination theory (man-
aging epilepsy and medical
care; socializing on a bud-
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Clinic Group 2-day course
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Individual 11 weekly mod-
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Clinic Group 2-day course
(14 hours)
N = 383 adolescents and
adults with epilepsy
























































































































































Clinic Individual Delivery during
routine visits













NR Clinic Group 2-day course
(14 h)



















Clinic Group 2-day course
(16 h)
N = 314 adolescents (≥



















and social aspects of epilep-
sy
NR Clinic Individual 2 - 3 days with
a total of 16
hours
N = 92 including children
with epilepsy aged 7 -
18; and parents of chil-
dren with epilepsy
Table 1.   Intervention methods, strategies, and treatment goals  (Continued)














Time points measured  
















































































































































CDI-Sa,d NA NA Physical activitya 1) baseline

















































































2) 8-week interim assessment 3) 16-week (postin-
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BDIa,c NA NA NA 1) baseline  
























































































































































SWLSdBDIa,c NA NA DCSES, SCS, knowl-



































NA NA NA CD-RISC (ns),
MMAS-8 (ns)
1) baseline























































































































































































































QOLIE-48cNA NA NA SSES-Cc, EKTCc 1) baseline (pretest),




Table 2.   E;ects of interventions  (Continued)
aprimary outcome measure(s) in study.
bincluded in meta-analysis.
Interpretation of post-intervention outcomes
cSignificant improvement in treatment group when comparing post-intervention outcomes of treatment and control group.
dNo significant diBerence between treatment and control group at postintervention based on mean comparisons.
NA: not applicable
ns - Not specified, with no information in the publication suggesting significant diBerence between treatment and control group at post-intervention based on mean comparisons
Outcome Measures
BAI - Beck Anxiety Inventory; BDI or BDI II - Beck Depression Inventory or Beck Depression Inventory II; B-IPQ - Brief - Illness Representations Questionnaire; BPRS - Brief Psychiatric
Rating Scale; BRFSS - Behavioral Risk Factor Surveillance System; CES-D - Center for Epidemiological Study on Depression scale; CDI-S - Children's Depression Inventory - Short;
CD-RISC - Connor-Davidson Resilience Scale; CHEQOL - Childhood Epilepsy Quality of Life scale; DASS21 - Depression Anxiety Stress Scale-21; DISABKIDS - Modular HRQOL
questionnaire; DCSES - Depression Coping Self-EBicacy Scale; EKP-G - Epilepsy Knowledge Profile-General; EKTC - Epilepsy Knowledge Test for Children; ELDQoL-SSS - Epilepsy
and Learning Disabilities Quality of Life Seizure Severity Scale; ESES - Epilepsy Self-EBicacy Scale; ESMS - Epilepsy Self-Management Scale; ESS - 10-item Epilepsy Stigma Scale;
ESI-R - Revised Epilepsy Stressor Inventory; GAD-7 - Generalized Anxiety Disorder-7; GAF - Global Assessment of Functioning; GEOS-YP - Glasgow Epilepsy Outcome Scale for
Young Persons; GSES - General Self-EBicacy Scale; HADS - Hospital Anxiety Depression Scale; HAMD - Hamilton Depression Scale; ISMI - Internalized Stigma of Mental Illness




































































































































and psychosocial consequences of epilepsy); LOC - Locus of Control Scale; LSSS - Liverpool Seizure Severity Scale; MADRS - Montgomery-Asbery Depression Rating Scale; MARS
- Medication Adherence Report Scale; MAS - Medication Adherence Scale; MEMS - Medication Event Monitoring System; mBDI - Modified Beck Depression Inventory; MCMI-III -
Millon Clinical Multiaxial Inventory-III; MINI - Mini International Neuropsychiatric Interview; MMAS-8 - Morisky Medication Adherence Scale (MMAS-8); MQOLIE-30 - Malay Quality
of Life Inventory in Epilepsy-30; MSPSS - Multidimensional Scale of Perceived Social Support; NDDI-E - Neurological Depressive Disorders Inventory-Epilepsy; NHS3 - National
Hospital Seizure Severity Scale; PedsQL - Paediatric Quality of Life Inventory PedsQL™; PHQ-9 - Patient Health Questionnaire-9; PI-ED - Paediatric Index of Emotional Distress;
PSQI - Pittsburgh Sleep Quality Index; PSS - Perceived Stress Scale; QOLIE-31, QOLIE-31-P, QOLIE-89 - Quality of Life in Epilepsy-31, Patient-weighted Quality of Life in Epilepsy-31,
Quality of Life in Epilepsy-89; SCS - Self-compassion Scale; SF12-PCS - Short-Form 12 Physical Health Score; SF12-MCS - Short Form 12 Mental Health Score; SF-36 - Short-Form 36;
(PCS - physical health score, MCS - mental health score); SIDAED - Side-eBects of Antiepileptic Drugs; SSEC-C - Seizure Self EBicacy Scale for Children; SSI - Seizure Severity Index;
SWLS - Satisfaction with Life Scale; UPCC - Utrecht Proactive Coping Competence; VAS scale (Helde 2005) - General satisfaction with the follow-up by the Neurological Clinic during
the last 2 years; WHODASII - World Health Organization Disability Assessment Schedule II; WHOQOL-BREF - World Health Organization Quality of Life instrument, short version;
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A P P E N D I C E S
Appendix 1. Cochrane Register of Studies (CRS Web) search strategy
1. MeSH DESCRIPTOR Neuropsychology Explode All AND CENTRAL:TARGET
2. MeSH DESCRIPTOR Rehabilitation Explode All AND CENTRAL:TARGET
3. MeSH DESCRIPTOR Mind-Body Therapies Explode All AND CENTRAL:TARGET
4. MeSH DESCRIPTOR Psychotherapy Explode All AND CENTRAL:TARGET
5. MeSH DESCRIPTOR Psychology, Applied Explode All AND CENTRAL:TARGET
6. #1 OR #2 OR #3 OR #4 OR #5 AND CENTRAL:TARGET
7. abreaction OR aromatherap* OR "behav* modification" OR bibliotherap* OR biofeedback OR catharsis OR conditioning OR counseling
OR counselling OR "crisis intervention" OR desensitisation OR desensitization OR "early intervention" OR "emotional freedom tapping" OR
("eye movement" NEAR2 (desensitisation OR desensitization OR reprocessing)) OR (feedback NEAR1 (psycholog* OR sensory)) OR flooding
OR "free association" OR hypnosis OR hypnotherapy OR imagery OR logotherapy OR meditation OR mindfulness OR "post traumatic stress"
OR PTSD OR psychodrama OR psychotherap* OR "residential treatment*" OR "rewind technique*" OR "stress manag*" OR "transactional
analysis" OR "thought restructur*" AND CENTRAL:TARGET
8. ((acceptance NEAR2 commitment) OR (adherence NOT "non-adherence") OR anxiety OR art OR assertive OR autogenic OR
autosuggestion OR aversive OR behav* OR "client cent*" OR cognitive OR color OR colour OR compassion* OR coping OR couples OR dance
OR depression OR directive OR exercise OR family OR gestalt OR "human givens" OR humanistic OR implosive OR interpersonal OR language
OR marital OR massage OR memory OR mentalisation OR mentalization OR music OR narrative OR nondirective OR "non-directive" OR
nonpharmacol* OR "non-pharmacol*") NEAR2 (therap* OR treatment* OR train* OR retrain* OR rehabilitat* OR adapt* OR intervention*
OR manag*) AND CENTRAL:TARGET
9. (panic OR "patient cent*" OR psycho* OR "quality of life" OR QOL OR "rational emotive" OR relaxation OR self* OR socioenvironmental
OR "socio-environmental" OR stigma OR systemic OR systems OR "therapeutic community" OR trauma) NEAR2 (therap* OR treatment* OR
train* OR retrain* OR rehabilitat* OR adapt* OR intervention* OR manag*) AND CENTRAL:TARGET
10. (adjustment OR attention OR confidence OR "day to day" OR loss OR physical OR reality OR suggestion) NEAR1 (therap* OR treatment*
OR train* OR retrain* OR rehabilitat* OR adapt* OR intervention* OR manag*) AND CENTRAL:TARGET
11. #6 OR #7 OR #8 OR #9 OR #10 AND CENTRAL:TARGET
12. (nonepileptic OR "non-epileptic"):TI AND CENTRAL:TARGET
13. #11 NOT #12 AND CENTRAL:TARGET
14. MESH DESCRIPTOR Epilepsy EXPLODE ALL AND CENTRAL:TARGET
15. MESH DESCRIPTOR Seizures EXPLODE ALL AND CENTRAL:TARGET
16. epilep*:AB,KW,MC,MH,TI AND CENTRAL:TARGET
17. #14 OR #15 OR #16
18. #13 AND #17
Appendix 2. MEDLINE search strategy
This strategy includes the Cochrane Highly Sensitive Search Strategy for identifying randomized trials (Lefebvre 2019).
1. exp Neuropsychology/ or exp Rehabilitation/ or exp Mind-Body Therapies/ or exp psychotherapy/ or exp Psychology, Applied/
2. (abreaction or aromatherap* or "behav* modification" or bibliotherap* or biofeedback or catharsis or conditioning or counsel?ing or
"crisis intervention" or desensiti?ation or "early intervention" or "emotional freedom tapping" or ("eye movement" adj2 (desensiti?ation
or reprocessing)) or (feedback adj1 (psycholog* or sensory)) or flooding or "free association" or hypnosis or hypnotherapy or imagery or
logotherapy or meditation or mindfulness or "post traumatic stress" or PTSD or psychodrama or psychotherap* or "residential treatment?"
or "rewind technique?" or "stress manag*" or "transactional analysis" or "thought restructur*").tw.
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3. (((acceptance adj2 commitment) or (adherence not "non-adherence") or anxiety or art or assertive or autogenic or autosuggestion or
aversive or behav* or "client cent*" or cognitive or colo?r or compassion* or coping or couples or dance or depression or directive or
exercise or family or gestalt or "human givens" or humanistic or implosive or interpersonal or language or marital or massage or memory or
mentali?ation or music or narrative or nondirective or "non-directive" or nonpharmacol* or "non-pharmacol*") adj2 (therap* or treatment*
or train* or retrain* or rehabilitat* or adapt* or intervention* or manag*)).tw.
4. ((panic or "patient cent*" or psycho* or "quality of life" or QOL or "rational emotive" or relaxation or self* or socioenvironmental or
"socio-environmental" or stigma or systemic or systems or "therapeutic community" or trauma) adj2 (therap* or treatment* or train* or
retrain* or rehabilitat* or adapt* or intervention* or manag*)).tw.
5. ((adjustment or attention or confidence or "day to day" or loss or physical or reality or suggestion) adj1 (therap* or treatment* or train*
or retrain* or rehabilitat* or adapt* or intervention* or manag*)).tw.




10. 7 or 8 or 9
11. exp *Pre-Eclampsia/ or exp *Eclampsia/
12. 10 not 11
13. (nonepileptic or "non-epileptic").ti.
14. 6 and 12
15. 14 not 13
16. (randomized controlled trial or controlled clinical trial or pragmatic clinical trial).pt. or (randomi?ed or placebo or randomly).ab.
17. clinical trials as topic.sh.
18. trial.ti.
19. 16 or 17 or 18
20. exp animals/ not humans.sh.
21. 19 not 20
22. 15 and 21
23. remove duplicates from 22
Appendix 3. PsycINFO search strategy
S14 S3 AND S12 AND S13
S13 TI ( (randomiz* OR randomis* OR controlled OR placebo OR blind* OR unblind* OR "parallel group" OR crossover OR cross-over OR
cluster OR "head to head") N2 (analy* OR method OR procedure OR study OR studies OR trial) ) OR AB ( (randomiz* OR randomis* OR
controlled OR placebo OR blind* OR unblind* OR "parallel group" OR crossover OR cross-over OR cluster OR "head to head") N2 (analy*
OR method OR procedure OR study OR studies OR trial) )
S12 S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11
S11 (adjustment or attention or confidence or "day to day" or loss or reality or suggestion) W1 (therap* or treatment or train* or retrain*
or rehabilitat* or adapt* or intervention or manag*)
S10 (panic or "patient cent*" or psycho* or "quality of life" or QOL or rational-emotive or relaxation or self* or socioenvironmental or socio-
environmental or stigma or systemic or systems or "therapeutic community" or trauma) W2 (therap* or treatment or train* or retrain* or
rehabilitat* or adapt* or intervention or manag*)
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S9 ((acceptance W2 commitment) or (adherence not "non-adherence") or anxiety or art or assertive or autogenic or autosuggestion or
aversive or behav* or "client cent*" or cognitive or colo#r or compassion* or coping or couples or dance or depression or directive or
exercise or family or gestalt or "human givens" or humanistic or implosive or interpersonal or language or marital or massage or memory
or mentali#ation or music or narrative or nondirective or non-directive or nonpharmacol* or non-pharmacol*) W2 (therap* or treatment
or train* or retrain* or rehabilitat* or adapt* or intervention or manag*)
S8 abreaction or aromatherap* or "behav* modification" or bibliotherap* or biofeedback or catharsis or conditioning or counsel#ing or
"crisis intervention" or desensiti#ation or "early intervention" or "emotional freedom tapping" or ("eye movement" N2 (desensiti#ation
or reprocessing)) or (feedback N1 (psycholog* or sensory)) or flooding or "free association" or hypnosis or hypnotherapy or imagery or
logotherapy or meditation or mindfulness or "post traumatic stress" or PTSD or psychodrama or psychotherap* or "residential treatment#"
or "rewind technique#" or "stress manag*" or "transactional analysis" or "thought restructur*"
S7 MM "Mind Body Therapy" OR MM "Aromatherapy"
S6 MM "Rehabilitation" OR MM "Psychotherapeutic Techniques" OR MM "Active Listening" OR MM "Animal Assisted Therapy" OR MM
"Cotherapy" OR MM "Dream Analysis" OR MM "Empty Chair Technique" OR MM "Ericksonian Psychotherapy" OR MM "Mirroring" OR
MM "Morita Therapy" OR MM "Motivational Interviewing" OR MM "Mutual Storytelling Technique" OR MM "Network Therapy" OR MM
"Paradoxical Techniques" OR MM "Cognitive Rehabilitation" OR MM "Neuropsychological Rehabilitation" OR MM "Neurorehabilitation"
OR MM "Occupational Therapy" OR MM "Physical Therapy" OR MM "Psychosocial Rehabilitation" OR MM "Therapeutic Social Clubs" OR
MM "Vocational Rehabilitation" OR MM "Activities of Daily Living" OR MM "Adaptive Behavior" OR MM "Disability Management" OR MM
"Habilitation" OR MM "Independent Living Programs" OR MM "Intervention" OR MM "Crisis Intervention" OR MM "Early Intervention" OR
MM "Family Intervention" OR MM "Group Intervention" OR MM "School Based Intervention" OR MM "Rehabilitation Counseling" OR MM
"Self Care Skills" OR MM "Support Groups" OR MM "Twelve Step Programs"
S5 MM "Psychotherapy" OR MM "Adlerian Psychotherapy" OR MM "Adolescent Psychotherapy" OR MM "Analytical Psychotherapy" OR
MM "Autogenic Training" OR MM "Behavior Therapy" OR MM "Brief Psychotherapy" OR MM "Brief Relational Therapy" OR MM "Child
Psychotherapy" OR MM "Client Centered Therapy" OR MM "Cognitive Behavior Therapy" OR MM "Cognitive Therapy" OR MM "Conversion
Therapy" OR MM "Eclectic Psychotherapy" OR MM "Emotion Focused Therapy" OR MM "Existential Therapy" OR MM "Experiential
Psychotherapy" OR MM "Expressive Psychotherapy" OR MM "Eye Movement Desensitization Therapy" OR MM "Feminist Therapy" OR
MM "Geriatric Psychotherapy" OR MM "Gestalt Therapy" OR MM "Group Psychotherapy" OR MM "Guided Imagery" OR MM "Humanistic
Psychotherapy" OR MM "Hypnotherapy" OR MM "Individual Psychotherapy" OR MM "Insight Therapy" OR MM "Integrative Psychotherapy"
OR MM "Interpersonal Psychotherapy" OR MM "Logotherapy" OR MM "Narrative Therapy" OR MM "Network Therapy" OR MM "Persuasion
Therapy" OR MM "Primal Therapy" OR MM "Psychoanalysis" OR MM "Psychodrama" OR MM "Psychodynamic Psychotherapy" OR MM
"Psychotherapeutic Counseling" OR MM "Rational Emotive Behavior Therapy" OR MM "Reality Therapy" OR MM "Relationship Therapy"
OR MM "Solution Focused Therapy" OR MM "Supportive Psychotherapy" OR MM "Transactional Analysis"
S4 MM "Neuropsychology" OR MM "Health Care Psychology" OR MM "Medical Psychology"
S3 S1 OR S2
S2 epilep* OR seizure* OR convuls*
S1 MM "Epilepsy" OR MM "Epileptic Seizures" OR MM "Experimental Epilepsy" OR MM "Grand Mal Seizures" OR MM "Petit Mal Seizures"
OR MM "Status Epilepticus"
W H A T ' S   N E W
 
Date Event Description
12 August 2019 New search has been performed Searches updated 12 August 2019; we include 11 new studies.




H I S T O R Y
Protocol first published: Issue 2, 2016
Review first published: Issue 10, 2017
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Date Event Description
25 July 2018 Amended Minor edits have been made to the text.
 
C O N T R I B U T I O N S   O F   A U T H O R S
Rosa Michaelis: protocol, literature search, 'Risk of bias' assessment of studies, contacting authors for missing data, data analysis,
interpretation and presentation of results.
Venus Tang: protocol, literature search, 'Risk of bias' assessment of studies, contacting authors for missing data, data analysis,
interpretation and presentation of results.
Sarah Nevitt: data analysis, interpretation and presentation of results.
Janelle Wagner: review and modification of protocol, critical review of treatment methods, contacting authors for missing data,
interpretation and discussion of results.
Avani Modi: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
W. Curt LaFrance Jr: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
Laura Goldstein: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
Milena Gandy: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
Rebecca Bresnahan: critical review of manuscript, esp. compliance of interpretation, discussion and presentation of results with Cochrane
standards.
Kette Valente: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
Kirsten A Donald: review and modification of protocol, critical review of treatment methods, interpretation and discussion of results.
Markus Reuber: eligibility and 'Risk of bias' assessment of Tang 2015, review and modification of protocol, critical review of treatment
methods, interpretation and discussion of results.
D E C L A R A T I O N S   O F   I N T E R E S T
RM: Dr Michaelis receives funding from the internal grant program (project IFF 2020-28) of the Faculty of Health at Witten/Herdecke
University, Germany. Dr. Michaelis received a travel stipend from the ILAE to attend the 33rd International Epilepsy Congress in Bangkok
Thailand (June 2019), during which the Task Force had a one-day meeting also related to the discussion of this update.
VT: Dr Tang is the author of one of the primary studies included within this review. However, she does not receive any financial benefits
from this treatment program. Moreover, she was not responsible for the extraction of data of her study for this review. She received travel
stipends from the ILAE to attend the 31st International Epilepsy Congress in Istanbul Turkey (September 2015) and the 33rd International
Epilepsy Congress in Bangkok Thailand (June 2019), during which the Task Force had one-day meetings each related to the study.
SN: none known.
JW: Dr Wagner received travel stipends from the ILAE to attend the 31st International Epilepsy Congress in Istanbul Turkey (September
2015) and the 33rd International Epilepsy Congress in Bangkok Thailand (June 2019), during which the Task Force had one-day meetings
each related to the study.
AM: Dr Modi received research funding from NIH and was a consultant to Fish and Richardson regarding adherence to medications in adults
with multiple sclerosis. She received travel stipends from the ILAE to attend the 31st International Epilepsy Congress in Istanbul Turkey
(September 2015) and the 33rd International Epilepsy Congress in Bangkok Thailand (June 2019), during which the Task Force had one-
day meetings each related to the study.
WCL: Prof LaFrance works on this Cochrane project that addressed evidence-based interventions for epilepsy reviewed by the ILAE
committee. He received travel stipends from the ILAE to attend the 31st International Epilepsy Congress in Istanbul Turkey (September
2015) and the 33rd International Epilepsy Congress in Bangkok Thailand (June 2019), during which the Task Force had one-day meetings
each related to the study. Prof LaFrance receives author royalties for the seizure treatment book Taking Control of Your Seizures: Workbook,
Oxford University Press, 2015. He studies evidence-based non-pharmacological interventions for people with seizures that are ethics
committee-approved and peer-reviewed to address any potential bias.
LG: Prof Goldstein is co-author of one of the primary studies included within this review. However, she does not receive any financial
benefits from this treatment program. Moreover, she was not responsible for the extraction of data for this review. She has received
honoraria for speaking, and educational activities not funded by industry; she receives royalties from the publication of Clinical
Neuropsychology (Wiley, 2004, 2013) and The Clinical Psychologist's Handbook of Epilepsy Cull 1997. This work represents independent
research part-funded by the NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and
the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. The views expressed are those of the author, and not
necessarily those of the NHS, the NIHR or the Department of Health.
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MG: Dr Gandy is the author of one of the primary studies included within this review. However, she does not receive any financial benefits
from this treatment program. Moreover, she was not responsible for the extraction of data for this review. Dr Gandy received a travel stipend
from the ILAE to attend the 33rd International Epilepsy Congress in Bangkok Thailand (June 2019), during which the Task Force had a one-




MR: Prof Reuber is responsible for developing and supervising a team of psychotherapists working in a clinical neurology department and
provides treatment to people with epilepsy. He therefore has an interest in demonstrating the eBectiveness of psychotherapy. However,
this potential bias is outweighed by his interest in the development of evidence-based treatments, encouraging him to assess the existing
evidence as objectively and impartially as possible. He received a travel stipend from the ILAE to attend the 33rd International Epilepsy
Congress in Bangkok Thailand (June 2019), during which the Task Force had a one-day meeting also related to the discussion of this update.
S O U R C E S   O F   S U P P O R T
Internal sources
• No sources of support supplied
External sources
• National Institute for Health Research, UK
This review update was funded by the National Institute for Health Research (NIHR) [Clinically eBective treatments for central nervous
system disorders in the NHS, with a focus on Epilepsy and Movement Disorders (SRPG project 16/114/26)]. The views expressed are
those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
• International League Against Epilepsy, Other
Support for meetings of the Psychobehavioral Treatments for Epilepsy Task Force
• Mahle foundation, Germany
For supporting the fellowship and fellowship-related travels of Rosa Michaelis
• Integrated Curriculum Anthroposophical Medicine (ICURAM), Germany
For supporting the fellowship and fellowship-related travels of Rosa Michaelis
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We further clarified the assessment of attrition bias. During the process of assessing attrition bias, we used a cut-oB value of ≥ 15% attrition
for short-term interventions (< 6 months) and a cut-oB value of ≥ 20% attrition for long-term interventions (≥ 6 months).
We amended the section on assessment of heterogeneity. Since we considered many diverse treatment types with expected diBerences in
the designs and included populations for this review, and some level of heterogeneity was to be expected, we assumed Chi2 results with
P < 0.01, and I2 over 70% as cut-oBs for a degree of heterogeneity of concern.
We amended the section on assessment of reporting bias. Rather than only comparing the reported outcomes with the outcome measures
and points of measurements stated in the study methods to assess reporting bias within the publication, we also assessed reporting biases
by comparing the reported outcomes with the original study protocol or comparable documents. We added that funnel plots would be
examined where 10 or more studies were included in analyses of total QoL scores.
We amended the section on assessment of reporting bias by including the assessment of treatment infidelity, treatment competence
(i.e. the training background of the professionals who delivered the treatment, and the quality of treatment delivery), and selective
recruitment.
We amended the search strategy by limiting our search to publications in English. We were asked for this amendment by the British National
Guideline Centre whose review methodology diBers from Cochrane. We complied with their request because we support the consideration
of these review results by national epilepsy guidelines.
We amended our categorization of psychological interventions. While our previous categorization included five categories (psychological
interventions, self-management interventions, adherence interventions, educational interventions, mixed interventions), we have now
included all psychological interventions that are not only educational in a new category called 'skills-based psychological interventions'.
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Discussions within the International League Against Epilepsy Psychology Task Force and within the broader psychotherapy research
community concluded that it is reasonable and pragmatic to emphasize the commonalities between these psychological interventions
rather than overestimating their diBerences.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Bias;  Energy Metabolism;  Epilepsy  [*psychology]  [*therapy];  Fatigue  [therapy];  Psychotherapy;  Quality of Life;  Randomized
Controlled Trials as Topic
MeSH check words
Adolescent; Adult; Child; Humans; Young Adult
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